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CHAPTER I 
INTRODUCTION 
1.1 GENERAL 
Hydroxamic acids Q ) are compounds characterized by one or more 
oxidized amide bonds, i.e. the hydroxamic acid functions.1-5 
R1 ƒ12 
^ — N R'.R^H.alkyl.aryl 
О > 
н 
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The first synthesis of a hydroxamic acid was described in 1869 
by H. Lossen.6 He reported that the reaction between diethyloxalate 
and hydroxylamine yielded an acidic compound which he named oxalo-
hydroxamic acid : 
о о
 и ы о и
 ov ,ο но он 
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H j H J 
hydroxamic acid hydroximic acid 
At that time it was difficult to distinguish between the two 
possible structures 2 and 3. During the past four decades the 
development and application of spectroscopic methods made it 
possible to establish the structure of the hydroxamic acid firmly 
as 2. 
Since the isolation in 1944 of aspergillic acid^t? (see 2.3), 
the first example of a naturally occurring hydroxamic acid, a 
substantial number of natural products which contain one or more 
hydroxamic acid functions have been found, mainly from microbial 
sources.
2
·
3
 All these compounds belong invariably to the class of 
the so-called secondary metabolites. In general, secondary 
2 
metabolites are distinct from primary metabolites in that they are 
frequently of relatively complex structure; in addition their 
distribution is restricted and more characteristic of specific 
sources.
8
»9 Whereas there are no sharp lines delimiting either 
class of compounds, primary metabolites are nearly universal in 
their distribution; they are the products of, and participants in, 
the cellular activities of nearly all living organisms, from 
microorganisms to man. 
Several of the naturally occurring hydroxamic acids are 
derivatives of N-hydroxy-a-amino acids.2.3,4b,10-13 7^
е
 synthesis 
and possible applications of hydroxamic acids derived from 
N-hydroxy-a-amino acids, e.g. 5, will be the subject of this 
thesis. It has been postulated 1 4 that N-hydroxy-a-amino acids 13 
are intermediates in a pathway linking L-a-amino acids and several 
"uncommon" amino acids. It seems reasonable that a similar 
biogenetica! and/or chemical relationship holds for acylated 
α-amino acids and compounds containing unconrnon amino acid 
residues, hydroxamic acids 5 acting as crucial intermediates 
(scheme I ) . 
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This hypothesis is based on the following considerations. 
First, as has been demonstrated before1^, only the route 
depicted in scheme I links N-hydroxy-a-amino acid derivatives 5 with 
the other uncomnon amino acid derivatives 6-10 (see for comparison 
ref. 15-17). 
Second, it has been shown that N-hydroxylation of amino acids 
and amides (4 •* 5) is a familiar degradative pathway among the 
metabolic processes of many organisms. 1 8" 2 7 The reaction is not 
limited to plants and microorganisms as N-hydroxy peptides have been 
found likewise in human and animal tumors.28,29 у^
е m o s
t notorious 
example of N-hydroxylation concerns the activation of 2-acetylamino-
fluorene 12 (scheme II), a carcinogenic aromatic amide19»24,30. 
after sulfate conjugation30 the N-hydroxy-2-acetylaminofluorene is 
a potent arylating agent. 
Scheme II 
oso; 
~
1
 2 3 
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Thirdly, several of the organisms that produce fungal metabolites 
featuring the unconmon amino acid residues 7-10 also produce 
N-hydroxyamino acid-containing metabolites.2.3.31 Species belonging 
to the genus Penicillium10,32,33
>
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 strepto-
myces11.35,36
 a r e
 examples of such organisms. 
The demonstration of N-hydroxy-a-amino acids 13 as intermediates 
in metabolic pathways, which has not received much attention until 
recently, has been impeded by the instability of these compounds, 
by the lack of a general synthesis and proper analytical techniques, 
and by their occurrence in only minute quantities in biological 
material. The lability of these compounds is caused by the strongly 
reducing properties of the free hydroxylamine. Oxidation of this 
functionality gives the corresponding α-nitroso compound 14 as a 
primary product, which decarboxylates readily to aldoxime 15. 2 0 
(see scheme III). 
Scheme III 
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On the other hand, N-alkylated- and N-acylated derivatives (hydrox-
amic acids, e.g. 5) of N-hydroxy-a-amino acids are fairly stable 
and have been identified as building stones of natural 
products.2.3,37 
1.2 INTRODUCTION TO THE CHAPTERS 
In this thesis several aspects of the chemistry of hydroxamic 
acids derived from N-hydroxy-a-amino acids 13 come up for discussion. 
Some general information concerning the properties and biosynthesis 
of hydroxamic acids is given in the second chapter. Also some 
structures of representative examples of naturally occurring hydrox-
amie acids are presented. The possible application of simple chiral 
hydroxamic acids as ligands in asymmetric, metal-catalyzed reactions 
is discussed in chapter III. Chapter IV reviews the crucial advances 
in our understanding of penicillin biosynthesis during the past 
decade. Further this chapter sets out our efforts to verify the 
postulate that an N-hydroxy peptide might be Involved as an inter­
mediate in penicillin biosynthesis. Finally, the results of 
experiments involving a mild conversion of a-oximino acid derivatives 
into corresponding primary and secondary N-hydroxy-a-amino acid 
derivatives are evaluated in Chapter V. 
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CHAPTER II 
THE CHARACTERISTICS OF HYDROXAMIC ACIDS 
2.1 INTRODUCTION 
The intention of this chapter is to furnish some insight into 
the chemistry and biological properties of hydroxamic acids in 
general. Before going to naturally occurring hydroxamic acids some 
attention 1s payed to the chemistry of hydroxamic acids. This 
knowledge is indispensable for understanding their biological mode 
of action and for recognizing their potential applicability in 
organic synthesis. 
2.2 CHEMICAL PROPERTIES OF HYDROXAMIC ACIDS 
2.2.1 Acidity 
As mentioned in the first chapter the oxidized amide bond is the 
outstanding chemical feature of hydroxamic acids. This functional 
group Is a weak proton donor.1 Whereas there is some ambiguity in 
the current literature, whether primary hydroxamic acids 1_ act as 
NH- or 0H-ac1ds,la>2 substituted (secondary) hydroxamic acids 2 are 
obvious OH-acids. 
R H R1 R2 
^—N \— N R.R'.R^alkyl.aryl 
о "b о Ъ 
H H 
I 2 
primary secondary 
hydroxamic acid hydroxamic acid 
The pKa-values of primary hydroxamic acids 1_ v a r y 1 » · ^ between 7 
and 10; secondary hydroxamic acids exhibit 3· 5 a pKa-value of 
9 
approximately 11. Unfortunately, there are some discrepancies in 
the reported pKa-values, presumably brought about by differences in 
the experimental techniques used to determine the values. 1· 3" 5 
Schemel 
R1 R2 R' R2 
w -—- H' 
α .ο .α ,ο 
The planarity of the hydroxamic acid group and its bond lengths 
indicate partial N-C(O) double bond character as found in amides6 
(see scheme I). The existence of stable rotamers, as a result of 
hindered rotation about the N-C(O) bond, has been demonstrated.6·7 
Usually the hydroxamic acids exist in a planar c/sfZ^-configuration, 
which is stabilized by an intramolecular hydrogen bond. 6· 7 (scheme 
I). However, there are some exceptions.6·7 Kolasa7 investigated the 
conformational behaviour of some N-formyl- and N-acetyl-N-hydroxy-
α-amino acid esters by ^ -NMR and IR-spectroscopy. These compounds 
exist as a mixture of Z/E rotamers (see scheme II), the ratio of 
which depends on the solvent used and on the nature of the substi­
tuants R1 and R2. 
Scheme Π 
R' 
R2 A ^ O M e R2 P-H 
ρ R2=HorCH3 
ft, j* 0 o" 
Η 
R' OMe 
cis(Z) trans(E) 
The free enthalpy of activation (ΔΟ*) for this interconversion has 
been estimated at about 16 kcal mol"1, which is ca. 5 kcal mol - 1 
lower than AG* of the corresponding Interconversion in amides. 7· 8 
10 
2.2.2 Formation of metal complexes 
Hydroxamic acids form isolable alkali metal and silver 
s a l t s 9 - 1 1 · ^ and also stable complexes with a large number of 
transition metals.3,4,12-19 y^e ability of hydroxamic acids to 
dissociate allows for attachment of a metal ion to the bidentate 
anion, creating a stable five-membered ring (see scheme III). 
S c h e m e l l l 
R' R 2 R' R2 R' R2 
\ ' ·Μη* \ / \ /. 
}-\—^* Η -— Η 
ο Ρ о .о .о а 
н мі" ч* м
1
"-'!* 
Spectroscopic methods have shown that both oxygen atoms of the 
donor ligand are involved in chelation17; delocalization over the 
chelate ring results in significant double bond character of the 
C-N bond.lS'ifì A few years ago, however, the first case of 
coordination of the NOH" group via the nitrogen atom was reported19 
(see scheme IV). It concerns a square-planar nickel complex 3 with 
trans geometry. 
SchimelV 
οΎ γ VcAo 
н-
0
 "
 Η
 Α 
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If a molecule, besides a hydroxamic acid function, also contains a 
carboxyl group it can act as a terdentate ligand as was demonstrated 
for N-formyl-N-hydroxyglycine 4 (see scheme I V ) . 1 6 
Effective competition between protons and chelating cations 
makes complex-formation a pH-dependent process.1^,15,19b Binding 
occurs in a stepwise manner as the pH is raised. Complexes with the 
ferric ion are the best known; in this case (scheme V) the 1:1 
11 
structure formed at low pH is transformed into a 3:1 complex as the 
pH approaches neutrality.12 
Scheme V 
\ ^ 0 Χι "V*^· K 2 \ ¿ A , 
Г . F e 3 * , Ι Feim ^ Ι . 
/Ν-ο- ^ ' '"V 
Fe(m) ^ = ; I . Fedii) 
J 2 О J3 
Formation (or stability) constants can be defined for the Individual 
steps. 1 5· 2 0 The formation constant for the overall reaction is 
numerically equal to the product of the constants for the three 
constituent processes (K
s
 = K1.IC2.K3). The Intensely burgundy-
coloured ferric complexes 5 have very high complexatlon constants 
(K
s
 up to 1 0 2 8 ) ; three hydroxamate groups create a complex with an 
octahedral configuration. 1 2· 1 3 When the three hydroxamate functions 
are present in the same molecule, as In the case of some 
siderophores 1 2· 1 3 (vide infra), the complex (K
s
 1 0 2 9 or higher) 
tends to retain the 3:1 structure even at low pH. 
Because hydroxamlc acids exhibit little cation selectivity, with 
the exception of a distinct preference for ferric ion, complexation 
with several metal ions 1s strong enough15·1*» to be of great 
utility. To Illustrate this, a few examples are presented. 
Copper(II) complexes have been used for Identifying and 
purifying hydroxamlc acids. 2 1 - 2 3 Treatment of a hydroxamlc acid 
with alcoholic copper(II) acetate results in the precipitation of 
a copper(II) complex. The hydroxamlc add can be liberated from the 
complex by bubbling H2S through a solution of the complex; copper 
sulfide precipitates and can be removed easily by filtration.22 The 
ability of hydroxamlc acids to form stable complexes with zinc ions 
underlies the method which Nishino and Powers 2 4 developed for the 
purification of zinc metalloproteases by column chromatography. To 
12 
that aim they synthesized an affinity adsorbent containing a 
hydroxamic acid moiety. The adsorbent appeared to be specific for 
several zinc metalloproteases, and a variety of conditions was 
developed for elution of the enzymes from the column.24 
During the isolation of N-hydroxy peptides from homogenized 
tumour-tissue advantage was taken of the relatively high affinity15 
of hydroxamic acids for aluminum(III).25»26 Under alkaline 
conditions the peptide fractions containing a hydroxamate moiety 
were completely retained on an alumina column, whereas they could 
be eluted from the column using an acidic eluent. 
In contrast with the ferric Ion (Kj = 10 1 1, see scheme V), the 
ferrous ion is bound only loosely to hydroxamic acids15 (K = 105)· 
This special feature can be used to explain the biological function 
of many hydroxamic acids. In section 2.3 more attention will be 
payed to this topic. 
2.2.3 Syntheses and reactions 
The most convenient methods for the synthesis of hydroxamic 
acids will be discussed in the chapters III, IV and V. In this 
section just a brief outline of some oxidative methods for their 
synthesis is given. 
Whereas N-acylation of hydroxylamines has long been used for 
the synthesis of hydroxamic acids, the direct oxidation of amides 
has only recently come under scrutiny. Following the discovery that 
trlmethylsilylation of secondary amides activates them towards 
oxidation to hydroxamic acids by the peroxo-molybdenum complex 
Mo05.HMPA,27 the scope of this reaction (eq.l) has been investigated 
in more detail by Sammes.28 Although he has used rather simple 
amides, the yields of the oxidation step are generally moderate to 
13 
low (< 48%). Liberation of the uncomplexed hydroxamic acids was 
R V 0 4<cH,b5lc1.NicA)3[
R
'Y0-
„ Ν . ΣΙΜοΟ,ΗΜΡΑ , ^ Ν ^ / 
R2^ ^ Н 5 R2 О 
EDTA,pH9 Ν * 1 
MOO, » I 
R2 vOH 
accomplished by extraction of the molybdenum ion with warm ethylene 
diaminetetraacetic acid (EDTA) at pH 9. Treatment of the molybdenum 
complexes with hydrogen sulphide, aimed at the precipitation of the 
metal as its sulphide, causes the undesirable reduction of the 
hydroxamic acid to the parent amide 6. 
Some attempts have been descr1bed29_3l t 0 convert imino ethers 
7 into hydroxamic acids (scheme VI). 
Scheme VI ^ ^ 2 ' " ,1 
R1 =R2= (CH2)n . У \ - f "OH 
R
^
0 Rlv_-.OCH3 R1 OCH3 ^\ 
1 ·- H ^ 1^0 *• R'COJCHJ.R'NHOH 
V " H R*- R 2 ' N ^ ва аь 
CO] = ROOH (MCPBAor TBHP) 
Oxidation of an acyclic imino ether followed by hydrolysis of the 
resulting alkoxyoxazirane leads to the corresponding ester 8a and 
hydroxylamine 8b 3 0 or to the nitroso dimer 9. 3 1 The product 
formation seems to be dependent on the nature of the residue R 1. 3 1 
In this way only cyclic hydroxamic acids can be synthesized in low 
yields. 2 9· 3 0 
A more elegant method for the preparation of hydroxamic acids 
is the oxidation of aldonitrones32 10 or derivatives thereof33 
(scheme VII). Acylation of the nitrone facilitates its oxidation; 
the formation of an O-acyl hydroxamic acid 11 offers the advantage 
14 
that this compound, in contrast with free hydroxamic acids, 3 4 is 
Scheme· VII 
В
1
 В
2
 D1 В 2 О' о 2 
" Г оде ^ΟΗ/Η,ΟΠ ι, / ^
о н 
ОН" 
Η OC(0)Ph 0 OC(0)Ph 
η 
protected from further oxidation by the peracid. Searching for a 
more direct conversion of a nitrone into N-formyl-N-hydroxyglycine 
12, Schoenewaldt ef.a/. found that nitrones can be cleaved under 
concomitant formylation by treatment with formic acetic anhydride 
at room temperature (eq.2). 3 5 
AT «ЦСО*.
 Н С О О Н М С Н э С О ) 2 0 M CH2C02H 
( e q 2 ) > = N * . ) _ N .ArCHÍOAcb 
Н О о он 
12 
The remaining part of this section is completely dedicated to 
the chemical reactivity of hydroxamic acids. Due to the presence of 
a hydroxyl group on the nitrogen atom these compounds behave quite 
different from amides in many aspects. An exception is the hydrolysis 
of the hydroxamic acid bond, which can be accomplished under both 
Scheme VIII 
R'COOH.F^NHOH 
R'COOH.R2NH2 
basic and acidic conditions.2 Acidic conditions (6N HCl, scheme 
VIII) are preferable in those cases where elimination reactions 
(videinfra) can Interfere. Hydrolysis with 6N HI converts the 
15 
hydroxylamine group into a primary amino group.12,13 
The hydroxamic acid bond is susceptible to oxidation and 
reduction. These reactions have mainly been used for the character­
ization of naturally occurring hydroxamic acids.^,13 Periodic acid 
is the reagent of choice for oxidation of the hydroxamic acid bond 
since the amide bond and other even more sensitive bonds (e.g. the 
ester linkage) remain unaffected (scheme IX). 
Scheme IX 
R1 R2 0 0 
о *
 ч
он ^
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The products of the "hydrolysis by oxidation" of secondary hydroxamic 
acids are an acid derived from the acyl moiety and a dimeric nitroso 
compound И . 1 2 » 13 c-Nitroso carbonyl compounds 15 are formed as 
transient intermediates In the oxidation of primary hydroxamic acids 
(13, R2=H) with tetraethylammonium periodate.12,36,37 These dleno-
philes can be trapped by cyclopentadiene to give the corresponding 
cydoadducts 16.36,37 
Treatment with zinc powder 1n acetic acid Is the most frequently 
used method for the reduction of hydroxamic acids to the corresponding 
amides.12»13,21,23 Another reagent which is very efficient for this 
purpose is the combination of hydrogen.gas and Raney nickel.12,38 
A mild method for the reduction of the N-0 bond of, among others, 
substituted N-hydroxy-2-azetidinones 17 (eq.3) was developed by 
Miller. 3 8 
16 
(eq3) 
R
' " i — | ТіС|з . R ' " T — | 
OH 
(eq4)
 У\ , — — h^s 1/ \
O Η 
A prerequisite is the presence of an acidic chelation site in the 
molecule, i.e. R2 and/or R^ (eq.4) must be a proton.38 Under 
strongly reducing circumstances amino acid aldehydes 19 can be 
obtained from the corresponding O-alkylated primary hydroxamic acids 
18 (eq.5). 3 9 
R R R 
I I I 
Boc-N-CH ^Hj Boc-N-CH pH, Boc-N-CH 
(eq 5) H Y-N LiAlHt H ) - N H;0 ^Н ^ _ н 
О ОСНэ *" О /ICH, 86-95%* О 
!§ ι·''" 19 
A characteristic reaction of hydroxamic acids, in particular 
cyclic ones (five- and six-membered rings), is thermal reduction to 
the corresponding amides. O-alkyl derivatives are particularly prone 
to this reaction (scheme X ) . 4 0 
Scheme X 
I 1 д Ι ί Δ l 1 
4Nt>0 ~^Γ S|-"N) Vc-R' ^Ni^C 4p 
ik.. " η о "н 
R'>iR! 
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Under analogous conditions N-hydroxy-2-azetidinone 20 isomerizes in 
low yield (20%) into the corresponding isooxazolidin-5-one 21 (eq. 
6 ) . 4 1 The same compound 21 can be obtained in 83% yield by treat­
ment of 20 with a catalytic amount of lithium ethanethiolate at 
room temperature.42 
17 
(eq6) 
H 
H î 
BocN»-T 1 
nJ—N 
Д.ЕЮАс 
H H 
BocN, 
20 
orLiSC.H, ,THF.20"C 
Introduction of a négative charge can also induce a rearrangement 
of hydroxamic acid derivatives. Recently Miller described the 
formation of a carbinolamine 23 by a [l,2]-an1onic rearrangement of 
substituted N-hydroxy-2-azetidinones 22 (eq.7).43 
( e q 7 ) 
¿ И-ч 
ΐΓ он 
22 
BrCH(C02Et)2 
KOH.DMSO, го'с 
τΓ 'ìbo^cOjEt 
COjEt 
-JX , он 
ElOjC ^ 
23 35-55V. 
Another example is a reaction known as the Lossen rearrangement44; 
O-acyl derivatives of hydroxamic adds 24 give Isocyanates 25 when 
treated with a base,2 or sometimes even just on heating (eq.8).2f45 
(eqe) 
OH w < R 2 C O ) 2 ° 
R'—NH, -· HjO 
R' Η 
0 0 - ( 
0 
и 
OH" 
Щл 
R ,-N=C=0 
25 
/h-N R·1 
The starting compound 24 is readily accessible by acylation of the 
corresponding primary hydroxamic acid with an acid chloride or 
anhydride. 2· 4 5 The same holds true for the synthesis of O-acylated 
secondary hydroxamic acids. 4 5· 5 7» 6 2 
Hydroxamic acids are sufficiently acidic to be O-methylated 
18 
with dia2omethane.21.40.57 ¡ n most cases, however, alkyl hal ides 
are used for this conversion.2,11,45 unsubstituted hydroxamic acids 
contain three different sites where an alkylating agent can attack. 
Usually alkylation of the hydroxyl group predominates2 (eq.9, route 
b). 
(eq9) 
R' H 
- УК , 
0 OR2 
When the hydroxyl group is protected, the regioselectivity of the 
alkylation depends on the reagent and experimental conditions used. 
Some examples are presented in scheme XI, eq.lO and scheme XII. 
Scheme XI 
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NaH-CHjI 
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26 
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NHBoc NHBoc 
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27 28 JCHjCsHs 
Olsen ef.a/.46 found that clean N-alkylation of the hydroxamate 
function of Boc-Ala-NHOBzl 26 is apparently unique for methyl iodide 
as the alkylating agent. Alkylation with ethyl iodide (or benzyl 
bromide) furnished a mixture of the N- and O-alkylated products (27 
resp. 28, ratio 4:1). Intermolecular alkylation of hydroxamates with 
alcohols mediated by diethyl azodicarboxylate-triphenylphosphine 
H,C H 
(eq10) β— N + BocNH-(CH2)3-OH 
О OCHjCeH, Р ( С б Н 5 ) з
 ВосМН-(Сн
г
)з-0 \CH2ctHí 
major product 
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(Mitsunobu reagent47) gives mainly or entirely the O-alkylated 
product (eq.10).48·49 Clean intramolecular alkylatlon on nitrogen 
has been reported in the preparation of ß-lactams 29 (scheme 
XII).49-56 
Scheme XII 
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Problems concerning the regioselectivity are not encountered in the 
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20 
alkylation of N-substituted hydroxamic acids; alkylation of the 
hydroxyl group is the only possibility (eq.ll). 5 7 
The last part of this section is mainly devoted to some special 
chemical features of hydroxamic acids, which are derived from N-
hydroxy-a-ammo acids. Compounds belonging to this class, /e N-
acyl-N-hydroxy-a-amino acid dervatives, undergo readily elimination 
reactions to yield the corresponding α-acylimino carboxylic acid 
derivatives (eq.12-14, scheme XIII). The elimination reaction can 
be facilitated by converting the OH-group into a better leaving 
group, for instance by acylation, alkylation or tosylation (eq.13 
and scheme XIII).^-66 Д5 f
a r a 5 known there is only one example of 
the successful isolation of such an acylimine (30, e q . 1 2 ) 5 8 : 
CH 3 
ÇH, \ 
н,с V—H н3с c*. „„ _ 
\ / \ r o c. carbonyldnmidazol \ // СОгЕІ 
(eq*) ) - N «ЬЕ. _ _ , _ _ _ ^ ^ N 
О ОН О 
30 
In the absence of a nucleophile they usually tend to rearrange to 
the corresponding enamino acid derivative (31, eq.13 or 32, scheme 
XIII).59-64 
R' 
3 <" 
R3 Р-~-ГГ%,в2 ,60-«:, 4? k c o 2 R ' E.3N benzene Δ ^
 HC / ^ C 0 2 R 
У~\ or TosCI EljN V~t " // \ ΟΓ 10SLI ί,Ι,Γί '' ^
о он о н 
31 
The acylimine can be captured in the presence of an excess of a 
hard nucleophile to yield the a-functionalized amino acid 
derivative 33 (scheme X I I I ) . 6 5 · 6 6 Reaction of an acylimine with 
H2O results in the formation of the corresponding a-keto carboxylic 
acid derivative (34, eq.14). 6 7 
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H,C fe» 
^ C O , R J 
R3 ACOTCHJCJHJ 
н
зЦ 
< 
-COjR2 
0 Ή 
32.70-97·/. 
33.60-91·/. 
1 . M U , С Н 2 С І 2
5 9
 o r ( R 3 . A c ) ЩН, benzene. Δ 6 2 " 6 4 
І І t-BuOK, M e O H 6 5 · 6 6 
(eq 14) 
\ 
OH 
NaOH 
EIOH 
/"-COj H20 /•~-co,H 
V. 
These methods for the synthesis of a-functlonalized amino acid 
derivatives and a.D-dehydroamlno acid derivatives are efficient and 
might be of general applicability. 
Nucleophilic substitution at nitrogen, resulting in N-0 bond 
dissociation, has been reported only a few times.66.68,69 Reaction 
of an N-acyl-N-hydroxy-a-am1no acid derivative 35 with an excess 
of ammonia leads to the formation of a hydrazine derivative 37 
(eq.15). 6 8 This result can be rationalized by the intermediacy of 
the acylimlne derivative 36; a hard nucleophile attacks the carbon 
(eqIS) 
о \эн 
R' 
R3 i - c ' 
к \ 
0 
35 w 
0
 N H 2
0 
37 
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atom (eq.l4), whereas a softer nucleophile yields the N-substi-
tuted product 3 7 . 6 6 · 6 9 
A substitution reaction which certainly cannot involve the 
intermediacy of an acylimine derivative was described by КігЬу 7^ 
(eq.16); intramolecular attack of a carbanion on the nitrogen atom 
of a modified hydroxamic acid function results in cleavage of the 
N-0 bond, under formation of an aziridinone (α-lactam) 38. 
H с 6 н 5 
CiHsCH, 'Bu X 
(íqW) ïLu' (F3C-SO;);0,ElaN > / > N 
о '
 ч
он CHJCIJ.-TOÏ.S?·«. о ^ Ч ^ 
38 
With respect to the last part of this section it may be 
concluded that some of the examples (eq.12-14, scheme XIII) show 
clearly that several routes depicted in the first scheme of chapter 
I are at least of chemical relevance. 
2.3 STRUCTURE AND BIOLOGICAL FUNCTION OF NA TURAL HYDROXAMIC ACIDS 
The past three decades have witnessed the compilation of a 
catalogue of microbial iron-containing or iron-binding compounds, 
most of which are classified as "siderophores" (Greek for iron 
bearers).12-14,71 Although the siderophores as chemical entities 
display considerable structural variation, most of them are either 
hydroxamates 39 or catecholates 40, and all exhibit a very strong 
affinity for Fe(III), the formation constant lying in the range of 
10 3 0 or higher (scheme XIV). 
Natural hydroxamic acid containing compounds are ubiquitous 
(fungi, yeasts, bacteria, algae, plants) and frequently bewildering 
in structural variety and biological implications. Before turning 
23 
Scheme XIV R' 0 
Y 
R2 0 " 
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R2 0 
1,0 
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3 
3 -
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to their biological function some remarks concerning their 
structure will be made. 
With the exception of actinonin (41) 7 2 they are all of the 
secondary type. 
HOCHj 
41, actmorm 
(Strtptomyces rœecpaUidus)72 
Most of the naturally occurring hydroxamic acids contain amino acid 
residues as building stones. With respect to these building blocks 
the compounds can be divided up into two classes encompassing 
either a-N-hydroxyamino acids or ω-Ν-hydroxyamino adds. Compounds 
that belong to the latter group contain, in addition to the 
α-amino- and carboxyl group, a terminal (ω-) hydroxylamine function. 
The ω-Ν-hydroxy derivatives of ornithine and lysine are the most 
conmonly found N-hydroxyamino acids that occur in natural hydroxamic 
acids.12-14,71,73-77 T W 0 examples, representative for this kind of 
compounds, are depicted in scheme XV. The characteristic structural 
feature of the ferrichrome family 42 is a cyclic hexapeptide 
containing a tripeptide sequence of Ns-acyl-Ns-hydroxy-L-ornithine 
24 
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H 
Η ι О 
о \ ^ - - _ / / н Ss/ ^/ г г 
R4 / / г— R \ / ' Н с=о o=ç 
/ ^ н ( Т ! ^ / II (сн
г
)ГД 
H—N' N C ^ J ^ e _ i V 
.(CH¡)3 
' " " • " " " ' Ν—ОН НО—Ν 
_ . | (СН2)4 О СООН О (СНД 
1 R ^ r s : = s o - ; - o = c I I II I II I 
0 = = С С - " ' ι ι
 N
^ ^н Η — С — Ν — С — С Н 2 — С — С Н г — С — N — С — Η 
\/н \ т \ м ι м 
. с ^ \ l С- НООС Н ОН Η СООН «^л
4
Ν (СН2)Г 
н 
/
 с
 ϊ /Χ y . a e r o b a c n 
Η // С *^ \ O (Aerobacter aerogenes) 
о ¿ . н 
42, terncfvome tamily (RiCH,) 
(Ustilago sphaerogena) 
and a tripeptide composed of small, neutral amino acids. Aerobactin 
43 is a compound that is made up of citric acid and two N E-acyl-N e-
hydroxy-L-lysine residues. 
As was explained before, in this thesis hydroxamic acids derived 
from Na-hydroxy-a-amino acids are highlighted. In scheme X V I ^ - 1 4 
all representatives of this class, found in nature until now, are 
depicted. It should be mentioned that some of them have been 
isolated from several sources. 1 2· 1 3 N-Hydroxy peptides have also 
been isolated from animal and human tumours. The exact structure of 
these compounds has not yet been elucidated; it was estimated that 
approximately one out of 300-500 peptide bonds is N-hydroxyl-
ated.25,26 
Concerning the biological function (and/or activity) of the 
naturally occurring hydroxamic acids it has been demonstrated that 
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they can act variously as potent growth factors (eg aspergillic 
acid derivatives 46), antibiotics {eg mycellanamide 45, aspergil­
lic acid derivatives 46, G 1549 49), cel1-division factors, tumour 
inhibitors (eg hadacidine 44) or antibiotic antagonists (eg 
fernchromes 42). Although the particular physiological activity 
cannot be assigned in each case to the hydroxamic acid moiety, it 
is the outstanding chemical feature of these molecules, and it may 
be expected to play a role in the biological action of molecules 
of which it is a part. 
It has been established that the hydroxamic acids are 
intimately associated with iron-transport phenomena 8^ 8 4 m those 
cases where they act as growth factors. Their synthesis can be 
precisely regulated. In severe iron deficiency a greater amount of 
these powerful sequestering agents for the very insoluble ferric 
ion is produced and excreted into the medium in massive amounts to 
scavenge the metal from inaccessible sources in the environment. 
Meanwhile, a highly specific transport system, localized in the 
cell membrane, protects the cell against the penetration of toxic 
quantities of inorganic iron and rejects the ligand unless it is 
laden with its specific metal ion. In the cell the ferric ion is 
probably reduced to the ferrous ion, which subsequently can be 
27 
delivered at the point of demand by the biosynthetic machinery of 
the cell.12 This assumption is based on the knowledge that the 
iron(II) complexes are very unstable15 and so provide a release 
mechanism for the iron. It has been proven that siderophore-
mediated iron incorporation into microbial cells involves highly 
specific recognition by receptors at the cell surfaces.14,85,86 
The metal center and adjacent functionalities seem to be the key 
for the recognition by the receptor. Since for a number of bacteria 
the specific outer membrane receptor for ferrichrome also serves 
as a common binding site for some phages,85 it has been suggested 
by Raymond14 that ferrichrome-competing phages possess some 
structural features similar to the hydroxamate functionality of 
the ferrichrome molecule (42). A striking property of the ferric 
hydroxamate growth factors is their power to antagonize the 
toxicity of the related antibiotics.12·13 Presumably the mechanism 
is one of competition for the same transport system, because further 
investigation has revealed close chemical similarity of the iron-
binding site between both antibiotic and its antagonist.13 
In the past the hydroxamic acids were divided into two classes 
according to their biological activity.I2 Those with growth-
promoting activity were designated as sideramines and those with 
antibiotic properties as sideromycins. This terminology is not 
entirely satisfactory, since a number of the compounds 1s neither 
growth-factor nor antibiotic. Further, some of the antibiotics can 
serve as growth-factors depending on the test-organism. Therefore, 
this classification has been abandoned and the term siderophore 
(or, depending on the author(s), siderochrome) was retained for all 
microbial iron transport factors. 
28 
Finally, it is worth mentioning that several synthetic and 
naturally occurring hydroxamic acids have already been used as 
therapeutic agents in medicine to combat accidental metal 
poisoning.14.87 in this way iron has been removed for example from 
iron-overloaded mice and humans. 1 4· 8 7 
2.4 BIOSYNTHESIS OF HYDROXAMIC ACIDS 
Inspection of the formulae of hydroxamic acids suggests that 
there are only two possible routes of biosynthesis that merit 
consideration; hydroxylation of the nitrogen atom may occur either 
before (pathway a, scheme XVII) or after (pathway b, scheme XVII) 
acylation. 1 2· 8 8· 8 9 
Scheme XVII 
R-NH2 
Whereas there is no chemical precedent for the direct oxidation 
of amino acids to N-hydroxy-a-amino acids, the biosynthesis of 
hadacidine 44 seems to proceed from the parent amino acid with 
an N-hydroxyamino acid as the first intermediate (pathway a ) . 8 8 
Although free N-hydroxyamino acids have not yet been isolated from 
any hydroxamate producing organism, strong evidence for their 
involvement has been obtained. Molecular oxygen was found to be the 
source of the oxygen in N-hydroxyglycine,88 the direct precursor of 
hadacidin. 
29 
Several of the hydroxamic acids that contain the hydroxamate 
group within a heterocyclic ring are derived from the appropriate 
amino acids, e.g. mycelianamide 45 (tyrosine, alanine)90, aspergil-
lic acid 46 (leucine, isoleucine)^! and pulcherriminic acid 47 
(leucine). 9 2· 9 3 In two cases (aspergillic acid, pulcherriminic 
acid) convincing evidence was provided that the oxidation of the 
ring nitrogen takes place by a specific enzymatic reaction after 
the cyclization has occurred (pathway b).88 It remains to be seen 
whether this is also true in the case of mycelianamide. 
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CHAPTER III 
CHIRAL HYDROXAMIC ACIDS AS LIGANDS IN ASYMMETRIC, 
METAL-CATALYZED REACTIONS 
3.1 INTRODUCTION 
Molecules that are not superimposable on their mirror images are 
chlral. 1 - 3 Based on the Greek word for "hand" (cheir), chirality 
means "handedness", in reference to that pair of non-superimposable 
mirror images we constantly have before us: our two hands. 
The organic constituents of plants, animals and microorganisms-
from the most primitive to the most highly developed- are composed 
of molecules that are chlral. Life processes on a molecular scale 
take place between chlral molecules in a chlral environment. Living 
organisms, as a consequence of their chiral nature, exhibit 
stereoselection (/.e. chiral discrimination) In their interactions 
with chiral substances.4 
Thus, the effect of biologically active substances (pharma­
ceuticals, agrochemicals), containing one or more chiral centres, 
sometimes changes drastically with the chirality of the 
molecules. 5 - 7· 9 6 One of the most dramatic examples of this change 
concerns the drug thalidomide (softenon),8 a hypnotic which was 
marketed in the sixties as a racemic mixture. It was withdrawn from 
о 
О Thalidomide 
0 0 " 
the market because its administration was associated with feta! 
abnormalities. In 1979 It was discovered that the hypnotic action 
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has to be attributed to the enantiomer with the R-configuration, 
whereas the teratogenicity (ability to cause birth defects) of the 
drug is due solely to the S-enantiomer.8·9 in spite of this 
knowledge most synthetic chi ral drugs are still marketed as 
racemates or diastereomeric mixtures.7 However, the situation is 
rapidly changing. The ever increasing demand for more selective 
drugs, insecticides etc., which show less toxic side-effects and 
are more environmentally acceptable is providing an important 
stimulus to chemists to prepare these compounds as optically pure 
isomers. 
The impressive advances that have been made in developing 
methods for the production of pure stereoisomers have been reviewed 
amply. 6· 1 0 - 1 6 The use of chiral reagents in catalytic quantities 
(i.e. chiral catalysis) offers one of the most promising approaches. 
Chiral catalysis17 is a synthetic method with great potential 
because, in the best examples, a large amount of the chiral product 
can be made with only a small investment of chiral material in the 
catalytic system. That is why chiral catalysts are becoming very 
important at a time when the chemical industry is seeking ways of 
conserving energy and of making the best possible use of available 
resources. 
Depending on the nature of the chiral catalyst one can 
distinguish between bio- and chemocatalysis. In the first case 
(immobilized) enzymes or Intact cells are used to exert catalytic 
activity.18"20 Although blocatalysts often constitute perfect 
chiral reagents, this kind of catalysts cannot always be applied to 
obtain the desired pure stereoisomer. This is mainly caused by the 
fact that most blocatalysts can furnish only one of the possible 
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stereoisomeric products. Besides, sometimes the isolation and/or 
use of biocatalysts is a demanding task and some of them display a 
limited substrate specificity. 
Therefore chemocatalysis, i.e. the use of relatively simple 
chiral compounds (nonenzymic) from natural or synthetic origin as 
catalyst, receives much attention too. In this way it is tried to 
complement or improve the results achieved with biocatalysts. There 
are also many examples of chemical systems which mimic the action 
of enzymes (see e.g. ref. 21-27). 
With respect to chemocatalysis the most innovative advances 
have been in the applications of metallo-organic chemistry in which 
the central metal atom along with one or more coordinated chiral 
ligands is used to guide and closely orient the stereochemical 
course of the reaction.14·17 Examples of such reactions are the 
homogeneous hydrogénations catalyzed by rhodium-chiral phosphine 
complexes,17 the peroxidic allyl alcohol oxidations catalyzed by 
titanium alkoxide and diethyl tartrate,17·28 the Ni(II)-catalyzed 
Grignard cross-coupling reactions,17·29 aldol condensations 
catalyzed by chiral Zn-complexes,30 and several other reactions 
like cydopropanatlon with carbenes,31 the allylatlon of carbon 
nucleoph1les,l7>32 Diels-Alder reactions,33 hydrosilylations, 
hydrocarbonylatlons and Isomerlzations.14·17 
The subtlety of the effects responsible for the asynuietric 
induction, i.e. the electronic and steric interactions in the 
transition state, makes it very difficult to design chiral inducing 
ligands, which are generally applicable. In this respect we became 
intrigued by the potential usefulness of chiral hydroxamic acids 
as ligands 1n asymmetric, metal-catalyzed reactions. Hydroxamic 
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acids form stable complexes with a large number of transition 
metal 5,34-36
 a property through which they are potentially 
applicable in various types of reactions. Although hydroxamic acids, 
which are usually cheap and readily accessible, have been applied as 
chiral ligands in some cases, 7 0 - 7 2 the chiral Induction by this 
class of compounds has never been investigated systematically. 
So, our aim was to Investigate chiral hydroxamic acids for 
their ability to induce chirality in various transition metal-
catalyzed reactions. In this chapter the synthesis of a few chiral 
hydroxamic acids is described. Subsequently, the results of their 
application as chiral ligands in the transition metal-catalyzed 
epoxidation of allylic alcohols (Sharpless-epoxidatlon) ,17,28
 a 
reaction which we regard as a touchstone for the viability of our 
approach, are reported. 
3.2 SYNTHESIS OF CHIRAL N-HYDROXY-DIOXOPIPERAZINES 
3.2.1 Introduction 
The first thing to be done was taking a decision with respect 
to the structure of the hydroxamic adds to be synthesized. Although 
it is difficult to predict whether a certain compound will be 
capable of exerting an efficient chiral Induction, it is not hard 
to imagine the primary conditions which have to be met in order to 
make a compound an attractive chiral ligand. Kagan37 has summed up 
these criteria for the synthesis and use of a chiral ligand : 
1. It must be coordinated to the metal during the step in which the 
chiral center on the substrate is created, and not exert merely 
a chiral medium effect. 
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2. The catalytic activity when the chi ral ligand is present should 
be reasonably good relative to that of the achiral catalyst. 
3. The structure of the ligand should allow for various chemical 
modifications to be made in order to permit the synthesis of 
variants. In this way optimal ligand-substrate matches can be 
sought. 
4. The synthesis of the ligand must be relatively easy. If possible, 
resolution is to be avoided, the starting material being a cheap 
one taken from the "chirai pool" 
5. It Is desirable to be able to get both antipodes of the ligand. 
We felt that hydroxamic acids of general structure 1 might 
satisfy these conditions. The bicyclic structure was settled upon 
W , 
because of Its rigidity. This feature and the bidentate nature of 
hydroxamic ac1ds34>38 should minimize the number of conformations 
the ligand can assume In the coordination sphere of the metal during 
the transition state. We intended to investigate the influence of 
the substltuents R1 and R2, at least one of them being a hydrogen 
atom, and of the chirality at Ce on the inductive power of I. 
There are several methods for synthesizing N-hydroxy-dioxopi-
perazines like 1^.39-44 j n scheme I some possible retrosynthetic 
pathways for 1^  are depicted. 
It Is clear that the target molecule Is an N-hydroxy-dioxoplper-
azine, i.e. a cyclic N-hydroxy dipeptlde, of (S)-prollne45 and an 
N-hydroxy-a-amlno add. We decided to prepare most of the 
39 
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contemplated compounds, R1 or R 2 being H, CH3, I-C3H7 or C6H5, 
according to route В, since this seemed to be the most straight­
forward and cheapest way. In only one case, R1 or R 2 being a benzyl 
group, route С was applied because the relevant o-halocarboxylic 
acid, needed for a synthesis according to route B, was not 
commercially available. 
3.2.2 Synthesis of N-(2-haJo-acyl)-(S)-proline methyl esters 
Thus, (S)-proline 2 was converted into the corresponding methyl 
ester, 4 6 which was isolated as its HCl-salt 3 (scheme II). This 
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salt 3 is rather difficult to handle due to its hygroscopic nature. 
The free amine 4 could be obtained as an oil by treatment of 3 with 
triethylamine. In most cases 4 was used directly in a coupling 
reaction with an a-halocarboxylic acid (see scheme III); otherwise 
it was converted into the stable and less hygroscopic 4-toluene-
sulfonic acid salt 5. 
?н ГЛ*» rv< 
Г
 Н
 і
н
Г 
Η 
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Scheme III shows how we tried to synthesize each of the various 
chinai hydroxamic acids. The first step involved a coupling of (S)-
proline methyl ester 4 with an a-halocarboxylic acid, the formation 
of the amide bond being promoted by the coupling agent dicyclohexyl-
carbodiimlde (DCC).47 Subsequently, ring closure was effected by 
treatment of the resulting products (10-13) with an excess of 
hydroxylamine in refluxing methanol. Since the applied chiral a-
halocarboxylic acids (7-9) were all optically inactive, the products 
consisted of two diastereomers. Theoretically the separation of the 
diastereomers could be carried out at any stage of the synthesis, 
i.e. after the coupling reaction or after the ring closure. In this 
respect we were confronted with a number of problems. In the 
following part of this section the specific properties of the 
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compounds, which underlay these problems, will be discussed in some 
detail. 
Compound 10 was obtained easily in 62% yield, based on 4. The 
synthesis of Π afforded a mixture of diastereomers, which could 
not be separated, in 54% yield. The diastereomeric ratio was 
approximately 2.4:1 as established by ÏH-NMR spectroscopy using the 
shift reagent Eu(fod)3. The chromatographic separation of the 
diastereomers of 12 proved to be feasible, furnishing the less 
polar diastereomer 12a in 33% yield and the other, more polar one 
12b in 23% yield.48 The ÎH-NMR spectrum of the latter showed 8 
peaks for the two diastereotopic methyl groups and 2 peaks for the 
methyl ester function, a phenomenon which must be attributed to the 
existence of two rotamers [trans and cis, ratio 2:1; see fig. 1). 
Fig. 1 
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It is well-known that hindered internal rotation of amide bonds 
can lead to the occurrence of distinct rotamers {cis and frans), 
which can be detected by ^ -NMR spectroscopy if their interconversion 
proceeds at a rate which is slow on the NMR time scale.49,50 
Whereas most peptide bonds exist exclusively in the trans form, 
especially proline-derived amides or peptides often show this 
peculiar behaviour.51 For the compound 1n question the coalescence 
temperature, i.e. the temperature at which the Interconversion is 
so fast that the ^ -NMR signals belonging to the different rotamers 
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coalesce completely,^ was found to be approximately 70 oC. This 
phenomenon was observed only with the more polar diastereomer of 
12 (12b). From the iH-NMR spectra of 10, Π and the less polar 
diastereomer of 12 (12a) it could not be deduced whether distinct 
rotamers exist in solution at room temperature. 
For the synthesis of compound 13 two different methods for the 
activation of the carboxylic acid function of 9 were applied. At 
first we synthesized 13 in 88% yield by treatment of the 4-toluene-
sulfonic acid salt 5 of (S)-proline methyl ester with the acid bro­
mide 18 In the presence of triethylamine (Scheme IV). The acid bro­
mide 18 was readily accessible by treatment of 9 with РВГ3, the 
yield being 40%. 
Scheme IV 
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Compound 18 had been chosen because all attempts to prepare the 
acid chloride 19a failed due to partial or complete substitution of 
the benzyllc bromine by chlorine, resulting in the formation of a 
mixture of 19a and 19b resp. pure 19b. The formation of 13 
proceeded smoothly provided that the reaction mixture did not 
contain any chloride Ions, since compound 13 was also prone to 
43 
OH 
Л< в ' 
φ н 
9 
PBrj/EtjO /Δ 
«ov. 
^ ο α , / Ο Μ Ρ 
Br 
Φ н 
18 
halide exchange. 
Unfortunately, we were confronted with a problem concerning the 
reproducibility of the results. While the yield remained unchanged, 
the ratio of diastereomers was different each experiment. It varied 
from nearly 50:50 to 100:0, the more polar diastereomer always being 
the major product. By means of X-ray diffraction52 it was established 
that both chi ral centres of the latter compound had the S-
configuratlon. Thus structure 13a (see also fig. 2) could be assigned 
to this compound. 
Fig. 2 Stereoview of 13a 
It was impossible to obtain the less polar diastereomer 13b as a 
pure compound by column chromatographic separation of 13a and 13b; 
at best a mixture enriched in 13b was obtained. 
3.2.3 Crystallization-induced asymmetric transformation of N-(2-bromo-2-
phenyl-acetyl)-(S)-proline methyl ester 
Attempts to find an explanation for the varying product ratios 
in the synthesis of 13 were hampered by the complexity of the 
iH-NMR spectrum. From the presence of two peaks for the benzyl i с 
hydrogen atom and the methyl ester function of each diastereomer it 
was deduced that distinct rotamers of 13a and 13b were present in 
solution. This conclusion was supported by the coalescence of the 
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relevant signals of both diastereomers at approximately 75 0C. 
Several explanations for the incidental formation of one pure 
diastereomer were considered. It was demonstrated that the product 
formation was not the result of a thermodynamically controlled 
epimerization,5^ which could have been caused by the presence of a 
small excess of triethylamine in some of the reaction mixtures. 
Another possibility, involving the transient formation of 
ketene 20 followed by asymmetric nucleophilic addition 5 4 of 4 to 20 
(eq.l), could also be ruled out, among others by the absence of 
0 H 
U> 20 
deuterium in the product obtained by coupling 18 with deuterated 
proline methyl ester 4.D (eq.2). 5 5 
I.n Я I \ .>*H ?Г N(C,H5)j 
Itq 2) / V>
 + J B r > 13a.b 
ч
^ с о
І
с н 3 o ^ X D <t> H 
4 0 18 
We perceived that the variation of the diastereomeric ratio 
also occurred when the coupling reaction was accomplished by 
applying the coupling reagent DCC (Scheme III; yield 13a/b : 59%). 
The results of these experiments ruled out the possibility that the 
observed product formation could be explained by the intermediacy 
of 20. Nevertheless, the last two experiments put us on the right 
scent. 
We found that dissolution of pure 13a or any mixture of 13a and 
13b in e.g. CDCI3, CH2CI2, CD3OD or EtOAc always resulted ultimately 
in the 'spontaneous' formation of a 50:50 mixture, but the 
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equilibrium was reached quite slowly. Evaporation of the solvent 
led to a crystallization-induced asymétrie transformation56; 
crystallization of pure 13a shifted the equilibrium of the dia-
stereomeric mixture (13a/b) completely towards precipitation of 13a. 
It was not investigated in detail whether the asymmetric 
transformation was caused by C-Η or C-Br bond dissociation. Since 
the chlorine analogue 21, prepared from 3 and 19b (eq.3), 5 7 did not 
l«q 
Ν ^αο,ΟΗ] 3' 0 <
H
 + JLa ***- 0 <
H
 + 0 <
H 
H
 ^ *
 H
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cr /V /Я· 
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ь
 i l * 22*/· l l b 2 θ , / · 
undergo this asymmetric transformation and since equilibration of 13 
in CD3OD gave no incorporation of deuterium at all, we are inclined 
to favour the latter assumption, i.e. C-Br bond dissociation. 
3.2.4 Ring closure 
The final step in the synthesis of the chiral ligands involved 
ring closure of the N-(2-halo-acyl)-(S)-proline methyl esters 10-13 
(and 21) by treatment with an excess of hydroxylamine (scheme III). 
Compound 14 was obtained from 10 in 25% yield after recrystallization. 
It is obvious that the conversion of the mixture lla/b into Iji gave 
a mixture of diastereomers. Although it was impossible to distinguish 
between the diastereomers of 15 on TLC, one pure diastereomer could 
be Isolated In 46% yield by careful column chromatography; 
structure 15b was assigned tentatively to this compound.58 Besides, 
the separation procedure furnished a mixture enriched in the other 
diastereomer 15a (ratio 4.5:1) in 6% yield. 
The products obtained after ring closure of 12a (61% yield) and 
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12b (20% yield) were identical in all respects with the exception of 
the specific rotation. In view of the results produced with the 
compounds 13a and 21b (vide infra) we reasoned that 12a was 
converted into 16a and that the primary product 16b formed from 
12b epimerized under the reaction conditions to the thermo-
dynamically more stable compounds 16a/16a' (Scheme V). 
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The specific rotation of the mixture 16a/16a' indicated that in 16b 
both chiral centres are liable, though not to the same degree, to 
proton abstraction. 
Compound 17a was readily accessible by ring closure of ІДа or 
21a, the former giving the best yield, viz. 75%. The absolute 
configuration of the ring-closed product 17a was determined by 
X-ray analysis^ (fig.3). Thus, 1t was proved that substitution of 
the halo atom proceeds stereospecifically according to an 5^2 
process. 
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Fig.3 Stereoview of 17a 
A mixture of diastereomers (17a/b) was obtained when a mixture 
of 13a/b or pure 21b was used as starting material. In the latter 
case 17b could be isolated in 14% yield. It was shown that this 
compound epimerized under the reaction conditions to 17a (eq.4); 
H;N0H/CH]0H/4 
(eq 4) j7b
 x ^ j7a 
compound 17a is thermodynamically more stable than 17b, presumably 
because of the 'trans' orientation of the bulky substituents at C3 
and Сб· Since the C6-(benzylic) proton is much more acidic than the 
Сз-proton, inversion proceeded probably only at the benzyl 1c chlral 
centre. 
3.2.5 Attempted synthesis of cyclo-[(S)-prolyl-N-hydroxyphenylalanyl] 
Unfortunately, all attempts to prepare 28 failed (Scheme VI). 
Whereas the synthesis of 25 caused no problems, the reduction of 25 
to 26, an interesting reaction because of the possibility of 
asymmetric Induction, proceeded quite slowly despite of the 
presence of a large excess of reducing agent. The ^ H-NMR spectrum 
of 26 was rather complicated and gave no clear indication for the 
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Scheme VI 
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presence of diastereomers and/or rotamers. Some preliminary attempts 
to cycUze 26 to 27 were not successful. 
3.3 TRANSITION METAL-CATALYZED ASYMMETRIC EPOXIDATION OF ALLYLIC 
ALCOHOLS : A TOUCHSTONE 
The following objective was to evaluate the chinai inducing 
abi l i ty of the hydroxamic adds 14-17 in the well-studied transition 
metal-catalyzed epoxidation of a l l y l i c alcohols. This type of 
reaction has attracted much attention during the last decade, 
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mainly because of the development by K.B. Sharpless 6 0· 6 1 of a 
catalytic system with overwhelming intrinsic prochiral face 
selectivity. His invention involves the use of catalytic amounts of 
titanium(IV) isopropoxide and diethyl(+)- or (-)-tartrate to effect 
a stereoselective reaction of tert-butyl hydroperoxide with allylic 
alcohols (eq.5). 
D-(-)-diithyl tartrate (unnatural) 
" O " 
<eq 5) ІСН])зСООН, T¡IO;-Pr)4 
СН
г
СІ
г
, -20"C 
Л-
R' 
он 
/ / 
70-90"/. yield 
>907. ее 
..
 0 .. 
L-Ы- diethyl tartrate (natural) 
The unique combination of reagents provides consistently the 
enantiofacial selection shown in eq. 5, regardless of the substitution 
pattern of the olefin. The scope and mechanism of the so-called 
Sharpless-epoxidation have been reviewed amply.17,28,62,63 
In order to find the best, catalytically active hydroxamic acid-
metal complex we intended to vary both the metal ion and the 
structure of the hydroxamic acid. The compounds 29, 6 4 30 and 31 
served as substrates (see eq.7), 31 being prepared in a two-step 
procedure from (E)-a-phenylclnnamlc acid 32 (eq.6). 
CH;N, A I DIBAL-H 
^» Ч^— ^». ^ Й — * 
Η Η 
32 33 
First of all the proper reaction conditions were established 
using 17a as chiral ligand. The results of these preliminary 
50 
experiments are summarized in eq.7/table 1. 
Ieq7) 
R' RJ 
Ri ^—OH 
IViVOIacac),, x'/. Iigand 
TBHP, CH,CI, 
R1 O R1 
R1 V_OH 
Table 1 
29 R U n - C ^ . R ^ R ^ H 34 
30 R, = [CH]);C=CHCH,CH,,R! = CHi,RJ = H 35 
3Í R ' . R ^ C J H ^ R ^ H 36 
Substrate 
29 
30 
30 
30 
30 
30 
30 
31 
X 
3 
3 
3 
3 
5 
3 
5 
5 
Iigand 
17a 
17a 
17a 
17a 
17a 
17a 
17a 
17a 
temp., "C 
0 
-20 -» +20 
-20 - +20 
20 
20 
0 
0 
0 - +20 
yield (%) 
77 67 
56 68 
47 69 
89 
75 
75 
17 
72 
e.e.(%)65.66 
38 
42 (2S,3S) 
43 (2S,3S) 
53 (2S,3S) 
57 (2S,3S) 
62 (2S,3S) 
66 (2S,3S) 
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The results show that the stereoselectivity increases as the 
temperature decreases and more equivalents of hydroxamic acid, with 
respect to vanadyl acetylacetonate, are used. The latter aspect 
deserves some further conment. 
It Is assumed7"·71 that the hydroxamic acid forms a complex 
with a vanadium(V)-species, which arises from the vanadium(IV)-
catalyst by tert-butyl hydroperoxide-mediated oxidation. In 
accordance with earlier proposal,70,73
 we think that cmp]ex 37 
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may be involved as an intermediate in the react ion. 
o=< VofcllTop 
ъ 
Probably, the complex is in equilibrium with its constituents, the 
excess of hydroxamic acid being necessary to shift the equilibrium. 
In this way the amount of vanadium species bearing no hydroxamate 
ligand is reduced to a minimum; the presence of such a species must 
be avoided since it would catalyze the formation of racemic epoxy 
alcohol. 
Typically our reactions proceeded much slower than the 
corresponding conversions accomplished with the Sharpless 
catalyst.61,63 Besides, the yield was lower as a longer reaction 
time was required for complete conversion. This made it 
unattractive to carry out the reaction at 0oC and/or in the 
presence of 5 equivalents of hydroxamic add. 
The results obtained with the other hydroxamic acids are 
depicted in table 2 (see also eq.7). From the data it may be 
concluded that the stereoselectivity is favoured by the presence 
of a bulky substituent at Cß in a frans orientation with respect 
to the proline ring (see structure 1). When the substituent and 
the proline ring are on the same side of the dioxoplperazine ring 
(c/s-configuratlon, i.e. 15b and 17b) only a poor chira! Induction 
is observed. 
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Table 2 
Substrate 
30 
30 
30 
30 
30 
30 
31 
31 
31 
31 
X 
3 
3 
3 
3 
3 
5 
3 
3 
3 
5 
ligand 
14 
15b 74 
16a 74 
16a/16a,74 
17b 75a 
17b 75a 
И 
15b 74 
16a 74 
17b 75a 
temp., 0C 
20 
20 
20 
20 
20 
20 
20 
20 
20 
0 - 2 0 
yield(%) 
76 
65 
73 
76 
77 
79 
64 
76 
85 
77 
e.e.(%) 6 5· 6 6 
23 (25,3S) 
13 (25,3S) 
50 (2S,3S) 
38 (2R,3R) 
3 (2S,3S) 
7 (25,3S) 
17 
4 
57 
5 75b 
Finally the influence of the metal ion on the reactivity and 
stereoselectivity was investigated briefly (eq.8/table 3). 
leq Θ) OH M, «·/. 17a 
TBHP, CH,CI,, JO'C 
OH 
30 35 
These reactions proceeded slower than the corresponding V-catalyzed 
epoxidations and the stereoselectivity was disappointingly low. 
Acquaintance with the formation (or stability) constants would 
have been helpful in determining the amount of hydroxamic acid 
needed for an optimum chiral induction. Unfortunately, there is not 
much information available on the complexation of hydroxamic acids 
with V, Mo or Ti.78 
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Table 3 
M 
1% Mo(CO)6 76 
1% Мо(СО)6 76 
10% Ті(0і-Рг)4 
10% ТІ(0і-Рг)4 
χ 
1,1 
3 
11 
21 
yield (%) 
64 
33 77 
62 77 
60 77 
е.е. (%)65.66 
10 (25,35) 
11 (25,35) 
27 (25,35) 
28 (25,35) 
3.4 A S YMMETRIC OXIDA TION OF SULFIDES 
A possible application we had in mind for the hydroxamic acid 
derived catalytic system concerned the asynmetric oxidation of 
sulfides to sulfoxides. The total synthesis of sparsomycin, a 
naturally occurring antibiotic and cytostatic, was one of the topics 
investigated by our group.79 An approach involving the oxidation of 
deoxosparsomycinöO-precursors with NaI04 was unsatisfactory, since 
predominantly undesired regioisomers were produced this way.79a 
Searching for a method for the regio- and diastereoselective 
oxidation our attention was focussed on the use of TBHP in 
combination with a chiral catalyst, i.e. a chiral vanadyl-hydroxam-
ate complex. To start with we selected thioanisole 38 as a simple 
model substrate to study the feasibility of the catalytic system. 
The results are summarized in eq.9/table 4. 
о 
, „, / ^ \ I·/. VOIaeac),, »V. hgand /p^\ II 
O s - C H ]
 TBHP,CH;C,; • C h - c H ' 
36 39 
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Table 4 
χ 
3 
3 
5 
3 
ligand 
17a 
17a 
17a 
17b 
temp., °C 
20 
0 
0 
0 
yield (%) 
69 
83 
77 
83 
wr 
-9.6° 
-13.3° 
-16.1° 
+4.Γ 
opt. purity (%)81.82 
6.5 (S) 
9 (S) 
H (S) 
3 (R) 
* c=1.7; acetone 
Only poor chiral inductions were realized. Besides, it turned out 
to be impossible to accomplish complete conversions. A rationale 
for this failure might be the following. Probably the sulfoxide 39 
has a higher affinity for the metal ion and thus competes with the 
starting material for a position in the metal complex. Our 
observations were confirmed by some literature reportsßlb»83·84 
describing that the reaction slows down and the optical yield 
lowers considerably when the amount of catalyst is reduced. 
3.5 CONCLUSIONS 
The preliminary results reported in this chapter are encouraging. 
Since the choice of the ligand is quite empirical, further research 
concerning the structure of the catalytically active metal complex 
will be necessary. To gain more insight into the influence of steric 
and electronic interactions on the stereochemical course of the 
reaction, additional variations in the ligand have to be considered. 
In this way an optimal ligand-substrate match, leading to improvement 
of the stereoselectivity without retarding the conversion too much, 
may be found. 
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Concerning the asymnetric oxidation of sulfides we conclude that 
the applied method, employing merely a catalytic amount of V5+, is 
not feasible for the synthesis of chiral sulfoxides of high optical 
purity. 
3.6 EXPERIMENTAL SECTION 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) 
and are uncorrected. Infrared spectra were measured with a Perkln-
Elmer Model 397 spectrophotometer. Proton magnetic resonance spectra 
were measured on a Varían Associates Model T-60 or a Bruker WH-90 
spectrometer. Chemical shifts are reported as S-values (parts per 
million) relative to tetramethylsilane as an Internal standard; 
deuteriochloroform was used as the solvent unless stated otherwise. 
Mass spectra were obtained with a double-focusing VG 7070E spectro-
meter. 
Thin-layer chromatography (TLC) was carried out by using Merck 
precoated silica gel F-254 plates (thickness 0.25 mm). Spots were 
visualized with an UV hand lamp, iodine vapor or Cl2-TDM.85 Hydrox-
amic acids were detected (red spots) by spraying with a 3% РеСІз 
(w/v) solution in concentrated HCl/MeOH (4:96, v/v). The allylic 
alcohols (29-31), the epoxy alcohols (34-36) and epoxy acetates 
were visualized by spraying with 50% H2S04/MeOH (v/v), followed by 
heating. 
For column chromatography Merck silica gel H (type 60) was used. 
The Miniprep LC (Jobin Yvon) was used for preparative HPLC. Solvent 
systems used were as follows : system A, МеОН/СНгСІг (2:98, v/v); 
system B, EtOAc/n-hexane (35:65, v/v); system C, EtOAc/n-hexane 
(1:4, v/v); system D, МеОН/СНгСІг (7:93, v/v); system E, МеОН/СНСІз 
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(7:93, v/v); system F, НеОН/СНгСІг (4:96, v/v); system G, МеОН/СНгСІг 
(3:97, v/v); system H, CH2CI2; system I, EtOAc/n-hexane (30:70, v/v); 
system J, EtOAc/n-hexane (1:1, v/v); system Κ, EtOAc/n-hexane (3:1, 
v/v). 
The α-halocarboxylic acids 6-9, geraniol 30, (E)-a-phenylcinna-
mic acid 32, and 70% aqueous TBHP were purchased from Janssen 
Chimica or Aldrich, Benelux. 
(S)-ProHne methyl ester hydrochloride salt 3 
This compound was prepared from (S)-proline (Janssen Chimica) 
according to the procedure described by St. Guttmann.46 [ a ] 2 0 : 
-33.2° (c=l.l; H2O), lit.46 [ a ] 2 4 : -34.0° (c=l.l; H2O); iH-NMR 
(O2O; t-BuOH) : δ 4.49 (m, IH, CHCO2), 3.83 (s, ЗН, CO2CH3), 3.44 
(m, 2H, CH2N), 2.65-1.82 (m, 4H, CH2CH2CH2N); (CDCI3/TMS) : S 4.52 
(m, IH, CHCO2), 3.83 (s, ЗН, СО2СН3) 3.55 (m, 2Н, СНгЮ, 2.69-1.78 
(m, 4Н, CH2CH2CH2N). 
(S)-Proline methyl ester 4 
Triethylamine (5.00 g, 49.5 mmol) was added dropwise to a 
stirred and chilled (0oC) solution of 3 (8.27 g, 50 mmol) in 50 ml 
of dry СН2СІ2· After completion of the addition the mixture was 
stirred at room temperature for 30 minutes. The solvent was 
evaporated In vacuo after which the resulting residue was washed 
thoroughly with Et20 (4 χ 100 ml). The ethereal solutions obtained 
after filtration were combined and concentrated in vacuo, thus 
affording proline methyl ester 4 as an oil in 72% yield 8 6; ^-NMR : 
δ 3.71 (m and s, 4H, CHCO2CH3), 3.21-2.65 (m, 2H, CH2N), 2.31 (s, 
IH, NH), 2.22-1.45 (m, 4H, CH2CH2CH2N). 
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(S)-Proline methyl ester 4-toluenesulfonic acid salt 5 
(S)-proline methyl ester 4 (4.64 g, 36 imol) was dissolved in 
50 ml of CH2CI2 and treated with a solution of 4-toluenesulfonic 
acid monohydrate (6.84 g, 36 mmol) in 100 ml of CH2CI2· After 
stirring at room temperature for 30 minutes the solution was dried 
over Na2S04 and concentrated to dryness in vacuo. Recrystallization 
of the residue from СНгСІг/п-Ііехапе afforded 5 as a white solid in 
82% yield based on 4 : thus the overall yield of 5 from 3 was 59%; 
^-NMR : δ 8.87 (br.s., 2H, NH2), 7.70 and 7.13 (M'BB·, 4H, C6H4), 
4.53 (m, IH, CHCO2), 3.72 (s, 3H, CO2CH3), 3.47 (m, 2H, CH2N), 
2.56-1.68 (m, 4H, CH2CH2CH2N), 2.37 (s, 3H, CH3C6H4); chemical-
ionization mass spectrum, m/e (relative Intensity) : 173 
([СНзС6Н450зН + 1]+, 26%), 130 ([4+ 1]+, 72%), 98 ([4 - 0СНз]
+
, 
15%), 70 ([4 - С02СНз]+, 100%); anal, caled, for C^HigNOsS : С, 
51.81; Η, 6.36; Ν, 4.65, found : С, 51.96; Η, 6.36; Ν, 4.65. 
General procedure for the synthesis of methyl N-(2-bromo-acyl)-(S)-
prolinates 10-13 
To a chilled (0eC) solution of proline methyl ester 4 (5.16 g, 
40 mmol) in 100 ml of EtOAc Q0-12) or CH2CI2 (13) 44 mmol of the 
relevant a-halocarboxylic acid (6, 7, 8 or 9) was added. 
Subsequently, DCC (9.06 g, 44 mmol) was added all at once to the 
clear solution, which was stirred at 0oC for 15 minutes and at 
room temperature overnight. The precipitate (dicyclohexylurea) was 
then removed by filtration and the filtrate was concentrated to 
dryness In vacuo. The residue was purified by column chromatography 
(solvent system A for 10 and 12; solvent system В for 11 and 13). 
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N-(2-Bromo-acetyl)-(S)-proHne methyl ester 10 was obtained as 
an oil, which solidified upon prolonged storage in a refrigerator, 
in 62% yield from 4. The compound was homogeneous on TLC (Rf 0.09, 
solvent system B) and could be recrystallized from EtOAc, m.p. : 
42-440C; ^-NMR : 5 4.69-4.39 (m, IH, CHCO2), 3.84 (s, 2H, CH 2Br), 
3.84-3.50 (m, 2H, CH2N), 3.73 (s, 3H, CO2CH3), 2.46-1.74 (m, 4H, 
CH2CH2CH2N); exact mass caled, for СаН^ВгНОз (M++1), m/e 250.0079, 
found : 250.0079; chemical-ionization mass spectrum, m/e (relative 
intensity) : 252/250 ([M+l]+, 63%) 220/218 ([М-0СНз]+. 20%), 
192/190 ([М-С02СНз]+, 100%), 172 ([М+2Н-Вг]+, 2%), 170 ([M-Br] +, 
18%), 142 ([M-Br-C0]+, 4%), 130 ([M+l-BrCHC0]+, 3%), 128 
([M-BrCH2C(0)]+, 5%), 112 ([М+1-Вг-С02СНэ]+, 2%), 70 ([C4H 8N]
+
, 
23%); anal, caled, for СвН^ВгМОз : С, 38.42; H, 4.84; Ν, 5.60, 
found : С, 38.15; Η, 4.80; Ν, 5.53. 
N-[(R,S)-2-Bromopropionyl]-(S)-proline methyl ester 12 was 
obtained as a mixture of diastereomers (yield : 54%), the ratio 
being approximately 2.4:1 as established by ^H-NMR spectroscopy 
using the shift reagent tris-(6,6,7,7,8,8,8-heptafluoro-2,2-dime-
thy1-3,5-octanedionato)europ1um, Eu(fod)3. The product was homoge­
neous on TLC (Rf 0.16, solvent system B) and could be recrystallized 
from EtOAc, m.p. : 125-1290C; iH-NMR : S 4.71-4.35 (m, IH, CHCO2), 
4.43 and 4.21 (2 χ q, IH, CHBr), 4.00-3.33 (m, 2H, CH2N), 3.75 and 
3.71 (2 χ s, ЗН, СО2СН3), 2.43-1.92 and 1.80 (m resp. d, 7H, 
CH2CH2CH2N and СНВГСН3); exact mass caled, for СдН^ВгМОз (М++1), 
m/e 264.0235, found : 264.0233; chemical-ionization mass spectrum, 
m/e (relative intensity) : 266/264 ([M+l]+, 70%), 234/232 ([М-0СНз]+, 
18%), 206/204 ([М-С02СНз]+, 100%), 186 ([М+2Н-Вг]+, 14%), 184 
(СМ-Вг]+, 39%), 156 ([М-Вг-С0]+, 26%), 130 ([М+1-ВгС(СНз)С0]+, 7%), 
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128 ([М-ВгСН(СНз)С(0)]+, 14%), 126 ([М+1-Вг-С02СНз]+, 6%), 70 
([C4H8N]+, 57%); anal, caled, for СдНідВгМОз : С, 40.92; H, 5.34, 
Ν, 5.30, found : С, 40.91; Η, 5.40; Ν, 5.27. 
N-[(R,S)-2-Bromo-3-methyl-butanoyl]-(S)-proline methyl ester 12: 
the procedure for the synthesis of 12 was unlike the other syntheses 
in that 1-hydroxybenzotriazole hydrate (6.73 g, 44 rrniol) was added 
to the reaction mixture prior to the addition of DCC. The reaction 
mixture had to be warmed up temporarily to achieve complete 
dissolution of the 1-hydroxybenzotriazole. Subsequently, treatment 
with DCC took place at 0oC again. Purification of the crude product 
by column chromatography (solvent system A) afforded a mixture of 
diastereomers in 86% yield. Separation of the diastereomers was 
accomplished by column chromatography, applying solvent system C. 
Compound 12a, N-[(S)-2-Bromo-3-methyl-butanoyl]-(S)-proUne 
methyl ester,48 was obtained in 33% yield. The compound was 
homogeneous on TLC (Rf 0.28, solvent system B) and was recrystallized 
from EtOAc/n-hexane, m.p.: 55-57^; iH-NMR : Б 4.71-4.34 (m, IH, 
CHCOz), 4.06 (d, IH, CHBr), 3.83-3.41 (m, 2H, D ^ N ) , 3.70 (s, ЗН, 
CO2CH3), 2.60-1.80 (m, 5H, CH2CH2CH2N and СН(СНз)2), 1.16 and 1.03 
(2xd, 6H, (СНз)2); exact mass caled, for СцН^ВгМОз (M++1), m/e 
292.0548, found : 292.0546; chemical-ionlzation mass spectrum, m/e 
(relative Intensity) : 294/292 ([M+l]+, 100%), 262/260 ([М-0СНз]+, 
15%), 234/232 ([М-С02СНз]+, 75%), 214 ([М+2Н-Вг]+, 61%), 212 
([М-Вг]+, 62%), 182 (11%), 154 ([М+1-Вг-С02СНз]+, 21%), 130 
([М+1-Вг(1-СзН7)СС(0)]+, 45%), 12Θ ([М-Вг(1-СзН7)СНС(0)]+, 82%), 
70 ([C4H8N]+, 9%); anal caled, for С Ц Н І ВГМОЗ : С, 45.22; H, 6.21; 
Ν, 4.79, found : С, 44.40; Η, 6.11; Ν, 4.69. 
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Compound 12b, N-[(R)-2-bromo-3-methyl-butanoyl]-(S)-proline 
methyl estera
 Was obtained in 23% yield. The compound was 
homogeneous on TLC (Rf 0.25, solvent system B) and was 
recrystallized from EtOAc/n-hexane, m.p.: 74-760C; 1H-NMR: δ 4.65 
-4.35 (m, IH, CHCO2), 4.00 (d, IH, СНВг), 3.91-3.36 (m, 2Н, СНгМ), 
3.76 and 3.73 (2xs, ЗН, СО2СН3), 2.62-1.74 (m, 5Н, CH2CH2CH2N and 
СН(СНз)2)» 1.20-0.95 (8 lines, 6Н, (СНз)2)· The ratio of rotamers 
was estimated at 2:1 in CDCI3. For the determination of the 
coalescence temperature (± 70oC) CD3NO2 (ratio rotamers 4:1) was 
used as solvent. Exact mass caled, for СцНідВгИОз (M++l), m/e 
292.0548, found: 292.0543; chemical-ionization mass spectrum, m/e 
(relative Intensity) : 363/361 ([M+C4H8N]
+
, 9%), 294/292 ([M+l])+, 
70%), 262/260 ([М-0СНз]+, 10%), 234/232 ([М-С02СНэ]+, 52%), 214 
([М+2Н-Вг]+, 37%), 212 ([М-Вг]+, 60%), 182 (4%), 154 
([М+1-Вг-С02СНз]+, 8%), 130 (СМ+1-Вг(І-СзН7)СС(0)]+, 22%), 128 
([М-Вг(і-СзН7)СНС0]+, 48%), 70 ([СдНвМ]-1-, 100%); anal, caled, for 
c l l H 1 8 B r N 0 3 : c. 45.22; H, 6.21; Ν, 4.79, found: С, 45.10; Η, 6.22; 
Ν, 4.77. 
N-[(R.S)-2-Bromo-2-phenyl-acetyl]-(S)-proline methyl ester 13, 
which was obtained in 59% yield, was homogeneous on TLC (Rf 0.24, 
solvent system B), no matter what the diastereomeric composition 
was. 
Compound 13a, N-[(S)-2-bromo-2-phenyl-acetyl]-(S)-proline methyl 
ester, could be recrystallized from EtOAc, m.p.: 137-1390C; 
[ a ] 2 2 : -2.5° (c=0.7; CHCI3); ІН-NMR : 6 7.62-7.27 (m, 5H, C 6H5), 
5.62 and 5.47 (2xs, IH, CHBr), 4.70-4.45 and 4.45-4.16 (2xm, IH, 
CHCO2), 3.82 and 3.69 (2xs, 3H, CO2CH3), 3.79-3.33 (m, 2H, CH2N), 
2.35-1.74 (m, 4H, CH2CH2CH2N); exact mass caled, for С^Н^ВгМОз 
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(M++1), m/e 326.0392, found: 326.0389; chemical-ionization mass 
spectrum, m/e (relative intensity) : 397/395 ([M+C^eN]-*·, 2%), 
328/326 ([Μ+1]+, 21%), 296/294 ([М-ОСНз]-1-, 1%), 268/266 
(СМ-С02СНз]+, 6%), 248 ([М+2Н-Вг]+, 14%), 246 ([М-Вг]+, 100%), 188 
([М+1-Вг-С02СНз]+, 2%), 130 ([М+1-С
б
Н5С(Вг)С(0)]+, 2%), 128 
([М-С6Н5СН(Вг)С0]+, 22%), 70 ([C4H8N]
+
, 12%); anal, caled, for 
c14 H16 B r N 03 : c. 51.55; H, 4.94; N, 4.29, found : C, 51.58; H, 4.99; 
N, 4.27. 
Equilibrium mixture of 13a and 13b (ratio 1:1); ^-NHR : δ 7.73-
7.24 (m, 5H, CeHs), 5.60, 5.56, 5.46 and 5.36 (4xs, IH, CHBr), 4.74-
3.99 (m, IH, CHC0 2), 3.87-3.32 (m, 2H, CH2N), 3.80, 3.75, 3.68 and 
3.57 (4xs, 3H, С02СНз), 2.45-1.73 (m, 4H, CH2CH2CH2N); the ratio of 
rotamers was 9:1 (13a) resp. 4.5:1 (13b). For the determination of 
the coalescence temperature (± 750C for both diastereomers) CD3NO2 
was used as solvent; in this solvent the ratio of rotamers was 
found to be 11:1 (13a) resp. 5.5:1 (13b). 
(R,S)-2-Bromo-2-phenyl-acetyl bromide 18 (a-bromophenylacetyl bromide) 
РВГ3 (171 g, 0.63 mol) was added all at once to a solution of 
2-bromo-2-phenyl-acet1c acid (32.44 g, 0.15 mol) in 100 ml of dry 
Et20. The reaction mixture was refluxed overnight. Then the solvent 
was removed by evaporation in vacuo, whereupon the pure product 18 
was obtained in 40% yield by distillation of the residue under 
diminished pressure (b.p. 1350C; 5 ran Hg). The product solidified 
upon prolonged storage in a refrigerator; ^-NMR (60 MHz) : 5 7.36 
(s, 5H, C6H5) and 5.69 (s, IH, CHBr); IR (CCI4) : 1810 cm"1 (C=0). 
N-[(R,S)-2-Bromo-2-phenyl-acetyl]-(S)-proline methyl ester 13 from 
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(S)-proline methyl ester 4-toluenesulfonic acid salt 5 and 2-bromo-
2-phenyl-acetyl bromide 18 
Triethylamine (0.84 g, 8.4 imiol) was added dropwise to a chilled 
(0oC) solution of 5 (1.21 g, 4 mmol) and 18 (1.22 g, 4.4 гшіоі) in 
4 ml of dry CH2CI2. The reaction mixture was stirred at room 
temperature for 2 hours after which the solvent was evaporated in 
vacuo. Subsequently, the residue was suspended in EtOAc, and washed 
successively with 0.1N aqueous HCl (two clear layers were obtained), 
5% aqueous МаНСОз (w/v) and brine. Finally the organic layer was 
dried over МагЗОд. Evaporation of the solvent in vacuo afforded a 
residue which was purified by column chromatography as described 
before. Thus compound 13 was obtained in 88% yield. 
N-[(R,S)-2-Chloro-2-phenyl-acetyl]-(S)-proline methyl estera 
Triethylamine (4.66 g, 46 irniol) was added dropwise to a chilled 
(0oC) and stirred solution of 3 (3.64 g, 22 mmol) and 2-chloro-2-
phenyl-acetyl chloride 19b (Janssen Chimica, 4.58 g, 24 гшіоі) in 
50 ml of dry CH2CI2. After completion of the addition, stirring was 
continued at room temperature for 4 hours. The product was isolated 
In 74% overall yield according to the same work-up procedure as 
described for 13. The diastereomers were separated by means of 
repeated column chromatography (solvent system B). 
N-[(S)-2-Chloro-2-phenyl-acetyl]-(S)-proline methyl ester 27a57 
was obtained in 22% yield from 3. The compound was homogeneous on 
TLC (Rf 0.20, solvent system B) and could be recrystallized from 
EtOAc, m.p. : 153-1550C; [ a ] 2 2 : -11.8" (c=0.7; CHCI3); iH-NMR : δ 
7.61-7.07 (m, 5H, CeHg), 5.55 and 5.37 (2xs, IH, CHCl), 4.69-4.42 
and 4.42-4.19 (2xm, IH CHCO2), 3.77 and 3.67 (2xs, 3H, CO2CH3), 
3.77-3.22 (m, 2H, CH2N), 2.47-1.71 (m, 4H, CH2CH2CH2N); the ratio 
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of rotamers is approximately 8:1; exact mass caled, for C14H17CINO3 
(M++1), m/e 282.0897, found : 282.0898; chemical-ionization mass 
spectrum, m/e (relative intensity) : 284/282 ([M+l]+, 74%), 252/250 
([М-0СНз]+, 6%), 248 ([M+2H-C1]+, 35%), 246 (CM-C1]+, 50%), 224/222 
([М-С02СНз]+, 34%), 218 ([M-C1-C0]+, 100%), 188 ([М+1-С1-С02СНз]+, 
12%), 156 (12%), 130 ([М+1-СбН5С(С1)С0]+, 16%), 128 
([M-C6H5CH(C1)C0]
+
, 90%), 70 ([C4H
e
N]+, 50%); anal, caled, for 
C14H16CINO3 : С, 59.68; H, 5.72; Ν, 4.97, found : С, 59.02; Η, 5.67; 
Ν, 4.89. 
N-[(R)-2-Chloro-2-phenyl-acetyl]-(S)-proline methyl ester 2U)57 was 
obtained in 28% yield from 3. The compound was homogeneous on 
TLC (Rf 0.24, solvent system B) and was recrystalllzed from EtOAc, 
m.p. : 107-109<>C; [ a ] 2 2 : -105.8e (c=0.7; CHCI3); ^-NMR : δ 7.63-
7.13 (m, 5H, C6H5), 5.55 and 5.37 (2xs, IH, CHCl), 4.76-4.29 (m, IH, 
CHCO2), 3.84-3.18 (m, 2H, СНгМ), 3.74 and 3.54 (2xs, ЗН, СО2СН3), 
2.43-1.70 (m, 4Н, CH2CH2CH2N); the ratio of rotamers is 
approximately 5:1; exact mass caled, for C14H17CINO3 (M++l), m/e 
282.0897, found : 282.0895; chemical-ionization mass spectrum, m/e 
(relative intensity) : 284/282 ([M+l]+, 97%), 252/250 ([М-0СНз]+, 
8%). 248 ([M+2H-C1]+, 73%), 246 ([M-C1]+, 61%), 224/222 ([М-С02СНз]+, 
50%), 218 ([M-C1-C0]+, 100%), 188 ([М+1-С1-С02СНз]+, 33%), 156 (12%), 
130 ([М+1-СбН5С(С1)С0]+, 35%), 128 ([M-C6H5CH(C1)C0]
+
, 78%), 70 
([C4HaN]+, 39%); anal, caled, for С^НібСІМОз : С, 59.68; H, 5.72; 
Ν, 4.97, found : С, 59.20; Η, 5.75; Ν, 4.90. 
For the determination of the coalescence temperature (± 750C 
for both diastereomers) CD3NO2 was used as solvent; in this solvent 
the ratio of rotamers was found to be approximately 8.5:1 for both 
diastereomers 21a and 21b. 
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General procedure for the synthesis of the bicyclic N-hydroxy-2,5-dioxo-
piperazines 14-17. 
To a solution of the relevant N-(2-halo-acyl)-(S)-prol1ne methyl 
ester 10-13 or 21 (10 imiol) 1n 100 ml of dry MeOH HONH2.HCI (6.95 g. 
100 mmol) and t-BuOK (11.22 g, 100 rnnol) were added successively. 
The resulting suspension was heated under reflux until completion 
of the reaction (2-72 hours) as monitored by TLC (solvent system B). 
After filtration of the reaction mixture the precipitate was washed 
thoroughly with MeOH/CHzClz (10:90, v/v), and the filtrate was 
concentrated to dryness 1n vacuo. The solid residue was suspended 
in 150 ml of Ме0Н/СН2СІ2 (10:90, v/v) and stirred at room temperature 
for a while. Filtration followed by removal of the solvent under 
reduced pressure afforded the crude product, which was purified by 
column chromatography (solvent system 0 (14), F (15 and 16) or G 
(17a and b)). 
The compounds thus obtained were contaminated slightly with 
Fe3 +, as could be deduced from their red colour. The impurity 
could be removed by treatment of a solution of the product with 
Spheron Oxlne 1000 (0.025-0.040 m m ) , 8 7 a powder consisting of 
polymer-bound 8-hydroxyquinoline.88 After filtration of the 
complexlng agent evaporation of the solvent in vacuo furnished 
mostly pure product. Sometimes removal of residual traces of ferric 
Ions had to be accomplished by washing the solid compound with a 
small amount of EtOAc. 
Cyclo-[(S)-prolyl-N-hydroxyglycyl] 14 was obtained in 25% yield 
after recrystallization from CH2CI2/CCI4, m.p. : 142-1440C. The 
compound was homogeneous on TLC (Rf 0.32, solvent system E); iH-NMR: 
б 6.63-5.49 (Ьг, IH, NOH), 4.63-4.01 (AB part of ABX spectrum and 
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m, ЗН, CH2N0 and СНСО), 3.91-3.32 (m, 2H, CHzN), 2.59-2.24 and 
2.24-1.67 (2xm, IH resp. ЗН, CH2CH2CH2N); IR (KBr) : 3360 (br), 
2800 (br) and 1660 (br) cm"1; exact mass caled, for С7Н1оМ20з (M+), 
m/e 170.0691, found : 170.0687; electron-Impact mass spectrum, m/e 
(relative Intensity) : 170 (M+, 20%), 154 ([M-0]+, 17%), 153 
([M-0H]+, 44%), 142 ([M-C0]+, 20%), 125 ([M-CH2N0H]+, 17%), 112 
(12%), 111 ([M-C0N0H]+, 21%), 98 (8%), 97 ([M-C(0)CH2N0H]+, 15%), 
83 (24%), 70 ([C4H8N]
+
, 100%), 69 (50%), 68 (20%), 56 (20%), 42 
(19%), 41 (37%), 28 (21%). 
Cyclo-[(S)-prolyl-(S)-N-hydroxy-alanyl] 15b was obtained in 46% 
yield.58 The compound was homogeneous on TLC (Rf 0.44, solvent 
system E) and could be recrystallized from CH2CI2/CCI4, m.p. : 
151-1530C; [ a ] 2 2 : -161.2е (c=0.235; MeOH); iH-NMR : 5 4.56-4.25 
(8 lines, IH, CHNO), 4.25-3.96 (m, IH, CHCO), 3.96-3.30 (m, 2H, 
CH2N), 2.68-2.22 and 2.22-1.77 (2xm, IH resp. 3H, CH2CH2CH2N), 1.66 
(d, 3H, CH3); exact mass caled, for C8H12N2O3 (M+), m/e 184.0848, 
found : 184.0848; electron-impact mass spectrum, m/e (relative 
intensity) : 184 (M+, 11%), 168 ([M-0]+, 59%), 167 ([M-0H]+, 17%), 
166 ([M-H20]+, 15%), 140 ([M-CH2N0]+, 11%), 125 ([М-СН(СНз)ИОН]+, 
34%), 123 (11%), 112 (6%), 98 (6%), 97 ([М-С(О)СН(СНз)М0Н]+, 35%), 
96 (6%), 70 ([C4H8N]
+
, 100%), 69 (50%), 68 (23%), 55 (10%), 44 
(46%), 43 (13%), 42 (26%), 41 (44%), 28 (32%). 
Moreover, a mixture enriched in the other diastereomer 15a 
(ratio 4.5:1) was obtained in 6% yield. This mixture of diastereo-
mers was also homogeneous on TLC (Rf 0.44, solvent system E); 
iH-NMR : б 4.55-3.95 (m, 2H, CHNO and СНСО), 3.95-3.32 (m, 2H, 
CH2N), 2.67-2.25 and 2.25-1.73 (2xm, IH resp. ЗН, CH2CH2CH2N), 1.67 
and 1.57 (2xd, together 3 lines, ЗН, CH3). 
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Cyclo-[(S)-prolyl-(R)-N-hydroxyvalyl] 16a was obtained in 61% 
yield from 12a. The compound was homogeneous on TLC (Rf 0.49, 
solvent system E) and could be recrystallized from CH2CI2/CCI4, 
m.p. : 170-172oC, [a] 2 2 = -145.5° (c=0.235; MeOH); ІН-NMR : 4.22 
and 4.22-4.02 (d resp. m, 2H, CHNO and CHCO), 3.88-3.30 (m, 2H, 
CH2N), 2.73-2.24 and 2.24-1.61 (2xm, 2H resp. 3H, CH2CH2CH2N and 
СН(СНз)2), 1.10 and 1.07 (2xd, 6H, (СНз)2); exact mass caled, for 
C10 H16 N2 03 ( M +). m/e 212.1161, found : 212.1165; electron-impact 
mass spectrum, m/e (relative intensity) : 212 (M+, 9%), 195 
([M-0H]+, 9%), 170 ([М-СНзС(Н)СН2]+, 25%), 153 ([M-C0N0H]+, 45%), 
141 ([M-C(0)CHN0]+, 54%), 125 ([М-СН(і-СзН7)МОН]+, 5%), 98 
([М-С(0)С(і-СзН7)М0Н, 5%), 70 ([C4H8N]
+
, 100%), 55 (7%), 41 (24%), 
28 (10%); anal, caled, for С ю Н ^ О з : С, 56.59; H, 7.60; Ν, 13.20, 
found : С, 56.18; Η, 7.56; Ν, 13.07. 
The mixture of 16a and Іба', obtained in 20% yield by ring 
closure of 12b, showed exactly the same data with the exception of 
the specific rotation; [a] 2 2 : +81.2° (c=0.235; MeOH). 
Cyclo-[(S)-prolyl-(R)-N-hydroxyphenylglycyl] 17a was obtained 
in 75% yield from 13a. The compound was homogeneous on TLC (Rf 0.49, 
solvent system E) and was recrystallized from МеОН/СНгСІг, m.p. : 
207-209oC(d); [a] 2 0: -111.7° (c=0.298; MeOH); ^-NMR: δ 7.37 (s, 
5H, CgHs), 5.41 (S, IH, CHNO), 4.31-4.01 (m, IH, CHCO), 3.87-3.30 
(m, 2H, CH2N), 2.64-2.29 and 2.29-1.70 (2xm, IH resp. 3H, 
CH2CH2CH2N); IR (КВг) : 3070, 2880, 1670 and 1630 cm"1; exact mass 
caled, for С^Н^МгОз (M+), m/e 246.1004, found : 246.1003; 
electron-impact mass spectrum, m/e (relative intensity): 246 ([M +], 
21%), 229 ([M-0H]+, 37%), 201 ([M-CH2N0H]+, 14%), 132 
([C6H5CH-N-C=0]
+
, 100%), 121 ([C6H5-CH=N-0H]
+
, 16%), 77 (23%), 70 
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([C4H8N]+, 40%), 51 (11%), 41 (14%), 28 (29%); anal, caled, for 
C13H14N2O3: С, 63.40; H, 5.73; Ν, 11.38, found: С, 63.50; Η, 5.73; 
Ν, 11.37. 
Ring closure of 21b afforded a mixture of 17a and 17b in 54% 
yield after column chromatography (solvent system G). After a 
second elution over silica gel (solvent system G) cyclo-[(S)-prolyl-
(S)-N-hydroxyphenylglycyl] 17b was isolated in 14% yield, based on 
21b. The compound was homogeneous TLC (Rf 0.46, solvent system E) 
and was recrystallized from CH2CI2/CCI4, m.p. : 184-1860C; [a] 2 0: 
-47.8° (c= 0.45; MeOH); ιΗ-Η№: δ 7.51 - 7.11 (m, 5H, СсН5), 5.32 
(d, IH, CHNO), 4.40 - 4.11 (m, IH, СНСО), 4.02 - 3.29 (m, 2H, СНгМ), 
2.69-2.39 and 2.28-1.74 (2xm, IH resp. 3H, CH2CH2CH2N); IR (KBr) : 
3110 (br), 2890 (br), 1660 and 1625 cm - 1; exact mass caled, for 
C13 H14 N2 03 ( M +). m / e 246.1004, found: 246.1007; electron-impact 
mass spectrum, m/e (relative intensity): 246(M+, 36%), 229 ([M-0H]+, 
34%), 201 ([M-CH2N0H]+, 12%), 132 ([СбН5СН=М-С=0]
+
, 100%), 121 
(CC6H5-CH=N-0H]
+
, 23%), 77 (28%) 70 ([C4H8N]
+
, 45%), 51 (12%), 41 
(18%), 28 (7%); anal, caled, for C ^ H ^ ^ : С, 63.40; H, 5.73; Ν, 
11.38, found : С, 62.93; Η, 5.76; Ν, 11.17. 
2-Benzyloximino-3-phenyl-propano¡c acid 23 
Phenylpyruvic acid sodium salt monohydrate 22 (7.71 g, 37.8 
mmol) was suspended in 160 ml of CHCI3. After the addition of 
O-benzylhydroxylamine hydrochloride salt (6.03 g, 37.8 mmol) the 
suspension was stirred at room temperature for 24 hours. Then 160 ml 
of H2O was added and stirring was continued until complete 
dissolution of all solids. The two clear layers were separated 
after which the organic layer was dried over N32504. Evaporation 
of the solvent in vacuo afforded 23 as a white solid in 95% yield. 
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Compound 23 was used in the next reaction without further purifica-
tion; ÌH-NMR : δ 7.31 and 7.22 (2xs, 10 H, 2x Cs»s)· 5.29 (s, 2H, 
CH2ON), 3.91 (s, 2H, CH2CN); IR (CCI4) : 3600-2500, 1770 and 1700 
cm
- 1
. 
2-Benzyloximino-3-phenyl-propanoyl chloride 24 
A solution of SOCI2 (12.6 g, 106 rmiol) in 28 ml of dry toluene 
was added at room temperature to a stirred suspension of 23 (9.30 
g, 34.5 (mol) in 35 ml of dry toluene. Stirring was continued for 
2h at 80eC after which the solvent and excess SOCI2 were evaporated 
in vacuo. To remove residual SOCI2 and liberated SO2, 70 ml of dry 
toluene was added and evaporated in vacuo; this was repeated twice. 
Finally residual traces of toluene were removed at a high vacuum 
pump. The crude product was obtained in 97% yield; ^-NMR : δ 7.35 
and 7.17 (2xs, 10H, 2x C6H5), 5.38 (s,2H, CH2ON), 3.87 (s, 2H, 
CH2CN); IR (CCI4) : 1740 cm"1. The compound was used irmiediately in 
the next reaction without further purification. 
N-(2-Benzyloximino-3-phenyl-propanoyl)-(S)-proline methyl ester 25 
A solution of triethylamine (3.03 g, 30 mmol) in 5 ml of dry 
CH2CI2 was added dropwise to a stirred and chilled (0oC) solution 
of 3 (2.49 g, 15 mmol) and crude 24 (4.32 g, 15 mmol) in 20 ml of 
dry CH2CI2· Stirring was continued at room temperature for 16 
hours. Then water was added to dissolve all solids. The resulting 
dear layers were separated, whereupon the organic layer was dried 
over N32504. The residue, obtained after evaporation of the solvent 
in vacuo, was purified by column chromatography (solvent system B ) , 
thus affording 25 as a yellow oil in 78% yield. The compound was 
homogeneous on TLC (Rf 0.40, solvent system B); ^-NMR: δ 7.28 and 
69 
7.21 (2xs, Ю Н , 2x C6H5), 5.18 and 5.13 (2xs, 2H, CH2ON), 4.80-4.62 
and 4.55-4.35 (2χ m, IH, CHCO2), 4.05 and 3.91 (AB-spectrum, Одв = 
13.2 Hz) and 3.97 (s, together 2H, СНгСМ), 3.77-3.31 (m, 2Н, СНгЮ, 
3.68 and 3.49 (2xs, ЗН, СО2СН3), 2.31-1.52 (m, 4Н, CH2CH2CH2N); 
according to this spectrum equal amounts of two rotamers are 
present. For the determination of the coalescence temperature 
(70-75<,C) CD3NO2 was used as solvent; in this solvent the ratio of 
rotamers was found to be approximately 1.5:1; exact mass caled, for 
C22 H25 N2 04 (M++l), m/e 381.1814, found: 381.1810; chemical-
ionization mass spectrum, m/e (relative intensity): 471 ([M+C7H7]+, 
10%), 381 ([M + 1]+, 100%), 321 {[М-С02СНз]+, 8%), 273 ([M-C7H70]+, 
11%), 128 ([M-C6H5CH2-C(=N-0Bzl)-C(0)]+, 84%), 118 ([C8H 8N]
+
, 16%), 
107 ([C7H70]+, 16%), 91 (1С7Н7У, 75%), 79 (16%), 70 ([C4HeN]+. 
20%). 
N-Benzyloxy-(R,S)-phenylalanyl-(S)-proline methyl ester 26 
Trimethylamine-borane (0.38 g, 5.2 mmol) was added at regular 
intervals to a stirred solution of 25 (1.01 g, 2.6 mmol) in 10 ml 
of dry dioxane, saturated with dry HCl. While stirring was 
continued at room temperature altogether 4.36 g (23 eq.) of the 
reducing agent was added spread over 10 days. Although the 
conversion was not complete, as monitored by TLC, the reaction 
was interrupted after 11 days. The reaction mixture was 
concentrated in vacuo. The resulting jelly-like material was 
dissolved in CH2CI2 and washed with 5% aqueous МаНСОз (w/v) and 
brine. The organic layer was dried over Na2S04 and then the solvent 
was evaporated in vacuo. Prior to purification of the residue by 
column chromatography (solvent system B), part of the borates was 
removed by crystallization from СНгСІг/п-Ьехапе. In addition to a 
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small amount of starting material (7%), pure 26 was obtained as an 
oil in 26% yield. The compound was homogeneous on TLC (Rf 0.17, 
solvent system B); iH-NMR : 5 7.45-7.08 (m, Ю Н , 2x C6H5), 4.77-
4.45 (m, IH, CHCO2), 4.61 (s, 2H, NOCH2), 3.87-2.85 (m, ЗН, СНгМ 
and CHNO), 3.71 (s, ЗН, СО2СН3), 2.75 (d, 2Н, CH2CHNO), 2.39-1.51 
(m, 4H, CH2CH2CH2N); exact mass caled, for C22H27N2O4 (M++1), m/e 
383.1971, found : 383.1968; chemical-ionization mass spectrum, m/e 
(relative intensity) : 383 ([M+l]+, 100%), 351 ([М-0СНз]+, 3%), 291 
([M-C7H7]+, 32%), 275 ([M-C7H70]+, 5%), 254 ([C6H5CH2CH(NH0Bzl)C0]
+
, 
8%), 245 ([М+1-0СНз-С7Н70]+, 17%), 226 ([C6H5CH2CH(NH0Bzl)]+, 29%), 
130 (49%), 128 ([М-СбН5СН2СН(МН0В2І)С0]+, 20%), 107 ([C7H70]+, 16%), 
91 ([C7H7]+, 61%), 79 (14%), 70 ([C4H 8N]
+
, 28%). 
Methyl E-a-phenylcinnamate 33 
A solution of α-phenylcinnamic acid 32 (c/s-form89, 11.2 g, 50 
nomol) was added dropwise to a stirred solution of an excess of 
diazomethane (100 mmol) in 400 ml of dry ether.90 During this 
procedure the reaction mixture was kept at 0oC. After completion 
of the addition the reaction mixture was stirred at room 
temperature overnight. The excess of diazomethane was removed by 
adding a few drops of acetic acid, after which the solvent was 
evaporated in vacuo. The product, obtained in quantitative yield 
as a yellow oil which solidified quickly, was used in the next 
reaction without further purification; ^H-NMR : 6 7.84 (s, IH, 
C6H5CH), 7.59-6.81 (m, 10H, 2x C6H5), 3.77 (s, ЗН, CO2CH3); exact 
mass caled, for C16H14O2 (M +), m/e 238.0994, found: 238.0986; 
electron-impact mass spectrum, m/e (relative intensity): 238 (M+, 
78%), 180 (50%), 179 ([М-С02СНз]+, 100%), 178 (76%), 165 (15%), 152 
(12%), 121 (88%), 89 (17%), 77(13%), 76 (13%), 51 (14%). 
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(E)-a-Phenylcinnamyl alcohol 3/ ((E)-2,3-diphenyl-2-propenol) 
A l.OM solution (22 ml, 22 mmol) of DIBAL-H 1n n-hexane was 
added carefully to a chilled (0oC) solution of 33 (2.38 g, 10 rmral) 
in 80 ml of dry toluene under an argon atmosphere. After stirring 
at 0oC for 30 min. and at room temperature for 1 hour the reaction 
was complete as judged by TLC (solvent system H). The reaction 
mixture was quenched with 2.5% (w/v) aqueous NH4CI (100 ml), 
whereupon the resulting pulp was filtered by suction using a 
sintered glass funnel. After adding EtOAc (100 ml) to the filtrate, 
the two layers were separated. The organic layer was washed with 
water and brine, dried over N32804 and concentrated In vacuo. The 
residue was purified by column chromatography (solvent system H), 
affording pure 31 in 66% yield. The product was homogeneous on 
TLC (Rf 0.27, solvent system H); m.p. : 70-72eC (lit.91 : 71-730C); 
iH-NMR: δ 7.34-6.85 (m, Ю Н , 2хС
б
Н5), 6.62 (s, IH, C6H5CH), 4.40 
(br.s., 2Η, СНгО), 1.72 (br., IH, ОН); (d6-DMS0): S 7.41- 6.81 (m, 
Ю Н , 2х С 6Н5), 6.60 (s, IH, С6Н5СН), 5.17 (br., IH, ОН), 4.19 
(br.s., 2Н, СНгО); UV : Ä m a x (EtOH), 222 and 255 nm (lit.9l : 222 
and 257 nm) ; exact mass caled, for C ^ H ^ O (M+), m/e 210.1045, 
found : 210.1042; chemical-ionization mass spectrum, m/e (relative 
intensity): 211 ([M+l]+, 3%), 210 (M+, 13%), 194 (16%), 193 
([M-0H]+, 100%), 139 (25%), 91 ( ^ 7 ] + , 11%), 49 (11%). 
Besides, a small amount (< 1%) of the Z-isomer was isolated; 
Rf 0.30 (solvent system H); iH-NMR : S 7.65-7.13 (m, Ю Н , 2х CeHs), 
6.93 (s, IH, CßHsCH), 4.69 (s, 2H, СНгО), 1.55 (s, IH, OH); UV : 
\nax ( E t 0 H ) . 271 nm (Ut. 9 1 : 273 nm); exact mass caled, for 
C15 H14 0 (M+)> m / e 210.1045, found : 210.1050; chemical-ionization 
mass spectrum, m/e (relative Intensity) : 211 ([M+l]+, 4%), 210 
72 
(M+, 18%), 194 (19%), 193 ([M-OH]+, 100%), 105 (10%), 91 ( [ С ; ^ , 
10%). 
General procedure for the epoxidation of allylic alcohols in the presence of 
one of the hydroxamic acids 14-17 
The allylic alcohol (3 mmol), the catalyst (V, Ti or Mo: 1-10 
mol%) and the hydroxamic acid (1.1 - 21 mol%) were dissolved 
successively in 60 ml of dry CH2CI2 under an argon atmosphere. The 
resulting solution was stirred at room temperature for 30 minutes. 
After adjustment of the desired reaction temperature {i.e. 0oC or 
20 oC), 1.5 ml of a 4.0M solution of tert-butyl hydroperoxide (6 
mmol) in dichloroethane or dichloromethane was added dropwise.9^ 
Stirring was continued at room temperature^ until completion of 
the reaction (1-10 days) as monitored by TLC (solvent system B ) . 9 4 
Then the reaction mixture was concentrated in vacuo and the residue 
was purified by column chromatography (solvent system I for 34, В 
for 35, and H for 36), affording the relevant epoxy alcohol in 17-
89% yield. 
trans-3-(n-Butyl)-oxiranemethanol 34 : Rf 0.20 (solvent system 
I); lH-mR : Б 3.95-3.45 (8 lines, 2H, CH2O), 3.08 (br., IH, OH), 
3.01-2.84 (m, 2H, СН0СН), 1.80-1.10 (m, 6H, CH2CH2CH2), 0.89 (m, 
3H, CH3); exact mass caled, for C7H15O2 (M+ + 1), m/e 131.1072, 
found : 131.1070; chemical-ionization mass spectrum, m/e (relative 
intensity) : 131 ([M + 1]+ , 15%) 113 ([M-0H]+, 29%), 95 (100%), 69 
(36%), 57 ([С^дГ, 8%), 43 (10%). 
Epoxygeraniol 35 : Rf 0.17 (solvent system I); ^-NMR : 6 5.09 
(br.t., IH, СНС(СНз)2), 4.00-3.52 (m, 2H, СНгО), 3.00 (dd, IH, 
CHCH2O), 2.36-1.34 (m, 5H, СН2СН2 and OH), 1.71 and 1.63 (2xs, 6H, 
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С(СНз)2). 1·33 (s, ЗН, СНз); exact mass caled, for СюНідОг (M++l), 
m/e 171.1385, found : 171.1385; chemical-ionization mass spectrum, 
m/e (relative intensity): 171 ([M+l]+, 4%), 153 ([M-OH]+, 30%), 135 
(49%), 123 (22%), 109 (70%), 95 (41%), 83 (32%), 69 (100%), 55 
(18%), 41 (44%). 
trans-2.3-Diphenyloxiranemethanol 36 : Rf 0.49 (solvent system 
B); iH-NMR: δ 7.17 (s, 5H, С 6Н5), 7.17-6.95 (m, 5Н, С6Н$), 4.50 
(s, IH, С 6Н5СН), 4.04 (d, 2Н, СНгО), 1.95 (t, IH, ОН); exact mass 
caled, for CisHisOz (M++1), m/e 227.1072, found : 227.1067; 
chemical-ionization mass spectrum, m/e (relative intensity): 227 
([M+l]+, 30%), 209 ([M-0H]+, 69%), 181 ([stilbene + 1]+, 46%), 167 
(58%), 131 (23%), 120 (33%), 105 (100%), 91 (22%). 
Generai procedure for the determination of the enantiomeric excess of the 
epoxy alcohols. 
Pyridine (0.166 g, 2.1 mmol) was added dropwise to a chilled (0oC) 
solution of the epoxy alcohol (2 rrmol) and freshly distilled acetyl 
chloride (0.165 g, 2.1 mmol) in 6 ml of dry CH2CI2.95 Subsequently 
the reaction mixture was stirred at room temperature until 
completion of the reaction as monitored by TLC (solvent system B). 
The reaction mixture was washed successively with 0.1N aqueous HCl, 
H2O, 1% (w/v) aqueous МаНСОз and H2O. After drying over N32804, the 
organic layer was concentrated In vacuo. The residue was purified 
by column chromatography (solvent system B), affording the epoxy 
acetates In approximately 85% yield. The e.e. of these compounds 
was established by ^-NMR spectroscopy using the chiral shift 
reagent tris-(3-(heptafluoro-propylhydroxymethylene)-d-camphorato) 
europium(III)(Eu(hfc)3, Janssen Chimica). 
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trans-3-(n-Butyl)-oxiranemethyl acetate (from 34); ^-NMR : 
δ 4.43-3.79 (AB part of ABX spectrum, 2H, CH2O), 3.03-2.75 (m, 2H, 
CHOCH), 2.08 (s, ЗН, СНзС(О)), 1.67-1.17 (m, 6H, CH2CH2CH2), 0.90 
(m, ЗН, СНз); exact mass caled, for C9H17O3 (M++1), m/e 173.1178, 
found : 173.1172; chemical-ionization mass spectrum, m/e (relative 
intensity): 173 ([M+l] + , 61%), 155 ([M-0H]+, 17%), 131 (6%), 113 
([М-СНзС02]+, 31%), 95 (100%), 69 (21%), 57 (7%), 43 (91%). 
Epoxygeranyl acetate (from 35) : Rf 0.45 (solvent system I ) ; 
^-NMR: б 5.05 (br.t., IH, СНС(СНз)2), 4.38-3.88 (AB part of ABX 
spectrum, 2H, СНгО), 2.96 (X part of ABX spectrum (dd), IH, 
CHCH2O), 2.24-1.35 (m, 4H, CH2CH2), 2.08 (s, ЗН, СНзС(О)), 1.66 and 
1.60 (2xs, 6H, С(СНз)2), 1.29 (s, ЗН, CH3); « a c t mass caled, for 
C12H2103 (M + +l). m/e 213.1491, found : 213.1484; chemical-
ionization mass spectrum, m/e (relative intensity): 213 ( [ M + l ] + , 
18%), 195 ([M-0H]+, 5%), 153 ([М-СНзС02]+, 40%), 135 (97%), 127 
(20%), 109 (40%), 95 (22%), 69 (60%), 43 (55%). 
trans-2,3-D¡phenyloxiranemethyl acetate (from 36); ^-NMR : 
S 7.15 (s, 5H, СбН5), 7.15-6.88 (m, 5Н, С6Н5), 4.61 and 4.35 (AB 
spectrum, Одв = 12.5 Hz, CH2O), 4.30 (s, IH, C6H5CH), 2.06 (s, ЗН, 
СНз). 
Asymmetric oxidation of thioanisole 38 
Vanadyl acetylacetonate (7.9 mg, 0.03 mmol), hydroxamic acid 17a or 
17b (22-37 mg, 0.09-0.15 mmol) and thioanisole 38 (0.372 g, 3 mmol) 
were dissolved successively in 60 ml of dry CH2CI2 under an argon 
atmosphere. After stirring at room temperature for 15 minutes the 
solution was cooled to CC. Then 1.5 ml of a 4.0M solution of TBHP92 
(6 mmol) was added dropwise, whereupon the reaction mixture was 
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stored in an refrigerator. The reaction was interrupted after 9-18 
days, depending on the amount of hydroxamic acid used, although the 
conversion was not complete as judged by TLC (solvent system H or 
J). Water (20 ml) was added dropwise to the chilled (0oC) reaction 
mixture. The layers were separated after stirring at 0oC for 15 
minutes and at room temperature for 30 minutes. The organic layer 
was dried over N32804 and concentrated in vacuo. The resulting 
residue was purified by column chromatography (solvent system K), 
affording pure methyl phenyl sulfoxide 39; ^-NMR (60 MHz): 6 
7.70-7.25 (m, 5H, C6H5), 2.66 (s, 3H, CH3). 
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CHAPTER IV 
SYNTHESIS OFN-HYDROXY ARNSTEIN TRIPEPTIDES : PROPOSED 
INTERMEDIATES IN THE BIOSYNTHESIS OF PENICILLIN 
4.1 INTRODUCTION 
More or less by chance Alexander Fleming (1929)1 observed 
antibiosis between a Pénicillium mold and neighbouring bacterial 
cultures. The antibacterial substance of Fleming's experiments 
proved to be penicillin,2 the oldest recognized antibiotic. The 
compound was the first microbial metabolite showing sufficient 
separation between toxicity to the bacterial cell and toxicity to 
the mammalian host to permit its use in the systematic treatment of 
bacterial infections of humans and animals. 
The recognition of the potential value of penicillin in 
medicine led to the inauguration of a monumental Anglo-American 
research programme during World War II aimed at producing the 
antibiotic in sufficient quantities for widespread use.3 The 
success of this enterprise was due largely to the rapid development 
of a fermentation process for large scale production of the 
antibiotic and to the selection of Pénicillium strains superior for 
antibiotic synthesis. 
Penicillin has turned out to be the progenitor of an important 
family of chemotherapeutic agents, the fi-lactam antibiotics.4·5 
Even over 40 years after their introduction, these compounds are 
still the most widely prescribed antibiotics used in medicine. The 
8-lactam antibiotics are made available for use in human medicine 
by virtue of microbial synthesis. Although totally synthetic methods 
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have been developed for the production of 0-lactam drugs,3"10 
currently all clinically used members of this class of antibiotics 
derive ultimately from a microbial source : fermentation still 
affords large quantities of 0-lactam compounds for use as anti-
biotics or as intermediates for semisynthetic variants.11 
Biogenesis of 0-lactam antibiotics has intrigued scientists 
already for decades. The investigation of the biosynthesis of the 
0-lactam antibiotics is not only of fundamental scientific 
importance, but has also some utilitarian aspects. The acquired 
knowledge may be used to improve the yield of penicillin from 
fermentation methods and to induce the production of new penicillins 
by adding appropriate precursors to the cultures. Especially the 
latter objective Is very Important and needs to be explained more 
fully. 
First and foremost is the constant need for new antibiotics 
with either different or broader antibacterial activities. A second 
spur is the search for 0-lactam antibiotics to combat bacteria 
which have built up a resistance against the more traditional 
penicillins. To be superior, any new antibiotic must at least 
resemble penicillin in its mode of action -inhibition of bacterial 
cell wall synthesis- and in its freedom from serious toxic effects. 
The first part of this chapter, i.e. 4.2 and 4.3, reviews our 
current knowledge of the biosynthesis of penicillin with particular 
emphasis on the youngest developments. 
The second part, i.e. 4.4-4.8, describes our attempts to verify 
the postulate that an N-hydroxy tripeptide might be Involved in 
penicillin biosynthesis. 
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4.2 STRUCTURE, OCCURRENCE AND BIOCHEMICAL MODE OF ACTION OF THE 
PENICILLINSAND CEPHALOSPORINS 
The discussion concerning the biosynthesis of p e n i c i l l i n w i l l 
cover to a certain extent the biosynthesis of cephalosporins too, 
since there exists a close biogenetic relat ionship between these 
two classes of compounds. 
The natura l ly occurring pen ic i l l i ns and cephalosporins are 
derivatives of a c/s-fused 0-lactam-thiazolid1ne ring system (penam) 
1_ and a c/s-fused ß-lactam-dihydrothiazine ring system (ceph-3-em) 
2, respectively. 
l,p»nam 2,ceph-3-«m 
The substitution pattern of the ring systems depends largely upon 
the organism producing the compound and the fermentation conditions. 
Actually one can distinguish between two kinds of fermentation.12-16 
One type, characterized by the potential production of an 
extensive range of penicillin antibiotics, has been classified as 
the Pénicillium type. An example of an organism exhibiting this 
kind of fermentation is Pénicillium chrysogenum. This mold 
incorporates many monosubstituted acetic acids (RCH2CO2H, where R 
is a nonpolar moiety) into penicillins so that the acid becomes the 
acyl substituent attached to the C-6 nitrogen in the penicillin 3 
via an amide linkage. 
Such aliphatic or aryl-substituted aliphatic carboxylic acids, or 
analogues which can easily generate such acids in vivo, can be 
present endogenously or added exogenously. Of the many penicillins 
biosynthetically producable this way, particularly benzylpenicillin 
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(penicillin G; 3, R= CßHs) and Phenoxymethylpenicillin (penicillin 
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V; 3, R= С6Н5О) are of great clinical utility. Two other products 
accumulate in this type of fermentation, especially when the 
availability of side-chain precursors Is limited. These are 
isopenidllin N (3, R= H02C-CH(NH2)(CH2)2), which has a S-I1nked 
L-a-aminoadipyl s1de-cha1n, and 6-aniinopen1c1llan1c a d d (6-APA; 4). 
The latter compound 1s an important Intermediate In the preparation 
of the so-called semi-synthetic penicillins, produced by acylatlon 
of the free amino group of 4. 
Cephaiosporlum acremonium typifies the organisms which show the 
other pattern of fermentation which is called the Cephaiosporlum 
type. These organisms excrete penicillin N, which has a 6-11nked 
D-a-aminoadlpyl side-chain, as the sole penicillin. It took some 
time before it was discovered that this compound Is formed 
intracellularly by eplmerization of the primary fermentation 
product Isopenidllin N. having the [--configuration In the side-
chain. 1 5· 1 7» 2 9 It is this type of fermentation which also yields 
a number of cephalosporin compounds, e.g. 5, R=H, OH or 0-С(0)СНз. 
π π π Η Η 
СОТ О ^ — Ni ,Jk. ^— N. Ж . 
1
 О ^ \ ^ CHjR О ^ ^yr^CHflÇCH, 
COjH 
6 
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The Cephalosporium type of fermentation so far encountered 
differs from the Pénicillium type in several aspects. It is 
insensitive to the addition of side-chain precursors to the 
fermentation medium. The cephalosporins and the penicillins which 
are excreted, have invariably the D-a-aminoadipyl side-chain. The 
amount of 6-APA (4) or 7-am1nocephalosporan1c acid (7-ACA; 6) which 
is formed in a Cephalosporium fermentation appears to be minimal 
or nil. 
As was mentioned already in the Introduction of this chapter, 
the curative effect of the ß-lactam antibiotics is attributable to 
their ability to inhibit bacterial cell wall synthesis. The 
bacterial cell wall Is a macromolecular network that surrounds the 
cell completely and provides its structural integrity. Of the 
several constituents of the cell wall, it is mainly the peptido-
glycan that determines the cell shape and imparts the rigidity 
necessary to protect the bacterium from osmotic rupture.18»19 
Except for minor variations and modifications, all bacterial 
peptldoglycans are similar in that they are built up of long, 
linear polysaccharide chains of alternating N-acetylglucosamine-
and N-acetylmuramyl peptide residues (see figure 1). These chains, 
extending 1n one direction, can be cross-linked directly or 
indirectly via the peptide side-chains. In the latter case the 
cross-link includes an short additional peptide. The length of such 
cross-linking peptides and their amino acid components vary with 
the species, e.g. in Staphylococcus aureus the chain is penta-
glyclne (figure 1). The extent of cross-linking varies with the 
bacterial species and growth conditions, and can range from as low 
as 25% in E. coll to more than 90% In S. aureus. 
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Fig. 1 : Completion of an indirect cross-link between two adjacent 
peptidoglycan chains in the bacterial cell wall 
N-Acetylglucosamine 
residue 
N Acetylmuramic 
acid residue 
Backbones of 
peptidoglycan chains 
-CK-Clv-D Ala 
/ 
The cross-linkage between parallel peptidoglycan chains 1s 
realized in the last stage of the cell wall synthesis through a 
transpeptidation reaction in which the amlno-termlnal glycine 
residue of the cross-linking chain displaces the carboxyl-terminal 
D-alanine from the end of the pentapeptide side chain of an 
N-acetylmuramylpentapeptide residue in the adjacent peptidoglycan 
chain. It is this reaction that is inhibited by 0-lactam 
antibiotics.18"21 
The transpeptidase Involved In this reaction reacts with Its 
H ÏH' н i \ н ÇH, 
H H H
'
NS5C„.. E¿Z E ÍZ-XH H /^'ΟΟ,Η ENZ 
7 
acyl-tniymt 
Irtactivt) 
90 
Substrate, an N-acetylmuramylpentapeptide residue, to form an acyl-
enzyme intermediate 7 with release of the terminal D-alanine residue 
(eq.l). This acyl-enzyme intermediate 7 then reacts with an amino 
group (e.g. Gly-NH2, fig. 1) from an adjacent peptidoglycan strand. 
Nowadays it is generally accepted that penicillin inhibits the 
transpeptidase by forming a covalent bond with an amino acid 
residue (serine?19·^) at the active site of the enzyme (eq.2). 1 9" 2 1 
R'NH, 
—X » 
Probably the resulting peni cilloyl-enzyme 8 is relatively stable 
and resistant to attack by cell wall amino groups. Hence, the 
transpeptidase Is irreversibly inhibited by penicillin. 
It has been proposed that penicillin Inactivates the peptido-
glycan transpeptidase so effectively by acting as a structural 
analog of the enzyme's natural substrate, the acyl-D-alanyl-D-
alanine terminus of the nascent peptidoglycan strand (see 
fig./eq.l). This theory is known as the "substrate analog 
hypothesis".21,22 when molecular models of penicillin and acyl-D-
alanyl-D-alanine are compared indeed a conformational similarity is 
observed (fig. 2 ) . In contrast with normal amide bonds, the amide 
bond in the ß-lactam ring is very reactive. X-ray analysis has 
shown that the N-atom in the B-lactam ring is distinctly pyramidal 
in both the penicillins and the cephalosporins23, indicating a 
lower amide resonance stabilization than in normal amides. 
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(eq2) 
CO,H 
penictlloyl- enzyme 
Isl ible) 
Fig.2 : Stereoprojection of penicillin (upper left) and acyl-D-
alanyl-D-alanine (lower right). The arrows indicate the 
amide bonds cleaved by the transpeptidase. 
This must be caused by the ring strain, which hinders an efficient 
orbital overlap of the ß-lactam carbonyl- and amino-function. 
Figure 2 shows that the highly reactive CO-N bond in the p-lactam 
ring of penicillin occupies a spatial position analogous to that 
of the CO-N bond In acyl-D-alanyl-D-alanine. 
Despite of these unique properties of the 0-lactam antibiotics, 
several strains of bacteria have, as indicated already before, 
built up a resistance against some of them. These bacteria are able 
to synthesize an enzyme, a so-called ß-lactamase, which can 
hydrolyze the CO-N bond 1n the ß-lactam ring (eq.3).20.24-26 
<«q3) 
/J- LACT 
CO,H 
9 pvKiUoic acid 
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The product of th is reaction, pen ic i l l o i c acid 9, is Inactive as an 
an t i b i o t i c . The ac t i v i t y of the enzyme depends markedly on the 
nature of the substltuents attached to the Mcyc l i c nucleus of the 
ß-lactam compounds.20,26 д 5 a consequence (seml-)synthetic p-lactam 
a n t i b i o t i c s bearing substltuents that render them unsusceptible to 
P-lactamase, are c l i n i c a l l y very important. 
4.3 BIOSYNTHESIS OF THE PENICILLINS AND CEPHALOSPORINS 
4.3.1 Introduction 
Several excellent reviews on penicillin biosynthesis have 
appeared in the last decade.13-15,27-29 j^is section reflects the 
current state of affairs. It must be emphasized that many of the 
facts mentioned in this section were not known when we started our 
research program (1981; see section 4.4). 
4.3.2 Formation of the penicillins and cephalosporins from the constituent 
amino acids 
The penicillins and cephalosporins are synthesized from the 
three amino acids L-a-aminoadipic acid 10, L-cysteine 11 and L-
vallne 13. The consecutive reactions leading to the antibiotics are 
depicted in scheme I. 
First the dipeptide 5-(L-a-aminoad1pyl)-L-cysteine 12 is formed, 
which then combines with L-vallne 13 to form 6-(L-a-am1noadipyl)-
L-cysteinyl-D-valine 14. It should be noted that the incorporation 
of L-val1ne 13 In the tripeptide 14 Is attended with inversion of 
its chlral centre. The tripeptide 14 Is named after Its discoverer, 
Arnstein.30 The next step is the cyclizatlon of the Arnstein tri­
peptide 14 to isopenidlHn N 15. Subsequently the metabolic fate 
of isopenidlHn N differs depending on the organism. 
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In Pénicillium chrysogenum, and other fungi exhibiting the 
Pénicillium type of fermentation, Isopenicillin N 1J> can be 
converted into one or more penicillins with a monosubstituted 
acetyl side chain derived from an appropriate monosubstituted 
acetyl-CoA precursor. Whether this happens by transacylation of 
isopenicillin N (15 -» 16), or deacylatlon to 6-APA 4 and subsequent 
reacylatlon, or via both processes, is not clear yet. 
In species showing the Cephalosporium type of fermentation, 
e.g. Cephalosporium acremonium and Streptomyces clavuHgerus, the 
6-(L-a-aminoadipyl) side-chain of 15 undergoes inversion and the 
resulting penicillin N ^7 1s excreted. Part of the penicillin N 17 
is converted Intracellularly into deacetoxycephalosporin С 18. This 
ring expansion reaction can be followed by an oxidation of the 
exocyclic methyl group, affording deacetylcephalosporin С 19. 
Subsequent acetyl at1 on yields cephalosporin С 20. 
4.3.3 Conversion of i-(L-a-aminoadipyl)-L-cysteinyl-D-valine into 
isopenicillin N 
After the Isolation30 of the Arnsteln tripeptide 14 its 
biochemical conversion into Isopenicillin N 15 has been introduced 
as a presumption,31 known as the Tripeptide Theory. It was 
fortified, more than 10 years later, when it was noted that the 
configurations of the constituent amino acids of 14 appear to match 
those of the corresponding units in 15.32,33 д significant break­
through was achieved in this field of research by the development 
of reliable cell-free systems. This enabled Abraham's 1 7» 3 4 and 
Baldwin's35 group to deliver further support for the Tripeptide 
Theory. 
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Some years later the enzyme Isopenldllln N synthetase (IPNS) 
that catalyzes the conversion of 14 Into ^5 was purified.3(>.37 
Subsequently, the gene encoding IPNS in Cephalosporium acremonlum 
was Isolated and, after cloning it Into an E. coll expression 
vector. Inserted into E. coli.38 The recombinant E. coll thus 
obtained, produced IPNS as the major protein of the cell (~ 20% of 
the cell protein). This may be considered as a highlight in 
3-lactam research. 
Before this major achievement was accomplished, several 
problems concerning the conversion of 14 into 15 were studied by 
means of cell-free systems, prepared by osmotic lysis of 
protoplasts of Cephalosporium acremonlum,17 or purified IPNS. 
This approach afforded a number of new insights. 
So it was established that the enzyme uses di oxygen as a 
cosubstrate for the oxidative cyclizatlon of 14 to 15 : one mol of 
dioxygen Is used for the synthesis of one mol of 15, which is the 
stoichiometry expected for the loss of four hydrogen atoms from 
14 (eq.4).39 
Ft1', OTT 
leg«) (LLD)-ACVIH) + 0¡ . ». Isopemcillin N (15) -t- 2H,0 
L-ascorbate, cátalas« 
To stimulate activity four cofactors are used in the incubation of 
the (LLD)-ACV 14 with a cell-free system or IPNS. It seems that of 
these cofactors only ferrous Ion has a primary function, whereas 
the other three, L-ascorbate, DTT and catalase, play a role in 
maintaining both the enzyme and its substrate in their active 
(-thiol) form.28 
To a certain extent the enzyme tolerates some structural 
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variations in the substrate (see also section 4.3.4). As far as the 
α-amlnoadipyl side-chain is concerned, the minimal structural 
requirement for N-acyl-L-cysteinyl-D-valine peptides to be 
converted into penicillin products by IPNS is that the N-acyl 
group has a six carbon or equivalent chain, terminating in a 
carboxyl group. 4 0· 4 1 This points to a distance between the 
binding site and the active site (which is probably bound to 
the cysteinyl thiol group of the substrate) which corresponds with 
the distance between the carboxyl group in the side-chain and the 
thiol group in a substrate. 2 8· 4 0 If the substrate does not fulfil 
the before-mentioned criteria it is not at all or only slowly 
converted into a penicillin, as was demonstrated by the slow 
formation of penicillin V (eq. 5; 23, R=PhOCH2) and penicillin G 
(eq. 5; 23, R=PhCH2) from the corresponding dipeptide derivatives 
(21, IUPhOCH2 or PhCH2, respectively).42 
Various features with respect to the stereochemical course of 
the oxidative condensation have been determined and are summarized 
in eq.5. 
H ® © .
 A 
© X0'H 
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Although a free or enzyme-bound intermediate has not yet been 
detected,4·' Baldwin succeeded in finding direct evidence for a 
stepwise ring closure involving initial ß-lactam formation, 
i.e. 21->22.44 This finding and the presence of at least one 
cysteinyl thiol in IPNS, whose blockade Inhibits the enzyme's 
activity,45 point to the formation of an enzyme-bound monocyclic 
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ß-lactam intennedlate like 22.27,28 Attempts to use 0-lactam 24 
as a substrate of IsopenicilHn N synthetase were unsuccessful as 
the pH-stability range of 24 and that of the enzyme do not overlap 
sufficiently.28.46 
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It has been shown45 that transfer of sulphur between the 
Arnsteln tripeptlde molecules (21, R»5-(L-a-am1noad1pyl)) does not 
occur during their conversion into IsopenicilHn N (23, 
R=6-(L-a-aminoad1pyl)), which Indicates that the Integrity of the 
cysteinyl C(3)-S bond Is maintained. 
The ß-lactam formation occurs with complete retention of the 
cysteinyl 3-pro-R-hydrogen and with complete loss of the cysteinyl 
3-pro-S-hydrogen (H*). 4 7 Similarly, the closure of the thlazolidlne 
ring by C-S bond formation (22->23) proceeds with complete retention 
of the valyl C-3 stereochemistry.48 It has been demonstrated 
clearly13-15.27-2^,45,47-53
 t h at all of the atoms of 21 except 
those which have been asterisked, are Incorporated into 23. The 
observation that the encircled protons are retained, rules out 
mechanisms Involving the formation of free Intermediates containing 
a dehydrocystelne (25) or a dehydrovaline (26) residue during ß-
lactam and thlazolidlne ring formation, respectively. 
R H JH R H ö L S H 
0
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It remains to be explained by which mechanism 14 is converted 
Into 15. The next section will be concerned with this question. 
4.3.4 Mechanism for the oxidation of b-(L-a-aminoadipyl)-L-cysteinyl-D-
valine 
4.3.4.1 Introduction 
Although the biogenetic precursors of penicillins and 
cephalosporins were established with relative ease, attempts to 
elucidate by which mechanism the fused ring systems are formed have 
met with considerable difficulties. A number of plausible 
Intermediates have been proposed on the basis of chemically 
feasible mechanisms for the formation of the penam nucleus.13"15 
However, over the past few years most of these hypothetical 
Intermediates have been precluded on the basis of isotopie 
labelling studies (see 4.3.3)lìi or, alternatively, by direct 
assessment of the synthesized "Intermediates" as substrates for 
cell-free Isopenicillin N synthesizing systems.15,28,54 
The Intention of this section 1s to summarize the prevailing 
ideas with regard to the mechanistic course of the cydization of 
the Arnstein trlpeptlde 14, affording isopenicilUn N 15. 
4.3.4.2 β -Lactam ring formation 
Despite intensive investigations the intimate details of the 
formation of the {(-lactam ring have not yet been elucidated 
completely. Since a large number of labelling experiments have set 
fairly rigid requirements for any proposed Mosynthetlc mechanism, 
only four general mechanisms, which are in accord with present 
experimental data, have remained. 
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In one of them, the intermediacy of an activated alcohol is 
proposed (scheme I I ) . 1 5 
Sehern» Il 
H ^SH 
_
 Η<>Γ^Ύ" 
Stereospecific hydroxylation at C-3 in the cysteinyl residue of 14 
followed by activation of the hydroxyl group, 27 •* 28, and intra­
molecular displacement of the activated hydroxyl group, 28 ·• 24, 
may yield the 3-lactam ring. As C-N bond formation proceeds with 
retention of configuration,47 both hydroxylation and intramolecular 
displacement would have to occur either with Inversion or with 
retention of configuration. However, while most hydroxylations at 
aliphatic carbon occur with retention, the intramolecular 
displacement 1s expected to occur with Inversion. Consequently, 
this mechanism Is rather improbable as it should Involve unusual 
stereochemistry. Besides, it must be noticed that at least 24 must 
be bound to the enzyme by its thiol functionality, since such a 
compound is not stable as a free Intermedíatele»4*» under the 
incubation conditions. 
A second proposal Involves oxidation at sulfur, resulting in 
the formation of the thioaldehyde Intermediate 30 (scheme III). 1 5 
This mechanism is contradicted by Baldwin's observation46*»*1 that 
under the incubation conditions 24 1s not stable and 1s converted 
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into 30, which subsequently reacts very fast Intermolecularly with 
a nucieophile. A slight modification of the mechanism depicted in 
scheme III, which meets this difficulty, involves the intermediacy 
of 31, an enzyme-bound thioaldehyde55 which is fomed by a Purmierer 
reaction^ of an appropriate sulfoxide and subsequently converted 
into an enzyme-bound ß-lactam like 22. This fits in with all 
available experimental data. 
S-ENZYME 
H,:>r^rN 
The feasibility of such a mechanism has been demonstrated by some 
model reactions.55 
As a third possibility, a free radical intermediate has been 
considered (scheme iv).27,57-60 E v e n though proceeding in low 
yields, reactions in model systems proved the feasibility of route 
д.57,59 Although the chemical validity of the other route (B) could 
not be established, 2 7· 6 0 a modified version of this mechanism 
(scheme V), also involving the intermediacy of isothiazolidinone 
32, was supported by experiments in model systems.61 
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Finally, the fourth alternative, i.e. a route via an N-hydroxy 
tripeptlde, will be discussed In section 4.4. 
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4.3.4.3 Thiazolidine ring forma tion 
In contrast with the uncertainty about the mechanistic pathway 
of 0-lactam ring formation, all information concerning thiazolidine 
ring formation points to a mechanism involving a free radical 
intermediate (scheme VI; R 1=R 2=Me). Attempts to model this ring 
closure by using artificially reactive systems were not always 
successful. 6 2 - 6 5 
On the other hand, convincing data supporting the intermediacy 
of a free radical intermediate were acquired, especially during the 
last few years, from experiments with structural analogues of the 
Arnstein tripeptide 14, characterized by substantial variations of 
the valyl moiety. 2 8· 6 6" 7 4 It was shown that isopenici 11 in N 
synthetase 1s able to accept such modified tripeptides and transform 
them Into substituted derivatives of Isopenicillin N. Besides, 
R »8 -1L - a - atninoadipyl ) 
S-ENZYME 
H H H I 
-Υ T T ν 
0
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Τ π .^ 
33 
H CO,H 
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R ' . R Î C H , 
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N » 1 1 * 5 , J»' 
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CO.H 
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dependent on the nature of the substltuents R1 and R 2 (scheme VI), 
the formation of new Ысусііс 0-lactams, containing a six- or even 
seven-membered heterocycle, was observed in some cases. Both the 
regio- and stereochemical course of the reactions were 1n accord 
with the formation of the free radical intermediate 33. From the 
results it is evident that the active site topology of the enzyme 
puts strong restraints on the rotational motion in 33 (see arrow) : 
only when R1 or R 2 1s deuterium, rotation is possible.2θ,4β,69 
Furthermore, as a working hypothesis an intermediate organoiron 
species 34 (scheme VII) has been suggested.28,74,75 such a species 
might undergo homolysis and subsequent recombination, affording 
the blcyclic product (see also section 4.8. ). 
Scheme VII 
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The attractiveness of this rationale 1s that it explains the 
function of the ferrous Ion, one of the cofactors used in 
incubations.28 
4.4 N-HYDROXYARNSTEIN TRIPEPTIDES AS INTERMEDIATES IN PENICILLIN 
BIOSYNTHESIS : A POSTULATE 
Since the formation of the ß-lactam ring as well as the 
thlazolidine ring Is an oxidative process, It has been proposed 
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that the N-hydroxy peptides 35-37 might be involved as intermediates 
in penicillin biosynthesis. 
35 X-H,Y=OH 
36 X'Y'OH 
37 Χ·ΟΗ,Υ = Η 
Ϋ 
It has already been mentioned that oxidation of nitrogen is an 
activating step In the metabolism of many nitrogen containing 
compounds (see section 1.1). Besides, 1t has been demonstrated that 
many natural hydroxamic acids arise from corresponding amides by 
direct oxidation (see section 2.4). A substantial number of natural 
products containing one or more oxidized peptide bonds, -C(0)-N(0H)-, 
have been found in nature, some of them being produced by species 
belonging to the genus Pénicillium.76-78 These compounds are of 
continuing Interest owing to their biological activity 7 6» 7 7· 7 9 and 
their proposed Intermediacy in the biosynthesis of microbial 
metabolites.80·81 
As was discussed in section 4.3, chlral labelling studies have 
placed severe restrictions on any mechanism proposed for the 
biochemical oxidation of the Arnstein tripeptide to the penam 
nucleus. Mechanisms, which satisfy the requirements for retention 
of the α-S and ß-pro-R protons of the cysteine residue and the 
α-hydrogen of the (D)-vallne residue, can however be formulated 
for the conversion of each of the N-hydroxy Arnstein tripeptides 
35-37 into isopeniclllin N. These mechanisms will now pass in 
review. 
Oxidation at the nitrogen of the valine residue in the 
tripeptide 14, followed by nucleophilic displacement by an anion 
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generated at the 3-carbon atom of the cysteine fragment has been 
proposed by Birch and Smith 8 2 (scheme VIII). 
Scheme VIII 
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Scott81 worked out this postulate by proposing the formation of 
a hydroxamic acid Intermediate 35 (scheme VIII; L=0H). This hypo-
thesis was supported by the model chemical reaction which Is 
depicted 1n eq.6.81 
(•Ч·6' \ / ' t-BuOK/THF 
50% 
The two other N-hydroxy peptides 36 and 37 were proposed as 
Intermediates by our group (see e.g. ref. 83). The mechanisms 
depicted in scheme IX may account for the eventual conversion of 
36 and 37 into isopenicillln N. In the first step water is 
eliminated to give 38a resp. 39a. Then 1n both compounds the double 
bonds rearrange to give the dehydro-lntermedlates 38b resp. 39b. 
Intramolecular attack on the double bonds 1n 38b by the valine 
nitrogen atom and the sulfur atom yields Isopenicillln N. In 39b 
only one double bond is present. NucleophiHc attack of the valine 
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nitrogen atom on this double bond gives the monocyclic intermediate 
39c, which has to be converted subsequently into isopenicillin N 
by thiazolidine ring formation via another mechanism. The mechanisms 
will only be compatible with the results of chiral labelling 
studies when the α-hydrogens, which are abstracted during the first 
step, are replaced 1n the original positions by the enzyme. This 
condition may be fulfilled if during the whole process the dehydro-
intermediates 38 and 39 remain enzyme-bound like depicted in scheme 
IX. It is worth noting that this assumption Is supported in that 
there is indeed no experimental evidence for the accumulation of 
any free Intermediate during the in vitro enzymatic transformation 
of the Arnstein tripeptide to Isopenicillin N. 
It has also been suggested that for the potential conversion of 
35 into isopenicillin N an alternative mechanism, analogous to those 
pictured in scheme IX, can be formulated (scheme X>). 
Scheme X 
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However, since the intermedlacy of 41 appeared to be in conflict 
with Baldwin's observation440»54 that 41 does not behave as 
a substrate of the IPNS, this Idea was abandoned. 
To test the validity of the postulate the N-hydroxy peptides 
35-37 had to be synthesized. Subsequently direct assessment of the 
synthesized 'intermediates' as substrates for a cell-free isopeni-
cillin N synthesizing system should prove whether they are converted 
into isopenicillin N or not. So, we aimed at the total synthesis of 
the three N-hydroxy peptides 35-37. The results of this 
investigation are presented in the next part of this chapter. 
4.5 GENERAL REMARKS WITH RESPECT TO THE SYNTHESIS OF N-HYDROXY 
PEPTIDES 
Before describing the results of our attempts to synthesize the 
N-hydroxy peptides 35-37 some general information concerning the 
synthesis of N-hydroxy peptides is given.ö4-87 
Although N-oxidation plays a role 1n the in vivo metabolism of 
amines and amides, N-hydroxy peptides are not yet accessible by in 
vitro oxidation of the peptide bond.88 Therefore unambiguous 
synthesis of N-hydroxy peptides, just as that of 'normal' peptides, 
must go through three stages : synthesis of adequately protected 
N-hydroxy amino acids, formation of the N-hydroxy peptide bond, and 
finally selective removal of one or more of the protecting groups. 
R' Y O R' Y О R' Y О 
Χ O R2 Χ Ο R' Χ Ο R1 
х = н,ор
г
, Υ=ΟΡ'Η ΧίΗ,ΟΗ,γ-ΟΗ,Η 
Asactivating group 
PaprolMting group 
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This process is illustrated in eq.7 for the synthesis of a 
dipeptide having one (X or Y = OH) or two (X = Y = OH) N-hydroxy 
functions. In contrast to 'normal1 peptide synthesis there are 
mainly two differences. 
First, due to the inductive effect of oxygen the nudeophiHclty 
of the hydroxylamine function, and even more so of the 0-benzyl 
derivative (vide infra), is decreased. Consequently coupling 
requires highly activated carboxyl groups.85 Secondly, for 
unambiguous N-acylation the use of O-protected N-hydroxy amino 
acid derivatives is often required. For this purpose the benzyl 
group was found to be the most suitable protecting group,89 although 
it causes increased steric hindrance and decreased nucleophlllclty 
compared to the corresponding free hydroxylamine function. It can 
be removed by hydrogenolysis,853·'' by treatment with boron tris-
(tr1fluoroacetate),85a«b or, as shown only recently,90 by treatment 
with sodium in liquid ammonia. 
A special problem anticipated in the synthesis of the N-hydroxy 
Arnstein tripeptldes concerns the synthesis of the N-hydroxy 
cysteine residue. Due to the presence of the easily oxidlzable 
sulfur atom this residue 1s not accessible by oxidation of cysteine. 
Eq.8 and 9 show how we Intended to circumvent the anticipated 
problems. 
The strategy employed involved nucleophlUc substitution of 
bromine in 42 by a suitable mercaptlde 1on. Then, by using a method 
developed in our laboratory,91"94 reduction of the oxime double 
bond should yield racemic 43. In order to achieve selective N-
acylatlon we preferred the use of O-protected N-hydroxy amino acid 
derivatives. Consequently a highly reactive carboxylic a d d 
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derivative was needed, i.e. an acid chloride (eq.9). 
4.6 ATTEMPTED SYNTHESIS OFN-[B-(L-<l-AMINOADIPYL)-L-CYSTEINYL]-N-
HYDROXY-D-VALINE (35) 
4.6.1 Introduction 
Our first goal was the synthesis of compound 35. Taking into 
account the special demands made upon N-hydroxy peptide synthesis 
we designed the synthesis plan depicted in scheme XI. 
It was agreed that Prof. Dr. J.E. Baldwin (Oxford University) 
would supply us with an amount of compound 48. So, in order to 
reduce the number of deprotection steps to a minimum, benzyl groups 
were used for the protection of the functional groups of 47, with 
the exception of the thiol functionality. The choice of the S-
protectlng group deserves some coment. 
It was recognized that only rather mild conditions could be 
used for the removal of the protecting groups. Basic conditions 
would be mischievous because it Is well documented that compounds 
like 49 and 35 undergo readily elimination of benzyl alcohol and 
H2O, respectively84 (see section 2.2.3). An acid-labile S-
protecting group would not be compatible with the conditions 
H I 
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(HBr/AcOH) used for the selective removal of the benzyloxycarbonyl-
group, 46 -* 47, at an early stage of the synthesis. So, we chose 
for a two-step deprotection of compound 49. 
First, all the benzyl groups would be removed by catalytic 
hydrogenolysls. It was realized that poisoning of the catalyst 
might be a problem. However, it 1s well-known95 that this can be 
prevented by modifying the catalyst or adaptation of the reaction 
conditions. The second step would involve a treatment with Hopkins 
reagent96 (HgS04/H2S04) to remove the remaining p-aminobenzyl group 
from the sulfur atom.97 Finally, decomposition97 of the resulting 
mercury complex with H2S should yield the free peptide 35. 
Before reporting the results of our attempts to construct 
tripeptide 35 according to scheme XI, attention will be payed to 
the synthesis of the starting materials. Several methods for the 
synthesis of compound 4Θ have already been published, see e.g. 
ref. 98. The synthesis of the compounds 44 and 45 will be the 
subject of the next two sections. 
4.6.2 Synthesis ofN-benzyloxycarbonyt-S-(4-nitrobenzyl)-L-cysteine 
The synthesis of 44 was a two-step procedure (scheme XII). The 
first step Involved protection of the sulfur atom of L-cysteine 51; 
nucleophilic attack on 4-n1trobenzyl chloride 52 afforded compound 
53 1n good yield.99 
Subsequently the benzyloxycarbonyl group was introduced, using 
the N-hydroxyphtalimlde derivative 54, 1 0 0 for the protection of the 
amino group. Purification of the product 44 was achieved by 
converting it into Its dlcyclohexylamine salt 55,ЮІ which could 
be crystallized from 2-propanol. 
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4.6.3 Synthesis of N-benzyloxy-D,L-vaHne benzyl ester 
Most syntheses reported so far for N-hydroxy-a-amino acid 
derivatives are laborious, give poor yields or have limited 
application.102»103 The method of choice for the synthesis of 
N-hydroxy-a-amino acid derivatives is reduction of the corresponding 
oximino compounds (eq.10). These precursors are readily available 
by reaction of hydroxylamines with a-keto acid derivatives. For the 
reduction mild reagents have to be employed to avoid over-reduction 
to the corresponding α-amino acids. Cyanoborohydrides meet this 
requirement; they have been used 1 0 3" 1 0 5 for the reduction (50-75% 
yield) of α-oximino carboxyllc acids (eq.lO; R2=H, X=0H). However, 
the reaction fails when esters or amides (eq.10; X=0R3 or NHR3) 
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are used because they compete with the oxime for protonation.83 
The use of a borane-pyridine complex as the reducing agent 
solves this problem (eq.10). 9 1 
««nor· pyridine-BH, or ICH, I. 
H* OR! 
When even stronger acidic reaction conditions are needed to 
protonate the oxime function, an amine-borane complex {e.g. 
(СНз)зН.ВНз) can be used, because it is more acid-stable than the 
borane-pyridine complex. It has been employed with esters, amides, 9 2 
p-nitrophenyl esters,^3 and for the synthesis of N-hydroxy 
tryptophane.^4 
Whereas this method seems to be of general applicability, its 
drawback is the formation of racemic mixtures. This didn't keep us 
from using this method for the synthesis of 45 (scheme XIII). 
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The preparation of 58 from 56 has been described before 93 
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Transesterification of 58 to 59 proceeded smoothly, affording crude 
59 in quantitative yield. Crude 59 could be used in the next step, 
involving reduction of the double bond 59 •» 45, without affecting 
the yield. Thus, on reduction of 59 with (СНз)зМ.ВНз in anhydrous 
ether, saturated with HCl, compound 45 was obtained in 65% yield 
after column chromatography. Ether Instead of an alcohol was used 
as solvent In this reaction to avoid possible transesterification. 
A slight impurity still present after the procedure could be 
removed by converting the desired compound 45 Into its hydrochloride 
salt 60. In contrast with the free base 45, the salt 60 offers the 
advantage that it can be stored for some time without significant 
decomposition. 
4.6.4 Attempted synthesis of N-[S-(4-nitrobenzyl)-L-cysteinyf]-N-benzyloxy-
D-valine benzyl ester 
After completion of the synthesis of 44 and 45, we had to 
consider means of achieving the coupling of these two fragments. 
From previous literature reports 8 5 a> b it was clear that a highly 
activated carboxylic acid derivative was required because of the 
low nucleophiliclty of the N-benzyloxy amino acid derivative 45. 
The acid chloride or mixed anhydride method seemed to be most 
suited for this purpose. Since the acid chlorides of amino acids 
<*q ") 
*γ ' COClj 
0''^OH 
Η tí „ 
O^CI 
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are usually difficult to prepare, we became intrigued by a report 1^ 
mentioning the use of phosgene for the activation of an amino acid 
(eq.ll). It must be emphasized that the authors 1 0 6 did not isolate 
and characterize the acid chloride 62: the activated compound, 
which was used in a two-fold excess, was in situ coupled with 63 to 
yield 64 (58%, based on 63). 
We employed this method in the coupling of 44 and 45 (eq.12), 
using only a slight excess of 44. 
COCl„(n-Bu)3N 
(eql2) и 
-78 — - 2 0 С 
SPNB 
H H I 
65 
60,(n-Bu),N 
-20'—+20"C 
SPf« 
H H I 
BzlÓ Ä ^ * 1 
46 
After column chromatography 46 was isolated as a mixture of 
diastereomers, but the yield was disappointingly low (25% based on 
60). Probably the low yield is due to decomposition of the 
Intermediate acid chloride 65, a supposition which was supported 
by the presence of starting material 45 as well as many impurities 
In the reaction mixture as monitored by TLC. 
A possible side reaction is depicted in scheme XIV; an 
Intramolecular cyclization may lead to the formation of an N-
carboxy-anhydrlde 66 (a so-called Leuchs anhydride).107·108 
Nudeophilic attack of 45 on compound 66 will yield directly 
compound 47. 
Under the reaction conditions used compound 47 can cydize 
to give 67, or, what is even more important, it can compete 
successfully with 45 for the available acid chloride 65 or anhydride 
66, because It is a much better nucleophile. 
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Because of the low yield and the fact that 65 may be prone to 
racemlzatlon, we gave up this method and turned to the mixed anhy­
dride method. 
Treatment of 45 with the isobutoxycarbonyl mixed anhydride of 
44 (eq.13) resulted in the formation of two products, viz. 46 (1%) 
and 69 (15%). 
AJ 
(eq 13) U СІ^ ^ О 
StjN, THF 
H 
Z N . 
SPNB 
XT 
о ^ чэ о 
68 
SPNB 
45 
H 
ZN 
- » 46 + 
H ^ CO,Bzl 
69 
The structure assignment of 69 Is based on the ^ -NMR spectrum as 
well as an Independent synthesis. The formation of compound 69 (eq. 
13) is difficult to rationalize. 
(eq14) 
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Under the reaction conditions a rearrangement, comparable with 
the thermal reduction of cyclic hydroxamlc a c i d s , 8 4 · 1 0 9 (46 •+ 69, 
eq.14) is unlikely. So, 69 has to result from attack of valine 
benzyl ester 70 on the activated carboxylic acid 68. Since there 
are no Indications that the starting material 45 was contaminated 
with valine benzyl ester 70, it must be assumed that 70 arises from 
disproportlonation of 45 in the reaction mixture (eq.15). 
CO.Bzl 
и 
(eq '5) H (CHCjH, ^C,H5CH = 0.45 - Η,Ν — - I 
V Η ~ Η NCO;Bzl 
В г і С Ч 
ΙΛ 
This is a well-known reaction 8 4» 1 0 3 0» 1 1 0 of free N-hydroxy-a-amino 
adds. 
In view of this negative result we Investigated several other 
possibilities to accomplish a good coupling reaction between 44 and 
45. Activation of carboxylic acid 44 with POCI3, 1 1 1 a method which 
has proven to be of great value in coupling reactions with very 
poor nucleophlles,112 gave hardly any product. No reaction at all 
was observed in a trial experiment with a coupling reagent developed 
by Steglich 1 1 3 (eq.16). 
1 0 V 
Jtt (eq16) // \ / H У · ' - χ > ^ " з . 'ι •• - J ' B z l 
О о 
71 72 
119 
Our next attempt was based on a method (eq.17) described In a 
Hungarian patent. 1 1 4 
O R ' . О -
/ i-.\ OÍWMJ \ A 200 С, no solvent Л / 
(eql7)RCOOH + ^ — N • ^ у — N / \ 
Cl R 
HCl.-CO) 
R / VR· 
The method differs from the others In that the roles of the 
reactants are reversed; the amine becomes 'activated' and the 
carboxyllc acid function Is the nucleophlle. Spande 1 1 4 applied this 
method successfully In the synthesis of 73 (eq.18). 
( * q 1 8 ) 
4 ' 
И 
CHjCOOH 
H ba H CHjCNÛ M Ρ 
СП C t H s C.H. 
73 
He could avoid excessive heating by using a catalytic amount of a 
base. However, the procedure failed when applied to 45 (eq.19; the 
Intermediate 74 was not Isolated). 
cocí, 
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Considering all attempts to couple the compounds 44 and 45 (or 60), 
it seemed that we had to be content with the results of the acid 
chloride method (eq.12). 
The next step In the reaction sequence was the selective 
removal of the benzyloxycarbonyl group from 46 (46 ·• 47, scheme XI). 
It has been shown that the benzyl oxycarbonyl group can be removed 
selectively In the presence of a benzyl ester.98a,115,116 However, 
treatment of the dipeptide derivative 46 with HBг 1n glacial acetic 
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acid gave a mixture of at least four products (eq.20). 
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Evidence, though being Inconclusive, was obtained that besides 75 
also 76 and 67 were formed. The formation of a ninhydrine-negative 
product, with simultaneous disappearance of a ninhydrine-positive 
product, was stimulated under the influence of silica gel or sodium 
hydrogen carbonate (75 •» 67?). No conditions could be found which 
gave only or predominantly 75. 
In view of these results another approach for the synthesis of 
47 had to be considered. Therefore attention was focused on a 
coupling reaction involving the use of an N-carboxy 
anhydride.107,108,117,118 j ^ e principle of this approach is shown 
in scheme XV. The amino acid 53 1s converted Into an N-carboxy 
anhydride (53 •» 66), which is provided subsequently with a 
protecting group on the nitrogen atom (66 -> 77). Ring opening by a 
proper nucleophlle (77 •» 78) and deprotection (78 •» 47) should 
afford the desired product. 
The function of the protecting group (Nps) is to prevent the 
amine function of 78 from interfering In the contemplated reaction 
(77 •* 78) by making it a poor nucleophlle. It has been shown that 
the o-n1trophenylsulfenyl(Nps)-group is very convenient for this 
purpose.119 It can be removed by acidic hydrolysis,120 by catalytic 
121 
desulfurization,121 or by treatment with nucleophiles.122 Because 
of the low nucleophllicity of 45 as compared with a free amine, a 
crucial role was assigned to this protecting group in our approach 
(scheme XV). 
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Attempts to purify 66 and 77 failed; both compounds decomposed 
rapidly on trying to recrystallize them. So, crude starting material 
had to be used in the subsequent steps. The coupling reaction (77 + 
45) yielded, besides a lot of starting material 45, a trace of the 
desired product 78 (<1%) and a small amount of 79. The structure of 
79 was confirmed amongst others by an independent synthesis. The 
formation of 79 can be rationalized by disproportionation of 45 
under the reaction conditions used (compare eq.15). 
At this point it was realized that the strategy had to be 
modified. Apparently, the carboxylic a d d 44 can not be activated 
properly for a coupling reaction with N-benzyloxy valine benzyl 
ester 45. The nucleophllicity of the valine nitrogen is reduced too 
much by the electron-withdrawing benzyloxy substituent, which may 
122 
hamper the reaction also sterically. In our opinion, the failure 
of the N-carboxy-anhydride approach (scheme XV) is mainly due to 
steric hindrance.87b
>
117a 
4.6.5 Revised strategy for the synthesis of N-[S-(L-a-aminoadipyl)-L-
cysteinyl]-N-hydroxy-D-vaHne (35) 
All that remained was using N-hydroxy valine benzyl ester 80 
Instead of 45 for the coupling with 44, despite of the drawbacks, 
like rapid dlsproportlonation and 0- versus N-acylation, associated 
with the use of unprotected N-hydroxy amino acids. Encouraged by 
two reports,85c,86 describing that selective N-acylation of free 
N-hydroxy amino acid derivatives can be achieved by employing N-
carboxy-anhydrldes, we devised the modified synthesis plan given 
in scheme XVI. 
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The first purpose was to prepare 80, unreported so far. 
Our attention was attracted by a paper 1 2 3 that describes the 
synthesis of optically pure N-hydroxy amino acid esters. This 
approach features conversion of optically active α-amino adds into 
the corresponding N-hydroxy-a-amlno acids by indirect oxidation 
without affecting the chlral center. By employing this method It 
should be possible to prepare 80 according to scheme XVII. 
Oxidation of the Schiff base 83 with m-chloroperbenzoic acid or 
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monoperphtaHc add, followed by treatment124 of crude 84 with 
HONH2.HCI afforded a mixture of starting material 70 and, probably, 
80. 
At that time however, a total synthesis of the target compound 
35 appeared in the literature.125 The strategy used shows much 
resemblance with ours and is sumnarlzed in scheme XVIII. 
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Some notable aspects of this synthesis must be highlighted. 
In the first place, the authors had been able, by modifying 
slightly Chimiak's method, 9 0' 1 2 3 to synthesize 80. Then, selective 
N-acylation of 80 with 85 had been achieved by using DCC as the 
coupling reagent in DMF. Several other methods gave only O-acylation 
(80 -» 87). In contrast with 0-acyl derivatives of simple hydroxyl-
amines.^S compound 87 could not be rearranged to the N-acylated 
product 86. 9 0 It was surprising that the hydroxamic acid function 
was not affected under the Ма/МНз(1) deprotectlon conditions (see 
for comparison eq. 15, section 2.2.3). 1 Z 7 
Finally, it was shown that 35 was not converted into isopeni-
clllin N by using a partially purified enzyme system derived from 
homogenized cells of Cephalosporlum acremonium (scheme XIX). 
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These results suggest that the N-hydroxy Arnstein tripeptlde 35 is 
not directly Involved as an Intermediate In penicillin biosynthesis. 
On the contrary, the compound was found to Inhibit the formation of 
isopenlcillln N from the Arnstein tripeptlde completely. 
A.7 ATTEMPTED SYNTHESIS OFN-fN'-^-fL-a-AMINOADIPYQJ-N'-HYDROXY-
L-CYSTEINYL)-N-HYDROXY-D-VAUNE(X) 
4.7.11ntroduction 
Prompted by Scott's results (scheme XVIII and XIX)125
 we 
directed our attention completely to the synthesis of 36 and 37. The 
most important difference between the synthesis of 35 on the one 
side and the synthesis of 36 and 37 on the other side arises from 
the necessity to Incorporate N-hydroxy cysteine into the tripep-
tide. As was explained before (see section 4.5) the only way to 
achieve this 1s by an Indirect synthesis of the fragment In question, 
which Implicates that the use of a protected cysteine derivative as 
starting material is avoided. In scheme XX this strategy Is worked 
out for the synthesis of 36. 
Coupling of the two fragments 91 and 45 was expected to be 
straightforward. NucleophiHc displacement of bromine by the 4-nitro-
benzyl mercaptlde 1on (92 ·• 94), followed by reduction of the double 
bond should give the protected N.N'-dlhydroxy dipeptlde 95 as a mix-
ture of four stereoisomers. Separation of diastereomers at this stage 
would afford two racemic mixtures (RR/SS and RS/SR). After coupling 
of 95 (RR/SS) with 48, via the acid chloride or mixed anhydride 
method, again a separation of diastereomers would be necessary. A 
two-step deprotection of 96 according to the same procedure as 
described for the synthesis of 35 (scheme XI) should yield 36. 
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4.7.2 Synthesis ofN-(3-bromo-2-benzyloximino-propanoyl)-N-benzyl-
oxy-D.L-valine benzyl ester 
Condensation of bromopyruvic acid 90 with O-benzylhydroxylamine 
(scheme XX) afforded the oxime 91 in 88% y ie l d . The synthesis of 92 
turned out to be more complicated than was ant ic ipated. Acylatlon of 
45 with the 4-nitrophenyl ester of 91 (/.e. 97) fa i l ed (scheme XXI). 
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The use of dlcydohexylcarbodiimide as coupling reagent also 
did not lead to any product formation. Considering Chimlak's 
experiences with coupling reactions involving mainly rather simple 
N-benzyloxy amino acid derivatives,85a,b
 o u r
 results were actually 
not surprising. He observed that yields exceeded 30% only when use 
was made of mixed anhydride or acid chloride activation of the 
carboxylic add. 
In an orientating experiment conversion of 91 into its iso-
butoxycarbonyl mixed anhydride, followed by treatment with 60 
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afforded a coupling product in only 20% yield (scheme XXI). However, 
the yield could be increased to 45% by applying the reaction 
conditions recommended by Benoiton (CH2CI2, N M P ) . 1 2 8 From iH-NMR-
and mass spectra it became clear that the product was not the 
bromine compound 92 but its chlorine analogue 98. Obviously complete 
displacement of bromine by chloride ions, present in the reaction 
mixture, had taken place. This side-reaction had to be avoided 
since 1t appeared that in the next step the chlorine compound, in 
contrast with 92, could not be converted smoothly into 94 (see 
scheme XX). 
The same problem, substitution of bromine by chlorine, turned 
up when the coupling of 91 and 45 was attempted via the acid 
chloride method (scheme XXII). The mixture of products (92 and 98), 
consisting mainly of 98, could not be separated by column 
chromatography. Finally pure 92 could be obtained in 54% yield by 
using the acid bromide 99 (scheme XXII), and keeping the reaction 
mixture free from chloride ions. When the hydrochloride salt 60 of 
N-benzyloxy valine benzyl ester was used in the coupling reaction 
equal amounts of 92 and 98 were formed. Crude 99 had to be used for 
the coupling reaction because the compound decomposed rapidly on 
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distillation : it was only possible to remove the phosphorous acid 
and the excess of ΡΒΓ3 from the reaction product. 
4.7.3 Attempted synthesis ofN-[N'-benzyloxy-S-(4-nitrobenzyl)-D,L-
cysteinylJ-N-benzyloxy-DX-valine benzyl ester 
The synthesis of 94 (scheme XX) proceeded smoothly (55% yield), 
unless the starting material 92 was contaminated with the 
corresponding chlorine analogue 98. It is obvious that this has to 
be attributed to the higher bond strength of the carbon chlorine 
bond, which makes 98 less susceptible to nucleophlllc attack. 
The reagent 4-nltrobenzyl mercaptan 93 was readily accessible 
by treatment of 4-nitrobenzyl chloride with potassium thioacetate 
and subsequent methanolysls of the resulting thioester 100, the 
overall yield of 93 being 80% (scheme XXIII). 
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Application of another method often used for the synthesis of 
thiols, 1 2 9 which should Involve the formation of S-(4-n1tro)benzyl-
isothiouronlum chloride 101 in this case, gave no product at all 
(scheme XXIII). 
The next step was the reduction of the double bond in 94 In 
order to obtain the fully protected N.N'-dihydroxy dipeptide 95 
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(scheme XX). In spite of the rigorous reaction conditions required 
(the solvent must be saturated with HCl) amine-borane complexes 
seemed to be most suited for this purpose.91-94,130 Actually it is 
the only class of compounds available for the selective reduction 
of α-oximino esters and amides.83,84 M 0 St other reducing agents 
convert oximes and their O-protected derivatives directly into 
the corresponding primary amines. 1 3 1 
Notwithstanding all our efforts we did not succeed in Isolating 
even a minimum amount of the desired product 95. The starting 
material 94 was consumed only very slowly no matter which reducing 
agent (pyridine.BH3 or (СНз)зН.ВНз) was used. An analytical TLC of 
the reaction mixture always suggested the presence of at least six, 
and sometimes even nine, different compounds. After extensive 
column chromatography minor quantities of two racemi с mixtures 
(a,b : RR/SS and RS/SR) of cyclic compound 67 were obtained (scheme 
XXIV). Application of the mild reduction method (МаВНзСМ/МеОН/рН 
3.1) described in chapter V gave no reaction at all. 
In one case the excess of reducing agent (pyridine.BH3) was 
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destroyed and removed, after which the crude product was treated 
with acetyl chloride and pyridine in order to obtain 102a (scheme 
XXIV). Purification by column chromatography afforded in addition 
to 67(a and b) only a small amount of 102b (scheme XXIV). From 
these results it may be concluded that any 95 formed during the 
course of the reaction is converted rapidly into the corresponding 
amine 47. 
The formation of 47 may proceed via two different mechanistic 
pathways, namely by overreduction of 95 under the reaction 
conditions or by disproportionation of 95 (see for comparison eq.15) 
during the work-up procedure. It was impossible to deduce from the 
experiments which route underlies the observed product formation. 
The question remains why the reduction proceeded so slowly. 
Although the exact mechanism of the reduction with amine-borane 
complexes Is not known, we are inclined to contribute this failure 
to steric hindrance. It has been noted03 that oximes bearing bulky 
substituants are reduced sluggishly. So, It 1s assumed that the 
whole amine-borane complex 1s Involved in the hydride transfer to 
the protonated substrate (eq.21), thus rendering the progress of 
the reaction more sensitive to steric hindrance. 
(*q21) 
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This could be one reason for our poor results. Perhaps there is 
still another reason. It 1s well-known that boranes can form stable 
complexes with thioethers.132 Since, according to the ^-NMR 
spectra, some of the by-products seemed to lack the sulfur-
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protecting group, 1t Is possible that displacement of the amine from 
the amine-borane complex by the divalent sulfur of 94 and/or 95 
could be the Initiating step of some side-reactions. 
4.7.4 Conclusions 
Attempts to design an alternative route to 95 have not been 
made since meanwhile literature reports44 had revealed some facts 
pointing to a mechanism in which 0-lactam formation precedes 
thlazolldlne formation during the biosynthesis of isopeniclllin N. 
Initial 0-lactam ring formation is incompatible with the inter-
mediacy of 36 In penicillin biosynthesis; no stepwise mechanism can 
be written down, exploiting both N-hydroxy functionalities of the 
N.N'-dlhydroxy trlpeptlde 36. 
4.8 SYNTHESIS OFN-[&-(L-a-AMlNOADIPYL)]-N-HYDROXY-L-CYSTEINYL-
D-VAUNE(37) 
4.8.1 Introduction 
In the course of our previous studies a wealth of Information 
on penicillin biosynthesis became available from literature reports, 
In particular from Baldwin's group. With respect to the mechamlsm 
they gave direct evidence for Initial 3-lactam ring formation and 
they found strong Indications that a radical intermediate is 
Involved In the formation of the thlazolldlne ring. The Isopenicil-
lin N synthetase seems to contain at least one cystelnyl thiol 
group, whose blockade Inhibits the enzyme's activity : this points 
to the formation of a disulfide bond between the enzyme and the 
substrate during the conversion. These results, which are described 
In more detail In section 4.3, place certain restrictions on any 
proposed mechanism of penicillin biosynthesis. So, it became clear 
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that out of the three N-hydroxy Arnstein tripeptldes 35-37 only 37 
remained as a possible intermedíate. Therefore all further 
attention was focused on the synthesis of this compound. 
The strategy followed shows (scheme XXV) much resemblance to 
that used for the synthesis of 36 (see scheme XX). 
This time the coupling reaction involving 91 was not expected to 
lead to problems with regard to the substitution of bromine (compare 
scheme XXI and XXII), since a simple coupling reagent like DCC 
would be sufficient to accomplish the reaction. 
At first we intended to synthesize just one protected trlpep-
tide, i.e. 114. However, since there was not much Information 
available on the deprotection of N-hydroxy peptides, we could not 
be certain how the protected and deprotected compounds (Π4, Π 7 
and 37) would behave under the deprotection conditions, i.e. In how 
far side-reactions would interfere with the Intended reaction. 
Therefore we decided during the course of the Investigation to 
readjust the protecting group strategy. 
By synthesizing two additional protected tripeptldes, i.e. IIS 
and U 6 , we hoped to avoid the risk of backing the wrong horse. 
Scheme XXV shows that without affecting the synthesis plan seriously 
various deprotection procedures could be incorporated by simply 
using different sulfur-protecting groups. The compounds 114-116 
seemed to be readily accessible by changing the nature of the 
mercaptan (93, 106, 107 resp.) employed at an early stage of the 
synthesis (105 -• 108, 109 or 110). 
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4.8.2 Synthesis of N-hydroxy-L-cysteinyl-D- аІіпв derivatives 111-113 
The 4-toluenesulfonlc acid salt 1 3 3 of D-valine benzyl ester 104 
was obtained in 76% yield by direct esterification of D-valine 103 
(scheme XXV) : this compound, an excess of benzyl alcohol and 
toluene were heated under reflux in the presence of 4-toluene-
sulfonic acid, the liberated water being removed azeotropically. 
Dicyclohexylcarbodiimide134 coupling of 91, prepared according to 
the procedure described in section 4.7.2, and 104 gave the crude 
product 105 (scheme XXV) in 89% yield. Although purification of 105 
is possible by column chromatography, affording the pure product in 
80% yield, crude 105 was used in the next reaction. Displacement of 
bromine by a suitable mercaptan (scheme XXV) proceeded smoothly, 
affording 108, 109 or П 0 in 91%, 82% and 62% yield respectively. 
In one case (91 ·* 108) the sequence of reactions was also done 
in reversed order, substitution of bromine in 91 preceding coupling 
with the valine fragment 104 (eq. 22). This alternative synthesis 
of 108 gave the product in an overall yield which was somewhat 
lower, namely 64% versus 73%. 
SPNB SPNB 
( e q 2 2 ) 9 i 0;NC6HtCH2SH(93l Τ Г» ^ 
EljN .OME , 80·/. 0 * O H pyridine, DCC, 80 V. 
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The next step, reduction of the oxime double bond (scheme XXV), 
turned out to be a more laborious job. We knew from previous 
work83>92 that, probably due to competitive protonation, the 
presence of an amide function in the molecule slows down the 
reaction rate, thus causing a relatively fast decomposition of the 
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reducing agent under the strongly addle conditions used. Hence, 
only an amine-borane complex of higher add stability than pyridine-
borane was suited for our purpose. This condition was satisfied by 
trimethylamine-borane. 
When executing our plan It proved to be very difficult to 
monitor the progress of the reaction by TLC. However, after having 
Isolated a small amount of 111 enough information was acquired to 
be able to optimize the reaction conditions as well as the work-up 
procedure. In spite of the use of a large excess of the reducing 
agent (14 eq.) complete conversion of the starting material was 
never achieved. The presence of the excess of the reducing agent 
and several by-products made extensive column chromatography 
necessary. 
Moreover, 1n consequence of the introduction of a new chi ral 
centre In the molecule the resulting mixture of diastereomers had 
to be separated. On TLC the mixtures of diastereomers of 111-113 
gave only one spot, no matter which eluant was used. By employing 
careful column chromatography one pure diastereomer of И 2 , having 
an unknown configuration at the cysteine chi ral centre, was obtained 
in 8% yield. The remaining material (38%) was a mixture of 
diastereomers which consisted for about 85% of the other 
diastereomer of 112. The separation was achieved as follows. 
First, CH2CI2 was used as eluant to remove the excess of the 
reducing agent : after l-2h it was changed by EtOAc/hexane (35:65, 
v/v). In this procedure the desired compound left the column in two 
separate portions. Usually the first portion consisted of one 
diastereomer, whereas the other portion was a mixture of both 
diastereomers. By repeating this procedure several times with the 
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mixture of diastereomers, the yield of the less polar diastereomer 
was raised while the remaining material became strongly enriched 
in the other diastereomer (up to 80-90X). The diastereomers of Ш 
and Π 3 (30% and 22% yield, respectively) could not be separated in 
this way. 
Because it is known 8 3· 8 4 that the reduction of a-oximino acids 
proceeds much easier than that of corresponding esters or amides, 
we studied whether a higher yield of compound 113 could be realized 
when reduction preceded the coupling (scheme XXVI). 
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The results of the first two steps were encouraging. 
Substitution of 91 with the mercaptan 107 was accomplished in 75% 
yield. The product U 9 had to be purified by column chromatography. 
Attempts to purify 119 or its dicydohexylamine salt by 
crystallization gave much lower yields (about 26%). As anticipated 
the yield of the reduction (119 -» 120) was better (55%) than in the 
former method. Besides, there was not such a large excess of 
reducing agent needed and the work-up procedure was less laborious. 
Because activation of the carboxyl group of 120 might lead to a 
product liable to polymerization by the presence of the weakly 
nudeophilic benzyloxyamino group, we used the N-carboxy anhydride 
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122, in which the nitrogen atom is protected, for the coupling with 
D-vallne benzyl ester. The anhydride 122 was obtained from 120 by 
using trichloromethyl chloroformate 121 (diphosgene). 8 7 a« b This is 
an easy to handle liquid substitute for phosgene,^ 5 which is a gas 
at room temperature. Katakai's method,^6
 w
hich involves in situ 
formation of phosgene from Ш under the influence of activated 
charcoal, was applied 1n this case. After filtration the reaction 
mixture was concentrated 1n vacuo and then the residue was used 
immediately for the synthesis of 113. 
Finally the crude reaction mixture, containing the coupling 
product 113, was treated with acetyl chloride and pyridine, 
affording the stable acetyl derivative 123. The model study of in 
situ acylation was carried out because there are some indications 
that compounds containing a free benzyloxyamino group, like e.g. 
111-113, disproportionate (see eq.15) during laborious work-up 
procedures Involving column chromatography. 
Column chromatographic purification afforded 123 in 5% yield 
based on 120. Complete separation of the dlastereomers did not 
succeed : two mixtures of dlastereomers, each enriched 1n one of 
the dlastereomers, were obtained. The overall yield of 123 via this 
route was 2% based on 91, while a similar transformation (91 -» 124) 
according to the former route (scheme XXV, eq. 23) afforded the 
product In an overall yield of 12%. 
(*q23) 
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So, the route involving the intermediacy of an N-carboxy 
anhydride like 122 was abandoned, because ultimately the synthesis 
depicted in scheme XXV furnished sufficient material for further 
studies. 
4.8.3 Synthesis ofN-benzyloxycarbonyl-L-a-aminoadipic acid 
α-benzyl ester 
Several methods for the synthesis of [N,Ca]-d1protected L-a-
aminoadipic acid have been published.98,137 p
o r
 the preparation of 
large quantities many groups start with an efficient synthesis of 
L-a-aminoadipic acid, which is subsequently protected at the a-
carboxyl- and amino group. Baldwin and co-workers^Sb.c developed 
two short routes for the synthesis of 48, which avoid the 
intermediacy of L-a-amlnoadipic acid. 
We chose a very short route, starting from the commercially 
available L-a-aminoadipic acid 126 (scheme XXVII). 
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The starting material is rather expensive. For that reason we did 
some model experiments, using the cheaper analogue L-glutamic acid 
140 
125 as starting material (scheme XXVII : 125 -• 127 - 129). 
The first step, protection of the amino group of 125, was 
carried out under Schotten-Baumann conditions.138 Compound ¿27 was 
obtained in 76% yield. Then, the a-carboxyl group of 127 was 
converted selectively into a benzyl ester (80% yield) by applying 
a procedure described by Nefkens.101b In order to secure that only 
the α-ester was isolated, the product was converted quantitatively 
into its dicydohexylamlne salt і з о . І 0 1 · 1 3 9 The specific rotations 
and melting points of the dicydohexylamlne salts of the a- and γ-
ester are quite different 1" 1· 1 3 9 and can therefore be used to 
identify the isomers. 
Subsequently, we studied the activation of the diprotected 
glutamic acid derivative 129. We tried to convert 129 into the 
corresponding a d d chloride 131 (eq.24), employing very mild 
reaction conditions.140 
0 
H
^ чГі (cocí), 
(eq2A) 129 „ ' 
О
H
 COjBil 
131 132 
н
4
 co2Bzi 
Though the IR-spectrum revealed a strong band at 1800 cm - 1 (C=0 
stretching), the compound did not behave as an activated carboxylic 
a d d at all; e.g. treatment with methanol In the presence of 
pyridine did not yield the corresponding methyl ester. Careful 
Inspection of the spectroscopic data revealed that 132 had been 
formed. 1 4 1 This pyroglutamic acid derivative142 must have been 
formed by intramolecular attack of the urethane nitrogen atom on 
the activated carboxylic acid. Such an intramolecular cycllzatlon 
is a well-known reaction of glutamic a d d derivatives.143 
141 
In another experiment we attempted to couple compound 129 and 
the protected N-hydroxy peptide Π 2 (a mixture of diastereomers) by 
using the mixed anhydride method (eq. 25). 
ο Vy/ 
s q 2 S , щ C l A ¿ _ 
NMP.CHjCl j 
133 134 
However, no reaction took place although we used optimized 
conditions as described by Benoiton.128 
From these results we concluded that we had to face the 
following dilemma. To achieve an efficient coupling the carboxyllc 
acid moiety had to be activated using a method that leads to very 
high activation. On the other hand ring closure as observed with 
the acid chloride 131 had to be avoided. We reasoned that a way out 
might be placing a second protecting group on the urethane nitrogen. 
4.8.4 Revised approach for the protection ofL-α-awinoadipic acid 
An efficient way to accomplish a suitable protection of the 
urethane nitrogen atom might be ring closure Involving the a-carboxyl 
group, 1 4 4 which would then be protected too. This approach has been 
used before for the protection of glutamic acid and its conversion 
into the v-acld chloride.112,144c scheme XXVIII shows the synthesis 
plan, featuring this approach. 
Protection of the amino group of L-a-am1noadipic acid (126 -» 
128) and subsequent condensation with paraformaldehyde (128 -» 135) 
proceeded smoothly. The product, an oil with very little Impurity, 
was used in the next step without purification. The acid chloride 
136 was obtained in nearly quantitative yield by treatment of 135 
with PCI5. 1 1 2 Its purity was at least 87% as estimated from the 
142 
xr 
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^-NMR spectrum. In contrast with the glutamic acid analogue (m.p.: 
76-78 eC), 1 4 4 c compound 136 was obtained as an oil. All attempts to 
crystallize the compound failed. 
It must be emphasized that the introduction of the cyclic 
system was stil! compatible with the deprotection procedures we had 
in mind. We expected that after removal of the protecting groups, 
including the benzyloxycarbonyl-group, the remaining cyclic system 
(see 140, eq.26) would be sufficiently labile to be cleaved with 
H2O. 
(eq26) 
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4.8.5 Synthesis of N-[&-(L-a-afninoadipyl)]-N-hydroxy-D,L-cysteinyl-
D-valine derivatives 138 and 139 
Reaction of an excess (1.5-2.0 eq.) of the crude acid chloride 
136 with the protected N-hydroxy dipeptides П 2 and 113, in the 
presence of pyridine (1.5-2.0 eq.) and a catalytic amount of 4-d1-
methylaminopyridlne, afforded the fully protected tripeptides 138 
and 139 In 81% and 58% yield respectively (eq.27). 
(eq 
I ^ /v ci 
β~^^\^*-1 112 or 113 » α~ϊ 
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The reaction was carried out with the less polar diastereomer 
of 112 as well as with the mixture of diastereomers which was 
enriched (80-90%) 1n the more polar diastereomer. In the latter 
case a mixture of diastereomers of 138 was obtained : these dia­
stereomers could be separated completely by employing the same 
chromatographic procedure as used for the separation of the 
diastereomers at the dipeptide stage (see section 4.8.2). Thus, 
both diastereomers of 138 were obtained in pure form. 
For the coupling reaction between 136 and 113 only a mixture of 
diastereomers of Ш was available. After coupling and purification 
a small amount (9%) of the less polar diastereomer of 139 was 
obtained; the remainder (49%) was again a mixture of diastereomers. 
The absolute configuration of the cysteine chlral centre in the 
pure diastereomers was not established. 
Compound 137 (eq.26) has not been prepared because It seemed 
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ultimately the least attractive one. Deprotection of 137 (compare 
scheme XXV) would involve the formation of a mercury complex of the 
deprotected tripeptide 37. From Prof. Baldwin 1 4 5 we learned that 
traces of mercury, which are difficult to remove from such a 
tripeptide, may inhibit the activity of the Isopenicillin N 
synthetase during an incubation experiment. Besides, it became 
clear that treatment with H2S, needed to liberate the tripeptide 
from its mercury complex, might cause reduction of the hydroxamic 
a d d function to the corresponding amide. 8 8 
4.8.6 Deprotection ofN-[S-(L-a-aminoadipyl)]-N-hydroxy-D,L-
cysteinyl-D-valine derivatives 138 and 139 
In theory it should be possible to remove all the protecting 
groups from 138 and 139 In one step by making use of Na/NH3 
( I ) 9 0 · 1 2 5 and В ^ С С Р з ^ / С Р з С О О Н 8 5 3 ^ . ^ respectively, followed by 
a work-up procedure Involving the use of H2O (eq.26, compare 
scheme XXV). 
For the reduction with Ма/МНз(1) we devised a special apparatus 
Fig. 3. 
mild r e d u c t i o n w i t h N a / N H j O ] 
s o p r o p a n o l / C O ; 
Sample in N H j U ) 
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assembly, which Is pictured schematically in figure 3. 
In a separate vessel, charged with several pieces of freshly cut 
sodium metal, ammonia was condensed. Then, the liquid аішіопіа was 
distilled under argon Into the reaction vessel, containing the 
compound to be deprotected (138). Under vigorous stirring the 
starting material dissolved completely in the liquid armonia, after 
which the ammonia was allowed to reflux. The condensing ammonia 
dissolved the sodium metal, which was placed on a sintered glass 
disc in the dropping funnel. Addition of the reducing agent to the 
reaction mixture could be controlled by the stopcock. As soon as 
the blue colour persisted for at least one minute, the addition was 
stopped. This reaction can be considered as a titration with 
solvated electrons. The advantage of the method is that moisture is 
excluded and the presence of a large excess of reducing agent in 
the reaction mixture is avoided. 
Compound 138 was deprotected In this way (eq.26). The mass 
spectrum of the crude product indicated that in addition to the 
desired compound 37 (M=379) another product had been fonned, having 
a molecular weight (№378) which was one unit lower than that of 
37. The formation of compound 141 (eq.28), as a result of nucleo-
philic attack by NH3 or NH2 on the ring system, 1s consistent with 
this observation. 
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It was clear that, in order to circumvent this side reaction, 
the deprotection procedure had to be modified in such a way that 
ring opening preceded sodium-liquid ammonia treatment. Scheme XXIX 
summarizes our attempts to achieve this. 
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One approach involved treatment of compound 138 with HBr/AcOH. 1 4 4 b 
It cannot be excluded that under these conditions the benzyl ester 
is also converted partially into the carboxylic acid. The crude 
product (142) was not characterized but subjected to sodium-liquid 
ammonia deprotection without further purification. 
In another attempt we tried to split up the cyclic system by 
simple hydrolysis. From literature reports 1 4 4 we knew that this 
could be accomplished easily under alkaline conditions. However, 
under such conditions the starting material would be prone to 
epimerization and i-ellminatlon. Therefore we had to employ acidic 
147 
conditions, for which we selected ^O+Zacetone. The crude product 
which was used as such in the sodium-liquid ammonia reaction, 
consisted of three compounds : besides the desired product 143 
small amounts of starting material 138 and of 112 were present, 
the latter obviously arising from hydrolysis of the oxidized amide 
bond. It was gratifying to conclude that both methods yielded a 
crude product that, according to mass spectroscopy, contained the 
desired product 37. 
The deprotected material was purified^47 according to a 
procedure developed by Baldwin's group for the purification of the 
Amstein tripeptide and several analogous compounds. Following this 
procedure a basic aqueous solution (pH 8-9) of the crude product 
was oxygenated and then subjected to reverse phase column 
chromatography (eq.29). 
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It appeared that a large number of by-products had been formed 
during the deprotection step, probably by 0-elimination and 
epimerization at one or more of the chiral centres. Furthermore, 
is should be realized that the oxidation step increases the number 
of products, because several combinations between compounds 
containing a free thiol group are possible. This is also the reason 
why a mixture of diastereomers 1s less suited for the deprotection 
reaction. 
It turned out that in all cases in which sodium-liquid ammonia 
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had been applied, the crude product was too contaminated to afford 
pure 144. Deprotection of the only available pure diastereomer of 
compound 139 (eq.26) with В(02ССРз)з/СРзСООН according to a 
literature procedure, 8 5 1 3· 1 4 6 followed by the same purification 
procedure as described in eq.29, afforded finally the pure N-
hydroxy Arnstein tripeptide 37 (as its disulfide 144) in 2% yield. 
Removal of the various side products by column chromatography 
was a time consuming job, in particular because the product, 
contrary to expectation, migrated much slower than the dimer of the 
'normal' Arnstein tripeptide 14. Since a lot of a-aminoadipic acid, 
or perhaps its cyclic amide (S-lactam), was isolated after reverse 
phase column chromatography, we assume that the low yield is caused 
by considerable hydrolysis of the oxidized amide bond during the 
work-up procedure. 
4.8.7 In vitro incubation of the N-hydroxy Arnstein tripeptide 37 with 
¡sopenicillin N synthetase 
The pure diastereomer of 37, obtained after deprotection of 139 
and of unknown chirality at the cysteine chiral centre, was tested 
as a substrate of Isopenicillin N synthetase. For that purpose the 
dimer 144 of the N-hydroxy tripeptide was administered to a purified 
enzyme system, derived from homogenized cells of Cephalosporium 
acremonium, under standard conditions.36·460 The ^ -NMR spectrum 
of the incubation mixture revealed the presence of two signals 
between δ 5-6 ppm (fig. 4a and 4b) : the signals of the B-lactam 
protons of Isopenidllin N usually appear In this area. Doping the 
NMR-sample with a small amount of penicillin N, which cannot be 
distinguished from isopenidllin N by NMR-spectroscopy, 1 4 5· 1 4 8 
proved that the compound formed was not Isopenidllin N (fig. 4c). 
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All the signals between S 5 and б ppm disappeared after treatment 
of the sample with β-lactamase (fig. 4d). 
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In a hole-plate a s s a y l 7 · ^ the incubation mixture showed 
antibacterial activity against Staphylococcus aureus : this 
activity was also destroyed by the action of B-lactamase. Obviously 
the starting material was converted quantitatively into a new ß-
lactam antibiotic. As a tentative conclusion of the observations we 
propose that N-hydroxy isopenlcillin N (145) had been formed (eq.30), 
OH SI ^ I H H 
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The downfleld shift of the ß-lactam protons H5 and H6, as 
compared with the corresponding protons of isopenlcillin N (fig. 
4c), can be attributed to the presence of the hydroxamic acid 
function. In the lH-№R spectra of the disulfides of 37 and the 
Arnstein tripeptide 14 the a- and 0-protons of the cysteine moiety 
show a comparable difference. 
Structure 146 can certainly not be assigned to the novel 
product, since It has been shown that the comparable monocyclic 
OH 
I b Η 
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compound, lacking the hydroxy! group on the exocycHc nitrogen 
atom, decomposes within a few minutes under the incubation 
conditions (eq.31).46 
4.8.8 Conclusions 
The N-hydroxy cysteine derivatives 111-113, 138, 139 and 37 
have been synthesized for the first time. Whereas In the synthesis 
of the compounds 111-113, 138 and 139 most reactions proceeded 
efficiently, the results of our attempts to prepare the N-hydroxy 
Arnsteln tripeptlde 37 from the fully protected tripeptides 138 and 
139 were rather disappointing. We succeeded In Isolating only a 
small amount of the desired product. Although time did not allow us 
to study optimization of the reaction conditions and the work-up 
procedures, we consider that there 1s still room for improvement of 
the deprotection procedures. 
It 1s clear that the N-hydroxy Arnstein tripeptlde 37 is not 
Involved as an Intermediate in the enzymatic conversion of the 
Arnstein tripeptlde 14 into Isopenicillin N 15. However, the 
Incubation experiment involving 144 may be the first example of the 
conversion of an N-substituted Arnstein tripeptlde into the 
corresponding penicillin. Work is In progress to Isolate the 
product and to collect support for the proposed structure 145. 
Because the absolute configuration of the cysteine chiral centre in 
the tested compound 37 1s not known, Baldwin's group 1s currently 
attempting to Isolate the other dlastereomer and to test 1t as a 
substrate of Isopeniclllin N synthetase : It is expected that this 
compound Is the (L,D,D)-N-hydroxy tripeptlde 147, which will probably 
not act as a substrate for the enzyme. 
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Since the postulate underlying our investigations turned out 
to be Incorrect, the mechanism of the formation of the 0-lactam ring 
during penicillin biosynthesis remains still unknown. Recently, 
Baldwin 2 8 proposed a mechanism which accounts for the closure of 
both rings (scheme XXX). In this model a crucial role is assigned 
to an iron I o n . 2 8 · 7 4 · 7 5 In view of this proposal. Involving the 
formation of a tripeptide-iron-enzyme complex, conversion of the 
N-hydroxy Arnstein tripeptide 37 into an isopenici 1 lin N analogue 
should be rather surprising! 
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Much more likely would be the Inhibition of the biosynthetic 
conversion due to complexatlon of the iron ion with the hydroxamic 
acid moiety. In this connection it is worth noting that several 
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hydroxamic acids are known to be powerful active, site-specific 
inhibitors of a number of metalloenzymes.15" Besides, it is 
astonishing that the isopenicillin N synthetase tolerates so many 
substantial variations of the substrate 2 8· 6 6 - 7 4 (see also section 
4.3.4.3). 
In spite of all investigations, elucidation of the exact 
biochemical mode of action of this enzyme remains for the time being 
a real challenge. 
4.9 EXPERIMENTAL SECTION 
Melting points were taken on a Koefler hot stage (Leitz-Wetzlar) 
and are uncorrected. Infrared spectra were measured with a Perkin 
Elmer Model 397 spectrophotometer. Proton magnetic resonance spectra 
were measured on a Varian Associates Model T-60 or a Bruker WH-90 
spectrometer. Chemical shifts are reported as 5-values (parts per 
million) relative to tetramethylsilane as an internal standard : 
deuteriochloroforrn was used as solvent unless stated otherwise. Mass 
spectra were obtained with a double-focusing VG 7070E spectrometer. 
Thin-layer chromatography (TLC) was carried out by using Merck 
precoated silica gel F-254 plates (thickness 0.25 mm). Spots were 
visualized with an UV hand lamp, Iodine vapor or Clg-TDM.151 
Sulfur-containing compounds gave sometimes characteristic yellow 
spots on TLC upon spraying with a 2% АдМОз (w/v) solution in 
water-ethanol (4:1, v/v) and 0.1N К2Сг2°7/СНзС00Н (1:1, v / v ) . 1 5 2 
Hydroxamic acids were detected (red spots) by spraying with a 3% 
РеСІз (w/v) solution in concentrated HCl/MeOH (4:96, v/v). 
For column chromatography Merck silica gel H (type 60) was used. 
The Miniprep LC (Jobin Yvon) was used for preparative HPLC. Solvent 
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systems used were as follows : system A, CH2Cl2/n-hexane (1:1, 
v/v); system B, CH2CI2; system C, EtOAc/n-hexane (35:65, v/v); 
system D, СНСІз/МеОН/НОАс (17:2:1, v/v/v); system E, EtOAc/n-hexane 
(1:2.5, v/v); system F, toluene/ethyl formate/formic acid (10:7:3, 
v/v/v); system G, МеОН/СНгСІг (0.5:99.5, v/v); system H, МеОН/СНгСІг 
(1:99, v/v); system I, 1.2-dichloroethane/n-hexane (2.5:1, v/v); 
system J, EtOAc/n-hexane (1:3, v/v); system K, EtOAc/n-hexane (1:1, 
v/v); system L, CH2Cl2/n-hexane (9:1, v/v); system M, EtOAc/n-
hexane (4:1, v/v); system N, CH2Cl2/n-hexane (3:1, v/v); system 0, 
СНгСІг/МеОН/НОАс (96.75:2.5:0.75, v/v/v); system Ρ EtOAc/n-hexane 
(1:4, v/v). 
S-4-Nitrobenzyl-L-cysteine S3 
Compound 53 was prepared according to a slightly modified 
literature procedure.99a L-Cystelne 51 (24.2 g, 0.2 mol) was 
dissolved in IN NaOH (400 ml, 0.4 mol). The solution was stirred 
vigorously, and 4-n1trobenzyl chloride 52 (34.3 g, 0.2 mol) 
dissolved in dioxane (300 ml) was added dropwise at 0°C during 30 
minutes. The reaction mixture was stirred at room temperature for 
16h. The resulting alkaline solution was washed twice with ether 
(200 ml) and acidified with concentrated HCl to pH 4.5. S-4-Nitro-
benzyl-L-cysteine precipitated immediately as its hemihydrate. The 
product was recrystallized two times from hot water (2000 ml). 
Yield : 39.7 g (75%); m.p. : 193-195eC (dec), (lit. : 233-234^, 
monohydrate"3; 172.5-174eC, anhydrous compound 9 9 0); ^Н-ШЯ (020, 
TFA; t-BuOH) : δ 8.00 and 7.51 (AA'BB', 4H, C6H4), 4.35 (t, IH 
CHCH2), 3.93 (s, 2H, SCH2C6H4), 3.12 (d, 2H, CHCH2S); anal, caled. 
for CioHi2N204S-0.5H20 : C, 45.28; H, 4.94; N, 10.56, found : C, 
45.11; H, 4.86; N, 10.53. 
155 
BenzyloxycarbonyloxyphtaJimide 54 
Compound 54 was prepared by using a slightly modified version 
of a published procedure. 1 0 0 Triethylamine (20.37 g, 0.2 mol) was 
added to a cooled (0oC) and stirred solution of N-hydroxyphtalimide 
(32.6 g, 0.2 mol) in 200 ml of DMF. The resulting, red solution 
was treated at 0°C with 36 ml of benzyl chi oroformate (purity ± 80%; 
0.2 mol). After completion of the reaction, indicated by the 
disappearance of the red colour, the reaction mixture was filtered 
to remove ЕІзМ.НСІ. The filtrate was poured Into 300 ml of H2O. The 
precipitate was collected, washed with water, and dried. 
Crystallization from 2-propanol afforded 54 in 91% yield; m.p. : 
99-10ГС; anal, caled, for C16H11NO5 : C, 64.65; H, 3.73; N, 4.71, 
found : C, 64.59; H, 3.77; N, 4.72. 
N-Benzyloxycarbonyl-$-(4-nitrobenzyl)-L-cysteine44 
To a vigorously stirred suspension of compound 53 (hemihydrate, 
13.2 g, 50 mmol) in 250 ml of CH2CI2 were added successively 54 
(14.85 g, 50 mmol) and Et3N (10.11 g, 100 ranol). After stirring for 
16h at room temperature 100 ml of IN HCl was added to the clear 
solution and the resulting two-phase system was stirred vigorously 
for a few minutes. The layers were separated, and the organic layer 
was washed with 0.1N HCl (100 ml) and H2O (3x80 ml), dried over 
Na2S04, and finally concentrated 1n vacuo to leave crude 44 (20.55 
g) as an oil. 
Purification of 44 via its dicyclohexylamlne salt 55 1 0 1 
Crude 44 was dissolved in 25 ml of dry EtOAc. After filtration 
of this solution freshly distilled dicyclohexylamlne (9.05 g, 50 
mmol) was added dropwise at O'C. The salt 55 precipitated within a 
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few minutes. It was isolated by filtration and subsequently 
recrystallized twice from 2-propanol to afford pure 55 in 80% yield. 
The free carboxylic acid 44 could be obtained quantitatively 
from its dicyclohexylamine salt 55 by washing a solution of 55 
(22.9 g, 40 mmol) in 500 ml of CH2CI2 several times with O.IN HCl 
(200 ml). Subsequently the organic layer was washed with H2O, dried 
over Na2S04 and concentrated to dryness in vacuo to afford pure 44 
as an oil. The compound was homogeneous on TLC (solvent system F) : 
Rf 0.28; iH-NMR : 5 8.08 and 7.40 (AA'BB', 4H, C 6H4), 7.30 (s, 5H, 
CeHs), 5.91 (br.d., IH, NH), 5.12 (s, 2H, OCH2), 4.84-4.36 (m, IH, 
CHCO2H), 3.76 (S, 2H, SCH2C6H4), 2.90 (d, 2Н, СНСНгЗ). 
The preparation of the compounds 45 and 57-59 is described in the 
experimental section of chapter V. 
N-Benzyloxy-D,L-valine benzyl ester hydrochloride 60 
N-Benzyloxy-D,L-valine benzyl ester 45 was dissolved in a 
minimum amount of dry ether. Subsequently dry HCl-gas was passed 
through the cooled (0°C) solution. After precipitation of the salt 
60, the HCl flow was continued for a few minutes. Then the product 
was collected by filtration, washed with dry ether and dried in 
vacuo over P2O5. Recrystallization from MeOH/ether afforded pure 60 
in 91% yield; m.p. : 36-380C; ^-NMR: δ 7.34 and 7.30 (2xs, 10H, 
2xC 6H5), 5.54 (s, 2H, CH2O), 5.29 (s, 2H, CH2O), 4.00 (d, IH, CHN), 
3.04-2.29 (m, IH, СН(СНз)2). 1.17 and 1.06 (2xd, 6H, (СНз)2). 
N-[N'-Benzyloxycarbonyl-S-(4-nitrobenzyl)-L-cysteinylJ-N-benzyloxy-D,L-
valine benzyl ester 46 
To a stirred and cooled (-780C) solution of 44 (4.28 g, 11 
mmol) in 100 ml of dry THF were added successively a solution of 
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С0СІ2 (1.15 g, 11.5 imiol) in 4 ml of dry CH2CI2 and trl-n-
butylamine (2.03 g, 11 mmol). Stirring was continued for about 25 
minutes; meanwhile the mixture was allowed to warm up to -гО'С. At 
this temperature a solution of 60 (2.63 g, 7.5 mmol) and tri-n-
butylamine (2.78 g, 15 mmol) in 75 ml of dry THF was added 
dropwise. Then the cooling bath was removed and the reaction 
mixture was stirred at room temperature for 2h. Subsequently the 
mixture was concentrated In vacuo. The residue was dissolved In 
EtOAc, washed with 0.1N HCl, H2O, and brine, and dried over N32504. 
The residue, obtained after evaporation of the solvent, was 
purified by column chromatography (solvent system G), affording 
compound 46 as an oil In 25% yield (based on 60). This mixture of 
dlastereomers was homogeneous on TLC (solvent system H): Rf 0.37; 
iH-NMR: 5 7.95 and 7.07 (AA'BB', 4H, C 6H4), 7.33 (s, 15H, ЗхСбН5), 
5.66 and 5.56 (2xd, IH, NH), 5.29-4.75 (m, 7H, ЗхСНгО and CHNH), 
4.68 and 4.58 (2xd, IH, CHNO), 3.67-3.20 (6 lines, 2xAB spectrum, 
2H, SCH2C6H4), 2.77-2.22 (m, 3H, CHCH2S and СН(СНз)2). 1.11-0.84 
(6 lines, 6H, (СНз)2); positive FAB mass spectrum, m/e (relative 
intensity): 686 ([M+l]+, Сз7Н40Мз085, 1%), 314 ([Сі^МОз]-
1
-, 
BzlO-NH2-Val-OBzl, 3%), 91 (^Ну]-·-, 100%); IR (CHCI3): 3420, 
1740, 1720, 1665, 1520 and 1350 cm"1. 
N-[N'-Benzyloxycarbonyl-S-(4-n¡trobenzyl)-L-cysteinyl]-N-benzyloxy-
D,L-valine benzyl aster 46, via the mixed anhydride method. 
To a stirred and cooled (-150C) solution of 44 (0.975 g, 2.5 
mmol) and trlethylamlne (0.252 g, 2.5 ranol) in 10 ml of dry THF was 
added isobutyl chi oroformate (0.360 g, 95%, 2.5 mmol). Stirring was 
continued at -IS'T for 10 minutes. Subsequently, a solution of 45 
(0.782 g, 2.5 mmol) in 10 ml of dry THF was added dropwise to the 
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Suspension. The reaction mixture was stirred at -150C for 30 
minutes and at room temperature for 16h. Then the reaction mixture 
was filtered and concentrated in vacuo. Purification of the residue 
by column chromatography (solvent system G) afforded 46 in 1% yield 
and N-benzyloxycarbonyl-S-(4-nitrobenzyl)-L-cysteinyl-D,L-vaHne benzyl 
ester 69 in 15% yield. Product 69, which might be a mixture of 
dlastereomers, was homogeneous on TLC (solvent system H): Rf 0.28; 
iH-NMR (60 MHz): δ 8.04 and 7.37 (AA'BB', 4H, СеНд), 7.26 (s, Ю Н , 
2хСбН5), 6.93 (d, IH, NHCHCO2), 5.90 (d, IH, NHCHCH2S), 5.10 
(br.s., 4H, 2XCH2O), 4.73-4.16 (m, 2H, CHCH2S and CHCO2), 3.76 (s, 
2H, SCH2C6H4), 2.99-2.62 (m, 2H, CHCH2S), 2.45-1.79 (m, IH, 
СН(СНз)2), 0.93 and 0.82 (2xd, 6H, (СНз)2). 
N-Benzyloxycarbonyl-$-(4-nìtrobenzyl)-L-cysteinyl-D-vaHne benzyl ester 69 
To a stirred and cooled (-45eC) solution of 44 (1.166 g, 3 
mmol) and triethylamine (0.303 g, 3 mmol) in 10 ml of dry THF was 
added Isobutyl chloroformate (0.431 g, 95%, 3 mnol). Stirring was 
continued for 10 minutes, while the temperature was allowed to rise 
to -150C. At this temperature a solution of 0-vallne benzyl ester 
4-toluenesulfonlc acid salt 104 (TO.TosOH, 1.137 g, 3 mmol) and 
triethylamine (0.303 g, 3 mnol) in 10 ml of dry THF was added 
dropwise. The reaction mixture was stirred at -150C for 30 minutes 
and at room temperature for 16h. After removal of the precipitate 
by filtration, the filtrate was concentrated 1n vacuo. The residue 
was dissolved in EtOAc, washed with H2O and brine, and dried over 
N32804. Evaporation of the solvent In vacuo, followed by purifica-
tion of the residue by column chromatography (solvent system B) 
afforded pure 69 as a white solid in 29% yield: Rf 0.28 (solvent 
system H). The 60 MHz ^ H-NMR spectra of compound 69 and the product 
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obtained according to the preceding procedure (from 44 and 45) were 
almost Identical; iH-NMR (90 MHz): 5 8.10 and 7.44 (AA'BB', 4H, 
C 6H4), 7.30 (s, 10H 2xC6H5), 6.70 (d, IH, J=8.8Hz, NHCHCO2), 5.65 
(d, IH, J= 7.5 Hz, NHCHCH2S), 5.18 and 5.10 (AB spectrum, 2H, J A B = 
11.9 Hz, CH2O), 5.11 (s, 2H, CH2O), 4.55 (dd, IH, J- 8.8 Hz resp. 
4.5 Hz, CHCO2), 4.46-4.23 (6 Unes, IH, CHCH2S), 3.76 (s, 2H, 
SCH2C6H4), 2.86 and 2.73 (AB part of ABX spectrum, 2H, ϋ/νχ = 5.3 Hz, 
Jßx « 7.0 Hz, JAB = Н.О Hz, СНСНгЗ), 2.46-1.87 (m, IH, СН(СНз)2), 
0.85 (t, 6Н, (СНз)2); chem1ca1-1on1zat1on mass spectrum, m/e 
(relative Intensity) : 580 ([M+l]+, C30H34N3O7S, 1%), 535 ([M-COz]*, 
1%), 473 ([M-C7H60]+, 1%), 445 (CM-C8H602]
+
. 3%), 401 ([М-СдНбОд]*, 
5%), 303 (5%), 257 (14%), 170 ( [ C y H ^ S ] * , 46%), 136 ([CjHeM^] 4, 
10%), 106 ([С7Нб0]+, 22%), 91 (^Η;]*, 100%); anal, caled, for 
C30H33N3O7S: С, 62.16; Η, 5.74; Ν, 7.25, found : С, 62.13; Η, 5.83; 
Ν, 7.21. 
N-Carboxy-S-(4-n¡trobenzyl)-L-cysteine anhydride 66 
All reactions Involving N-carboxy anhydrides were carried out 
1n a nitrogen atmosphere. THF (30 ml) and finely ground 53 (2.65 g, 
10 ішюі) were charged to a three-necked, round-bottomed flask, 
fitted with a reflux condenser. The equipment had been flushed with 
dry nitrogen for 0.5h before use. Phosgene addition was begun at a 
moderate rate and gentle external heating was applied to bring the 
stirred reaction mixture to 45-50<>C. Phosgene addition and stirring 
were continued at 45-50<'C to give a clear solution, and for a 
further 15 min. to complete the reaction. When phosgene addition 
and heating had been stopped, nitrogen was bubbled through the 
solution to remove some of the excess phosgene (30-60 min.). 
Finally the mixture was filtered and evaporated to dryness In 
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vacuo, using a water bath at a temperature not exceeding 35°C. The 
greyish solid residue which was obtained in nearly quantitative 
yield could not be recrystallized because of decomposition; ^-NMR 
(d6-DMS0): 6 9.08 (s, IH, NH), 8.13 and 7.53 (AA'BB', 4H, C6H4), 
4.75 (t, IH, CHN), 3.95 (s, 2H, SCH2C6H4), 2.90 (d, 2H, CHCH2S); 
IR(KBr): 3330 cm"1 (NH), 1840 and 1785 cm"1 (C=0). 
N-(2-Nitrophenylsulfenyl)-N-carboxy-S-(4-nitrobenzyl)-L-cysteine 
anhydride 77 
Crude 66 (2.82 g, 10 mmol) was dissolved in 30 ml of dry THF 
and the solution was cooled to 0oC. Then o-nitrophenylsulfenyl 
chloride (1.9 g, 10 mmol) was added to the stirred solution, 
followed by a solution of ЕІзН (1.01 g, 10 nrnol) in 10 ml of dry 
THF, which was added dropwlse. The reaction mixture was stirred at 
0oC for 30 minutes, after which the precipitate was removed by 
filtration. The filtrate was concentrated in vacuo at 35 0C. 
Attempts to crystallize the product failed. The freshly prepared 
oil was used In the next reaction without further purification. 
A ttemp ted syn thesis o f Ν-[Ν'- (2-nitrophenylsulfenyl)-S- (4-nitrobenzyl) -
L-cysteinyl]-N-benzyloxy-D,L-valine benzyl ester 78. 
To a stirred solution of 60 (1.74 g, 5 mmol) in 10 ml of dry 
THF were added successively a solution of Et3N (0.50 g, 5 mmol) in 
10 ml of dry THF and a solution of crude 77 (4.3 g, 10 nriol) in 40 
ml of dry THF. The reaction mixture was stirred at room temperature 
for five days. Then the precipitate was removed by filtration and 
the filtrate was concentrated In vacuo. The residue was dissolved 
In 150 ml of CH2CI2, washed with a 5% aqueous citric acid solution 
(2x50 ml), 5% aqueous МаНСОз (50 ml) and H2O (2x50 ml), and dried 
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over N32504. The organic solvent was evaporated in vacuo to afford 
an oily residue (3.0 g), which was subjected to column chroma­
tography (solvent system B). Two of the fractions obtained were 
further purified by preparative TLC on silica using solvent system 
H as eluant to afford a trace of 78 and a few mg of 79, both as a 
mixture of diastereomers. Exact yields were not determined. 
Compound 7Э: Rf 0.30 (solvent system B); ^-NMR: 6 8.39 -7.80 
and 7.67-6.84 (2xm, 18H, 2хСбН4 and 2xC 6H5), 5.16-4.43 (m, 5H, 
2xCH20 and CHN0), 4.10-3.61 (m, IH, CHNS), 3.50-3.22 (m, 3H, NH and 
SCH2C6H4), 3.08-2.23 (m, 3H, CHCH2S and СН(СНз)2), 1.02 and 0.86 
(2xd, 6H, (СНз)2). 
Compound 79: Rf 0.27 (solvent system B); iH-NMR: δ 8.32-7.16 
(m, 13H, 2XC6H4 and С6Н5), 6.86 (d, IH, NHCO), 5.17 (s, 2H, СНгО), 
4.60 (dd, IH, СНСО2), 3.77 and 3.64 (2xs, 3H, NHS and SCH2C6H4), 
3.42 (5 lines, IH, CHNS), 2.86 (d, 2H, CHCH2S), 2.44-1.93 (m, IH, 
СН(СНз)2), 0.89 (4 lines, 6H, (СНз)2). 
N-(2-Nitrophenylsulfenyl)-S-(4-nitrobenzyl)-L-cysteinyl-D-valine benzyl 
ester 79 
To stirred suspension of 0-vallne benzyl ester 4-toluene-
sulfonlc acid salt 104 (1.78 g, 4.7 mmol) In 30 ml of dry THF were 
added successively Et3N (0.474 g, 4.7 mmol) and a solution of crude 
77 (2.15 g, 4.95 mmol) in 20 ml of dry THF. The clear solution was 
stirred at room temperature for one day. After filtration and 
evaporation of the solvent in vacuo, the resulting residue was 
dissolved in EtOAc, washed with a 5% aqueous citric acid solution 
(3x80 ml), a 5% aqueous МаНСОз solution (3x100 ml) and brine (100 
ml), and dried over N32504. Evaporation of the solvent In vacuo 
afforded a waxy solid (1.7 g), which was purified by column 
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chromatography (solvent system B). Pure 79 was obtained as a yellow 
solid in 27% yield: Rf 0.27 (solvent system B); ^-NMR: δ 8.31-7.16 
(m, 13H, 2хСбН4 and C6H5), 6.89 (d, IH, J = 9.0 Hz, NHCO), 5.16 (AB 
spectrum, 2H, CH2O), 4.61 (dd, IH, J = 9.0 and 4.5 Hz, CHCO2), 3.83 
and 3.78 (2xs, 3H, NHS and SCH2C6H4). 3.47 (q, IH, J=6.0 Hz, 
CHCH2S), 2.86 (d, 2H, J=6.0 Hz, CHCH2S), 2.41-1.97 (m, IH, 
СН(СНз)2), 0.88 (t, 6H, (СНз)2); chemical-ionization mass spectrum, 
m/e (relative intensity): 599 ([M+l]+, C28H31N4O7S2, 0.6%), 536 
([M-N03]+, 0.9%), 446 ([C22H28N305S]+. 10%), 430 ( [ M ^ H ß ^ S r , 
3%), 303 ([СдНдМзОбЗгГ or [СюНцМгОбЗг]*, 7%), 257 ([СдНдМгОзЗг]-1·, 
12%), 167 ([C7H5N02S]+, 5%), 154 (CC6H4N02S]
+
, 100%), 138 
([C7H8N02]+, 35%), 108 ([C7H80]
+
, 13%), 91 (CC7H7]+, 76%); anal. 
caled, for C28H30N4O7S2: C, 56.17; H, 5.05; N, 9.36, found: C, 
55.62; H, 5.05; N, 9.20. 
N-(4-Methoxybenzyl¡dene)-D-val¡ne benzyl ester 83 
D-Val1ne benzyl ester 4-toluenesulfonic acid salt 104 (1.89 g, 
5 ішіоі) was dissolved In CH2CI2 and treated with triethylamine 
(0.505 g, 5 mmol). The resulting solution was washed thrice with 
H2O, dried over N32804, and concentrated in vacuo to afford 
D-valine benzyl ester 70. The free amine was dissolved in 6 ml of 
dry CH2CI2. The solution was added to a mixture of 4-methoxy-
benzaldehyde (0.63 g, 4.6 nrnol) and activated 4A molecular sieves 
(± 2 g) in 6 ml of dry CH2CI2. The mixture was stirred for 16h at 
room temperature, filtered and concentrated in vacuo to afford 
compound 83 as an oil in quantitative yield; ^H-NMR: S 8.05 (s, IH, 
CH=N), 7.63 and 6.81 (AA'BB1, 4H, C 6H4), 7.21 (s, 5H, C6H5), 5.13 
(S, 2H, OCH2), 3.74 (s, 3H, OCH3), 3.61 (d, IH, CHCO2), 2.70-1.90 
(m, IH, СН(СНз)2), 0.93 (d, 6H, (СНз)2). 
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3-Bromo-2-benzyloximino-propanoìc acid £ί 
A suspension of benzylhydroxylami ne hydrochloride (Janssen 
Chimica, 16 g, 100 mmol) in 150 ml of H2O was added at room 
temperature to a vigorously stirred solution of bromopyruvic acid 
90 (Fluka AG, 16.7 g, 100 mmol) In 100 ml of H2O. The suspension 
was stirred at room temperature for 2h. The crystalline product 
was collected by filtration and washed twice with 0.05N HCl (50 ml) 
and H2O (50 ml). The compound was recrystalllzed from МеОН-НгО, 
and subsequently dried thoroughly in a vacuum desiccator charged 
with phosphorus pentoxlde: 91 was obtained in 88% yield. M.p.: 
147-148^; iH-NMR: S 7.37 (s, 5H, СбН 5), 5.40 (s, 2Н, CHzO), 4.20 
(s, 2Н, СНгВг); exact mass caled, for СюНцВгМОз (M++1), m/e 
271.9922, found: 271.9918; chemical-ionizatlon mass spectrum, m/e 
(relative intensity): 274/272 ([M+l]+, 7%), 256/254 (M-0H]+, 4%), 
192 ([M-Br]+, 25%), 107 ([C;^]-··, 11%), 91 (^Н;]*, 100%); anal. 
caled, for СюНюВгМОз: С, 44.14; H, 3.70: Ν, 5.15, found: С, 
44.40; Η, 3.74; Ν. 5.10. 
4-Nitrophenyl (3-bromo-2-benzylox¡mino)propanoate 97 
DCC (1.35 g, 6.5 rimol) was added all at once to a stirred and 
cooled (0oC) solution of 91 (1.72 g, 6.3 mmol) and 4-nitrophenol 
(0.96 g, 6.9 mmol) in 50 ml of EtOAc. The reaction mixture was 
stirred at 0oC for 30 minutes and at room temperature for 16h. 
Dicyclohexylurea was removed by filtration and the solvent was 
evaporated In vacuo. The residue was recrystalllzed from 2-propanol, 
affording 97 as a white solid In 73% yield. The compound was homo-
geneous on TLC (solvent system B): Rf 0.68. M.p.: 93-950C; ^-NMR: 
δ 8.18 and 7.30 (AA'BB', 4H, СеНд), 7.37 (s, 5H, С
б
Н5), 5.43 (s, 
2Н, ОСНг), 4.27 (s, 2Н, ВгСНг). 
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N-(3-Chloro-2-benzyloximino-propanoyl)-N-benzyloxy-D,L-valine benzyl 
esterOS 
Isobutyl chloroformate (0.29 g, 95%, 2.0 mmol) was added to a 
stirred and cooled (-50C) solution of 91 (0.57 g, 2.1 imol) and 
N-methylplperidine (0.20 g, 2.0 πτηοΐ) in 40 ml of dry CH2CI2. After 
10 minutes a cold solution of 60 (=45.HCl, 0.70 g, 2.0 imiol) and 
N-methylpiperidine (0.20 g, 2 mmol) in a few ml of dry CH2CI2 was 
added dropwise to the cooled reaction mixture. Stirring was 
continued for Ih at -5°C and for 16h at room temperature. After 
being washed with 0.1M aqueous citric acid, the reaction mixture 
was dried over N32804 and concentrated in vacuo. The residue was 
purified by column chromatography (solvent system I), affording the 
chloro-compound 98 in 45% yield. The product was homogeneous on TLC 
(solvent system I): Rf 0.62; ^-NMR: б 7.27 (m, 15H, 3x CeHs), 5.18 
(s, 2H, ОСНг), 5.13 (2, 2Н, ОСНг). 4.93 (s, 2Н, C(0)N0CH2), 4.63 
(d, IH, СНСО2), 4.36 (AB spectrum, 2H, СНгСІ), 2.79-2.27 (m, IH, CH 
(СНз)2). 1·02 and 0.93 (2xd, 6H, (СНз)2); exact mass caled, for 
C29H32CIN2O5 (M++1), m/e 523.200, found 523.198; chemical-ionlzation 
mass spectrum, m/e (relative intensity): 613/615 ([M+C7H7]+, 9%), 
523/525 ([M+l]+, 32%), 487 (CM-C1]+, 5%), 314 ([С^НгдИОз]-1-, 3%), 
181 ( [ С І Д Н І З Г , 25%), 107 ([C7H70]
+
. 14%), 91 (^Η;]-·-, 15%), 77 
[СбН5]+, 100%). 
3-Bromo-2-benzyloximino-propanoyl bromide 99 
РВГ3 (61.3 g, 226 mmol) was added dropwise to a suspension of 
91 (9.96 g, 36.6 rrniol) In 23 ml of dry ether at room temperature. 
Subsequently, the reaction mixture was heated under reflux for 3 
days. After cooling to room temperature the brown solution was 
decanted and the residual phosphorous acid was washed twice with 
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dry ether. The combined ethereal solutions were concentrated in 
vacuo after which the excess РВГ3 (b.p. 530C, 8 rtriHg) was removed 
by distillation under diminished pressure, leaving crude 99 (10.7 
g, i 87%) in the distillation flask. The crude product, probably 
a mixture of the E- and Z-isomer, was used in the next reaction 
without further purification; ih-NMR (CCI4): & 7.25 (s, 5H, CQHS), 
5.40 and 5.27 (2xs, 2H, OCH2), 3.97 and 1.98 (2xs, 2H, СНгВг); IR 
(CCI4) : 1760, 1740, 1580, 1025, 880 and 700 cm"1. 
N-(3-Bromo-2-benzyloxmino-propanoyl)-N-benzyloxy-D.L-vaHne benzyl 
ester 92 
The free amine of 60 was obtained in quantitative yield by 
washing a solution of 60 (1.36 g, 3.9 mmol) 1n 35 ml of CH2CI2 
with H2O (2x 20 ml), drying the organic layer over N32804, and 
evaporating the solvent 1n vacuo. The residue (45, 1.22 g, 3.9 imol) 
was dissolved in 5 ml of dry CH2CI2· To the cooled (0oC) solution 
were added successively a solution of the crude a d d bromide 99 
(1.51 g, s 4.5 imo]) in 5 ml of dry CH2CI2 and a solution of 
pyridine (0.308 g, 3.9 mmol) in 2 ml of dry CH2CI2. After completion 
of the addition the reaction mixture was stirred at room temperature 
for 5h. The precipitate was removed by filtration, and the filtrate 
was diluted with CH2CI2 to a total volume of 35 ml. The solution 
was washed with an 0.1M aqueous citric acid solution (2x 25 ml) and 
H2O (25 ml), dried over N32804 and concentrated 1n vacuo. The 
residue was purified by column chromatography (solvent system I) to 
afford pure 92 as an oil in 54% yield. The product was homogeneous 
on TLC (solvent system I): Rf 0.62; iH-NMR: δ 7.23 (s, 15H, ЗХС6Н5), 
5.16 (s, 2H, ОСНг), 5.10 (s, 2Н, OCHz), 4.92 (s, 2H, C(0)N0CH2), 
4.60 (d, IH, CHCO2), 4.16 (s, 2H, СН2ВГ), 2.76-2.29 (m, IH, 
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СН(СНз)2). 1.00 and 0.92 (2xd, 6H, (СНз)2); exact mass caled, for 
C29 H32 B r N2 05 (M ++l). m/e 567.149, found : 567.148; edemi cal-
ionization mass spectrum, m/e (relative intensity): 595/597 
(CM+C2H5]+, 3%), 567/569 (01+1]+, 25%), 4Θ7/4Θ9 ([M+C2H5-C7H80]
+
, 
8%). 397 ([M-C7H6Br]
+
, 15%), 181 ( [ Ο ^ Η ^ ] * , 20%), 107 ([07470]+, 
27%), 91 ([C7H7]+, 100%). 
4-Nitrobenzylmercaptan (4-nitro-a-toluenethiol) 93 
This preparation was carried out under a nitrogen atmosphere. 
Potassium thioacetate (11.4 g, 0.1 mol) was added all at once to a 
stirred solution of 4-n1trobenzyl chloride (17.2 g, 0.1 mol) in a 
mixture of EtOH (200 ml) and l,4-d1oxane (50 ml). Stirring was 
continued until completion of the reaction (± 2h) as monitored by 
TLC (solvent system J). Then the solvent was evaporated in vacuo. 
EtOAc was added to the residue and the resulting suspension was 
washed twice with water. After drying the clear organic layer over 
НагЗОд the solvent was evaporated in vacuo. The residue was 
recrystallized from EtOAc/petroleum ether 60°-80'' to afford 
4-nitrobenzylthioacetate 100 as a pale yellow solid in 92% yield. 
The thloester 100 (21.1 g, 0.1 mol) was dissolved In 375 ml of 
dry MeOH under a nitrogen atmosphere. HCl was passed through the 
solution until completion of the reaction (± 2h) as monitored by 
TLC (solvent system K). Then the reaction mixture was filtered and 
concentrated in vacuo. The residue was recrystallized from EtOH 
(± 250 ml) to afford 4-nltrobenzyl mercaptan as a pale yellow solid 
in 87% yield; m.p.: 55-570C (lit.153: 57-580C); iH-NMR: δ 8.07 and 
7.38 (AA'BB', 4H, C6H4), 3.79 (d, 2H, CH2S), 1.83 (t, IH, SH). 
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N-[3-(4-N¡trobenzylthio)-2-benzylox¡m¡no-propanoyl]-N-benzyloxy-D,L-
valine benzyl ester 94 
A solution of triethylamine (0.124 g, 1.22 mnol) in 10 ml of 
dry DME was added dropwise to a stirred solution of 92 (0.683 g, 
1.20 mmol) and 4-nitrobenzyl mercaptan (0.216 g, 1.28 mmol) in 20 ml 
of dry DME at room temperature and In an argon atmosphere. Stirring 
was continued until completion of the reaction (± 6h) as monitored 
by TLC (solvent system L). Triethylamine hydrobromide was removed 
by f i l t ra t ion and the solvent was evaporated in vacuo. The residue 
was dissolved in CH2CI2 (50 ml), washed with 0.05N HCl (30 ml) and 
H2O (30 ml). After drying over N32804 and evaporation of the 
solvent in vacuo, the residue was purified by column chromatography 
(solvent system L). Pure 94 was obtained as a solid In 55% yield. 
The compound was homogeneous on TLC (solvent system L): Rf 0.57; 
iH-NMR: б 7.95 and 7.18 (AA'BB', 4H, C6H4), 7.27 (s, 15H, Зх C6H5), 
5.19 (s, 2H, OCH2), 5.11 (s, 2H, OCH2), 5.00 (AB spectrum, 2H, 
C(0)NOCH2), 4.72 (d, IH, CHCO2), 3.60 (s, 2H, CH2S), 3.43 (s, 2H, 
CH2S), 2.75-2.35 (m, IH, СН(СНз)2), 1.03 (d, 6H. (СНз)2); 
chemical-ionlzatlon mass spectrum, m/e (relative intensity): 656 
( [ M + l ] + , Сз6Нз8Мз075, 4%), 550 ([М-С7Н5ОГ, 5%), 170 ([C7H8N02S], 
5%), 106 (CC7H60]+, 24%), 102 (57%), 92 ([C7H 8 ] + , 14%), 85 (100%). 
Attempted synthesis of N-[N'-benzyloxyfl'-acetyl-S-(4-nitrobenzyl)~D.L-
cysteinyl]-N-benzyloxy-D,L-valine benzyl ester 102a 
With Intervals of several hours seven portions of pyridine.BH3, 
0.043 g (0.46 rmiol) per portion, were added to a solution of 94 
(0.30 g, 0.46 mmol) in a few ml of dry Et20, saturated with dry 
HCl. After stirring at room temperature for two days the reaction 
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was complete as monitored by TLC (solvent system L). The reaction 
mixture was concentrated in vacuo. The residue was dissolved in 
EtOAc, washed with 0.1N HCl, 1% aqueous МаНСОз and brine, dried over 
N32304, and concentrated in vacuo. The residue (0.185 g) was 
dissolved in 1 ml of dry CH2CI2. To the stirred solution were 
added successively a solution of acetyl chloride (0.044 g, 0.56 
mmol) in dry CH2CI2 (2 ml) and a solution of pyridine (0.044 g, 
0.56 mmol) in dry CH2CI2 (2 ml). After stirring at room temperature 
for 16h the reaction mixture was diluted by adding 15 ml of 
CH2CI2. Subsequently the solution was washed with 0.05N HCl (20 ml) 
and H2O (20 ml), dried over Na2S04, and concentrated in vacuo. 
Purification of the residue by column chromatography (solvent 
systems successively Ε, К and M) afforded, among others, the 
following oily products: 102b, 7% yield; the compound, probably 
a racemate, was homogeneous on TLC (solvent system M): Rf 0.82; 
iH-NMR: 6 7.95 and 7.07 (AA'BB', 4H, C6H4), 7.66-7.18 (m, 5H, 
C6H5), 7.33 (S, 5H, C6H5), 6.19 (d, IH, NH), 5.55-5.28 (m, IH, 
CHNH), 5.25 and 4.80 (AB spectrum, 2H, J A B = 9.4 Hz, NOCH2), 5.20 
(s, 2H, CO2CH2), 4.67 (d, IH, CHNO), 3.56 and 3.44 (AB spectrum, 
2H, J A B = 13.4 Hz, C6H4CH2S), 2.75-2.29 (m, 3H, CHCH2S and 
СН(СНз)2), 2.07 (s, ЗН, С(О)СНз), 0.94 (t, 6Н, (СНз)2); chemical-
lonization mass spectrum, m/e (relative intensity): 594 ([M+l]+, 
C31H36N3O7S. 3%), 488 ([M-C7H50]+, 3%), 314 ([Τ 1 9Η24Ν03]
+
, 
Bzl0-NH2-Val-0Bzl, 37%), 206 ([С^Н^НОг] 4-, 10%), 170 ([C7H8N02S]
+
, 
16%), 138 ([C7H8N02]+, 9%), 107 ([С7Н7ОГ, 39%), 91 ( ^ 7 ] + , 91%), 
41 (100%). 
67a, 1% yield; the compound was homogeneous on TLC (solvent 
system M) : Rf 0.66; 1Н-Ы№ : 8.20 and 7.49 (AA'BB', 4H, C 6H4), 
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7.36 (s, 5H, CeHs), 6.15 (br.s., IH, NH), 4.99 and 4.89 (AB 
spectrum, 2H, J A B = 10.2 Hz, OCH2), 4.07-3.77 (m, 2H, CHNO and 
CHCH2S), 3.84 (s, 2H, C6H4CH2S), 3.20 and 2.70 (AB part of ABX 
spectrum, 2H, JAX = 3.3 Hz, Οβχ = 8.8 Hz, Одв = 14.0 Hz, CHCH2S), 
2.66-2.23 (m, IH, СН(СНз)2), 0.99 (t, 6H, (СНз)2); exact mass caled. 
for C22H26N3O5S (M++1), m/e 444.1593, found 444.1589; chemical-
ionizatlon mass spectrum, m/e (relative intensity) : 444 ([M+l]+, 
9%), 338 ([M-C7H50]+, 7%), 275 (CM-C7H6N02S]
+
, 3%), 170 
([C7H8N02S]
+
, 7%), 138 (CC7H8N02]+, A%), 107 (CC7H70]+, 20%), 106 
([С7НбО]+, 30%), 91 ([C7H73+, 74%), 41 (100%). 
67b, 6% yield; the compound was homogeneous on TLC (solvent 
system M) : Rf 0.55; ^-NMR : 6 8.19 and 7.48 (AA'BB', 4H, C6H4), 
7.36 (s, 5H, C6H5), 6.34 (br.s., IH, NH), 4.98 and 4.92 (AB 
spectrum, 2H, JAB = 9.9 Hz, OCH2), 4.10-3.86 (m, 2H, CHNO and 
CHCH2S), 3.82 (s, 2H, C6H4CH2S), 3.22 and 2.60 (AB part of ABX 
spectrum, 2H, ϋ
Α
χ = 2.7 Hz, Οβχ = 10.5 Hz, J A B = 13.7 Hz, CHCH2S), 
2.56-2.24 (m, IH, СН(СНз)2), 1.05 and 0.95 (2xd, 6H, (СНз)2); exact 
mass caled, for C22H26N305S (M++l), m/e 444.1593, found 444.1589; 
chemical-ionization mass spectrum, m/e (relative intensity) : 444 
([M+l]+, 5%), 338 ([M-C7H50]+, 6%), 275 ([M^HeNOzS]-·-, 16%), 170 
([C7H8N02S]
+
, 39%), 138 ([C7H8N02]
+
, 11%), 107 ([C7H7O]4·, 41%), 106 
(СС7НбО]+, 45%), 91 ([C7H7]+, 100%). 
D- аііп benzyl ester 4-toluenesulfonic acid salt 104^3 
D-Valine 103 (Janssen Chimica, 11.7 g, 100 mmol) and p-toluene-
sulfonic add monohydrate (22.8 g, 120 птлоі) were pulverized and 
added to a mixture of 75 ml of benzyl alcohol and 100 ml of toluene 
in a 500 ml round-bottomed flask. The suspension was heated under 
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reflux to remove the water azeotropically. The water was trapped 
with the aid of a Dean-Stark apparatus. A clear solution was 
obtained soon after reflux began. After 3-4h of reflux the reaction 
mixture was allowed to cool to room temperature. The desired 
compound precipitated and was isolated by filtration with suction. 
The crude product was washed with toluene and cold ether, and 
recrystalllzed from MeOH-ether to afford 104 in 76% yield; m.p. : 
159-16ГС (lit. 1 3 3 b : 159-1610C); ^H-NMR : S 7.73 and 7.04 (AA'BB', 
4H, СбНд), 7.24 (s, 5H, CgHs), 5.14 and 4.95 (AB spectrum, 2H, 
JAB = 12.7 Hz, OCH2), 3.86 (d, IH, CH-N), 2.38-1.93 (m, IH, 
СН(СНз)2). 2.28 (s, 3H, CH3C6H4), 0.88 (d, 6H, (СНз)2); exact mass 
caled, for D-val1ne benzyl ester, С^Н^МОг (M++1), m/e 208.1338, 
found : 208.1336; chemical-lonization mass spectrum, m/e (relative 
Intensity) : 208 ([M+l]+, H-Val-0Bzl, 26%), 173 (M+l]+, TosOH, 98%), 
91 ([C7H7]+, 91%), 72 (44%); anal, caled, for C ^ s N O s S : C, 60.14; 
H, 6.64; N, 3.69, found : C, 60.14; H, 6.68; N, 3.63. 
З-Вгото-2-benzyloximino-propanoyl-D-valine benzyl ester 105 
Trlethylamlne (5.55 g, 55 mmol) was added dropwise to a stirred 
and chilled (O^) solution of 104 (20.85 g, 55 mmol) in 200 ml of 
CH2CI2. Subsequently, a suspension of 91 (14.96 g, 55 mmol) in 100 
ml of CH2CI2 was added to the cold solution. Finally, DCC (Janssen 
Chimica, 12.0 g, 58 плюі) was added all at once, and stirring was 
continued at 0oC for 10 minutes and at room temperature overnight. 
Dlcyclohexylurea was then removed by filtration and the filtrate 
was concentrated to dryness in vacuo. The residue was dissolved in 
200 ml of EtOAc, washed with 0.1N HCl and brine, dried over 
anhydrous Na2S04, and concentrated in vacuo. Column chromatography 
(solvent system A) of the residue afforded 105 as an oil in 80% 
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yield. The compound was homogeneous on TLC (solvent system A) : Rf 
0.18; ^-NMR : 5 7.34 (s, 10H, 2x C6HS), 7.13 (d, IH, J = 9.5 Hz, 
NH), 5.31 (s, 2H, CH2O), 5.18 and 5.17 (AB spectrum, 2H, CH2O), 
4.64 (double d, IH, J = 9.5 Hz and 5.0 Hz, CH-N), 4.21 (s, 2H, 
СН2ВГ), 2.44-1.96 (m, IH, СН(СНз)2), 0.94 and 0.86 (2xd, 6H, 
(СНз)2); exact mass caled, for C22H26 B r N2 04 ( M + + 1 ) . m/e 461.108, 
found : 461.106; chemical-ionization mass spectrum, m/e (relative 
intensity) : 553/551 ([M+C7H7]+, 16%), 463/461 ([M+l]+, 54%), 381 
([M-Br]+, 26%), 327/325 ([M-a^^CgHs]··-, 15%), 291 (CM-C7H6Br]
+
, 
17%), 91 ([C7H7]+, 100%). 
3-(4-Nitrobenzylthio)-2-benzyloximino-propanoic acid 118 
A solution of triethylamine (0.202 g, 2 mmol) in a few ml of 
dry DME was added dropwise to a stirred solution of 91 (0.273 g, 
1 rnnol) and 4-nitrobenzyl mercaptan (0.186 g, 1.1 mmol) in dry OME 
at room temperature and in an argon atmosphere. Stirring was 
continued until completion of the reaction as monitored by TLC 
(solvent system F). After filtration the reaction mixture was 
concentrated In vacuo. The residue was suspended in EtOAc, washed 
with 0.1N HCl (3 times), H2O and brine, dried over N32504, and 
concentrated to dryness in vacuo. The residue was dissolved in a 
minimum amount of EtOAc. Addition of dicyclohexylamine (0.181 g, 
1 mmol) resulted in the formation of a white precipitate, the 
dicyclohexylamine salt of 118. The salt was isolated by filtration, 
suspended in CH2CI2 and washed with 0.1N HCl (4 times) and H2O. 
Subsequently, the organic layer was dried over МагЗОд and 
concentrated to dryness in vacuo, affording nearly pure 118 in 80% 
yield. The product could be recrystallized from МеОН/НгО; m.p. : 
141-143eC. The compound was homogeneous on TLC (solvent system F) : 
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Rf 0.58; iH-NMR (CDCI3/CD3OD) : 5 7.94 and 7.29 (AA'BB', 4H, C6H4), 
7.28 (s, 5H, C6H5), 5.26 (s, 2Н, ОСНг), 3.75 (s, 2Н, C6H4CH2S), 
3.47 (s, 2Н. CH2C=N). 
3-(4-Nitrobenzylth¡o)-2-benzylox¡mino-propanoyl-D-val¡ne benzyl 
ester 108 
Entry A : from 118. 
Dicyclohexylcarbodiimide (2.27 g, 11 mmol) was added all at 
once to a solution of П 8 (3.60 g, 10 mnol), 104 (4.17 g, 11 rtmol) 
and pyridine (0.87 g, 11 mmol) in EtOAc at 450C. The mixture was 
stirred at room temperature for 2 hours, filtered, washed with 0.1N 
HCl (3 times), H2O and brine, dried over N32804, and concentrated 
in vacuo. The residue was purified by column chromatography (solvent 
system B) affording 108 as an oil in 80% yield. 
Entry В : from 105. 
A solution of triethylamine (0.464 g, 4.6 mmol) in 5 ml of dry 
DME was added dropwlse to a stirred solution of 105 (1.06 g, 2.3 
mmol) and 4-nitrobenzyl mercaptan 93 (0.389 g, 2.3 mmol) in 20 ml of 
dry DME at room temperature and in an argon atmosphere. Stirring 
was continued until completion of the reaction (± 3h) as monitored 
by TLC (solvent system N). The reaction mixture was filtered and 
concentrated in vacuo. The residue was dissolved in CH2CI2· The 
solution was washed with 0.1N HCl (2 times) and H2O, dried over 
N32804, and concentrated in vacuo. The residue was purified by 
column chromatography (solvent system B) affording 108 In 91% yield. 
The compound was homogeneous on TLC (solvent system B) : Rf 0.17; 
iH-NMR : S 8.05 and 7.42 (AA'BB', 4H. C6H4), 7.38 (s, Ю Н , 2XC6H5), 
7.18 (d, IH, NH), 5.24 (s, 2H, OCH2), 5.21 (AB spectrum, 2H, OCH2), 
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4.61 (dd, IH, J = 9.0 Hz and 4.5 Hz, NCHCO2), 3.77 (s, 2H, 
C6H4CH2S), 3.48 (s, 2H, CH2C=N), 2.47-2.00 (m, IH, СН(СНз)2), 0.95 
and 0.87 (2xd, 6H, (СНз)2); exact mass caled, for C29H32N3O6S 
(M++1), m/e 550.201, found 550.202; chemical-lonlzation mass 
spectrum, m/e (relative Intensity) : 550 ([M+l]+, 100%), 442 
([M-C7H70]+t 5%), 414 ([M-C8H702]
+
, 4%), 413 ([М^НбНОгГ, 6%), 
382 ([M-C7H5N02S]+, 11%), 170 ([C7H8N02S]+, 6%), 107 ([C7H70]+, 
16%), 106 ([C7H60]
+
, 17%), 91 ([С7Н7Г, 90%). 
3-Benzylthio-2-benzyloximino-propanoyl-D-vatine benzyl ester 109 
A solution of tMethylamine (1.66 g, 16.4 mmol) in 10 ml of dry 
OME was added dropwise to a stirred solution of 105 (3.78 g, 8.2 
mnol) and freshly distilled benzyl mercaptan 106 (1.02 g, 8.2 rrmol) 
in 80 ml of dry OME at room temperature and in an argon atmosphere. 
After completion of the reaction (± 3h) as monitored by TLC (solvent 
system N) the reaction mixture was filtered and concentrated In 
vacuo. The residue was dissolved in CH2CI2. washed with 0.1N HCl 
(2 times) and H2O, dried over N32604, and concentrated in vacuo. The 
residue was subjected to column chromatography (solvent system B) 
to afford pure 109 as an oil in 82% yield. The compound was 
homogeneous on TLC (solvent system B) : Rf 0.34; ^-NMR : £ 7.35 
(s, Ю Н , гхСбНб), 7.23 (s, 5H, C6H5), 7.16 (d, IH, NH), 5.22 (s, 
2H, ОСНг), 5.20 and 5.16 (AB spectrum, 2H, JAB = 12.1 Hz, OCH2), 
4.63 (dd, IH, J = 9.0 Hz and 4.8 Hz, NCHCO2), 3.71 (s, 2H, 
C6H5CH2S), 3.51 (S, 2H, CH2C=N), 2.46-1.98 (m, IH, СН(СНз)2), 0.95 
and 0.87 (2xd, 6H, (СНз)2); exact mass caled, for C29H33N2O4S 
(M++1), m/e 505.216, found 505.217; chemical-ionization mass 
spectrum, m/e (relative Intensity) : 505 ([M+l]+, 46%), 399 
([M-C7H5O;]-··, 3%), 382 ([M-C7H6S]+, 8%), 181 ( [ C ^ H ^ ] * , 4%), 137 
174 
([CeHgS]+, 9%), 123 ([C7H7S]+, 6%), 107 ([C7H70]+, 16%), 91 
([C7H7]+. 100%). 
3-(4-Methoxybenzylthio)-2-benzyloximino-propanoyl-D-valine benzyl 
ester 110 
A solution of triethylamine (7.07 g, 70 rrniol) in 70 ml of dry 
1,2-dimethoxyethane was added dropwise to a stirred solution of 
105 (16.13 g, 35 rnnol) and 4-methoxy-a-toluenethiol 107 (Aldrich, 
6.47 g, 42 irniol) in dry DME (280 ml) at room temperature and under 
argon. Stirring was continued until completion of the reaction as 
monitored by TLC (solvent system B). Triethylamine hydrobromide was 
removed by filtration and the solvent was evaporated. The residue 
was dissolved in EtOAc, washed with 0.05N HCl and H2O, and dried 
over anhydrous N32504. Evaporation of the solvent in vacuo afforded 
a crude product, which was purified by column chromatography 
(solvent system B). The product was obtained as an oil in 62% yield. 
The compound was homogeneous on TLC (solvent system B) : Rf 0.25; 
^-NMR : δ 7.33 (s, ЮН, 2хСбН5), 7.16 and 6.74 (АА'ВВ', 4Н, С6Н4), 
6.95 (d, IH, J = 9.0 Hz, NH), 5.20 (s, 2H, СН2О), 5.20 and 5.15 
(AB spectrum, 2H, J A B = 12.0 Hz, CH2O), 4.62 (double d, IH, J = 9.0 
Hz and 4.8 Hz, CH-N), 3.75 (s, 3H, OCH3), 3.66 (s, 2H SCH2C6H4), 
3.48 (S, 2H, SCH2C=N), 2.45-1.94 (m, IH, СН(СНз)2), 0.94 and 0.86 
(2xd, 6H, (СНз)2); exact mass caled, for C30H35N2O5S (M++1), m/e 
535.227, found : 535.228; chemical-ionization mass spectrum m/e 
(relative Intensity) : 656 ([M+CeHioO]+t 1%), 535 ([Μ+1]
+
, 7%), 
427 ([M-C7H70]+, 2%), 415 ([M-C^O]*, 1%), 382 ([M-C 8H 80S]
+
, 7%), 
153 ([CeHgOS]-··, 11%), 121 ([C8H90]
+
, 100%), 107 ( ^ 7 0 ] + , 23%), 91 
([C7H7D+. 67%). 
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N-Benzyloxy-S-(4-n¡trobenzyl)-D,L-cysteinyl-D-val¡ne benzyl 
ester 111 
With intervals of 45 minutes seven portions of (СНз)зМ.ВНз, 
0.58 g (7.9 rmol) per portion, were added at room temperature to a 
stirred solution of 108 (2.17 g, 3.95 rnnol) in 20 ml of dry dioxane, 
saturated with dry HCl. After completion of the reaction (± 8h) as 
monitored by TLC (solvent system F), the solvent was evaporated in 
vacuo. The residue was dissolved in CH2CI2, washed with H2O (3 
times) and brine, dried over ^ З О д , and concentrated in vacuo. The 
residue was purified by column chromatography, using successively 
solvent system В and C, affording Ш _ as an oily mixture of 
diastereomers in 30% yield. The mixture showed only one spot on 
TLC (solvent system C) : Rf 0.38; iH-NMR : S 8.12 and 7.41 (AA'BB', 
4H, C6H4), 7.33 (s, 10H, 2XC6H5), 6.10 (t, IH, NH), 5.15 (s, 2H, 
CO2CH2), 4.73 (s, 2H, NOCH2), 4.73-4.50 (m, IH, CHCO2), 4.02-3.27 
(m, IH, CHNO), 3.73 and 3.71 (2xs, 2H, C6H4CH2S), 3.08-2.47 (m, 2H, 
CHCH2S), 2.47-1.96 (m, IH, СН(СНз)2), 1.08-0.63 (m, 6H, (СНз)2); 
exact mass caled, for СгдНздМзОбЗ (M++l), m/e 552.217, found : 
552.216; chemical-lonizatlon mass spectrum, m/e (relative 
intensity) : 552 ([M+l]+, 2%), 446 ([M-C7H50]+, 6%), 399 
([M-C7H6NOS]
+
, 4%), 338 ([M-C8H7N04S]+, 8%), 170 ([CyHß^S]-·-, 83%), 
138 ([C7H8N02]+, 22%), 136 ([C7H6N02]+, 21%), 107 ( [ C ? ^ ] * , 27%), 
106 ([C7H60]+, 51%), 91 ([С7Н7Г, 100%). 
N-Benzyloxy-S-benzyl-D.L-cystelnyl-D-valine benzyl ester 112 
Compound П 2 was prepared from 109 as described above for 111. 
Purification by column chromatography, using successively solvent 
system В and C, afforded two fractions of 112, in a total yield of 
46%. The first fraction (8%) was homogeneous on TLC (solvent system 
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С) : Rf 0.54. According to the iH-NMR spectrum this fraction 
consisted of one diastereomer (i 95%) : 6 7.31 (s, 10H, 2XC6H5), 
7.23 (s, 5H, CgHs), 6.16 (d, IH, NH), 5.18 and 5.10 (AB spectrum, 
2H, J A B = 11.9 Hz, CO2CH2), 4.71 (s, 2H, NOCH2), 4.58 (dd, IH, 
J = 9.0 Hz and 4.7 Hz, CHCO2), 3.66 (s, 2H, C6H5CH2S), 3.58-3.37 
(5 lines, IH, CHNO), 2.87 and 2.65 (AB part of ABX spectrum, 2H, 
JAX = 4.5 Hz, Jßx = 9.2 Hz, JAB = 14.3 Hz, CHCH2S), 2.45-1.91 (m, 
IH, СН(СНз)2). 0.94 and 0.85 (2xd, 6H, (СНз)2); exact mass caled. 
for C29H35N2O4S (M++1), m/e 507.232, found : 507.231; chemical-
ionization mass spectrum, m/e (relative intensity) : 597 ([M+C7H7]+, 
1%), 507 ([M+l]+, 47%), 399 ( [ N ^ 7 0 ] + , 10%). 384 ([M-C7H6S]
+
, 
12%), 107 ([C7H70]+, 22%), 91 (^Н?]"1-, 100%). 
The other fraction (38%) was also homogeneous on TLC (solvent 
system C) : Rf 0.54. According to the ^-NMR spectrum this fraction 
was enriched in the other diastereomer (up to 85%) of 112. The next 
NMR-signals were assigned to this compound : 6 7.33 (s, 10H, 
2ХС6Н5), 7.25 (S, 5H, CeHs), 6.10 (d, IH, NH), 5.16 (s, 2H, 
CO2CH2), 4.73 (s, 2H, NOCH2), 4.61 (dd, IH, J » 9.0 Hz and 4.7 Hz, 
CHCO2), 3.66 (s, 2H, C6H4CH2S), 3.64-3.42 (5 lines, IH, CHNO), 2.88 
and 2.61 (AB part of ABX spectrum, 2H, J^ = 4.5 Hz, ϋβχ = 9.1 Hz, 
JAB = 14.3 Hz, CHCH2S), 2.40-1.97 (m, IH, СН(СНз)2), 0.92 and 0.84 
(2xd, 6H, (СНз)2). 
N-Benzyloxy-S-(4-methoxybenzyl)-D,L-cysteinyl-D-vaUne benzyl ester 113 
(CH3)3N.BH3 (Aldrich) was added at room temperature in seven 
portions with 45 minutes Intervals, 2.19 g (30 mnol) per portion, 
to a stirred solution of U O (8.01 g, 15 mmol) in 75 ml of dry 
dioxane, saturated with dry HCl. After stirring at room temperature 
for 8-9h, the reaction mixture was concentrated to dryness in 
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vacuo. The residue was dissolved in CH2CI2. washed with a 5% 
aqueous МаНСОз solution and H2O, dried over anhydrous МагЗОд, and 
concentrated to dryness in vacuo. The residue was purified by 
column chromatography. Solvent system В was used to elute the 
borates after which it was changed by solvent system С to elute the 
desired compound. A mixture of two diastereomers of И З was 
obtained as an oil in 22% yield. On TLC (solvent system C) the 
mixture showed only one spot : Rf 0.46; iH-NMR : δ 7.33 (s, П Н , 
2хСбН5 and NH), 7.17 and 6.81 (AA'BB', 4H, C6H4), 6.15 (br, IH, 
H-NO), 5.15 (s, 2H, CO2CH2), 4.73 (s, 2H, N-OCH2), 4.73-4.50 
(m, IH, NCHCO2), 3.76 (s, 3H, OCH3), 3.63 (s, 2H, SCH2C6H4), 
3.63-3.31 (m, IH, CH-NO), 3.05-2.41 (12 lines, 2x AB part of ABX 
spectrum, 2H, CH-CH2S), 2.41-1.95 (m, IH, СН(СНз)2), 1.02-0.71 (m, 
6H, (СНз)2); exact mass caled, for C30H37N2O5S (M++1), m/e 537.242, 
found: 537.241; chemical-ionizatlon mass spectrum, m/e (relative 
Intensity): 537 ([M+l]+, 5%), 429 ([M-C7H70]+, 3%), 277 ([M-CeHgOS-
С7НбО] +, 8%), 121 ([C 6H90]
+
, 100%), 107 ([C7H70]+, 39%), 91 
([C7H7]+, 99%). 
3-(4-Methoxybenzylthio)-2-benzyloxim¡no-propanoic acid 119 
A solution of 91 (4.08 g, 15 itmol) and 4-methoxy-a-tolueneth1ol 
107 (2.54 g, 16.5 itmol) in 45 ml of dry OME was treated with 
tri ethyl ami ne (3.18 g, 31.5 ιπηοΐ) at room temperature and under 
argon. After stirring for 16h at room temperature the reaction 
mixture was filtered and concentrated In vacuo. EtOAc (100 ml) and 
IN HCl (40 ml) were added to the residue and the resulting two-phase 
system was stirred vigorously for a while. Then the layers were 
separated and the organic layer was washed with H2O and brine, 
dried over N32504, and concentrated to dryness in vacuo to afford 
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crude 119. The product was subjected to column chromatography 
(solvent system 0) to yield pure 119 (75%) as a solid; iH-NMR: 
δ 7.34 (S, 5H, CeHs), 7.17 and 6.75 (AA'BB', 4H, C6H4), 5.28 (s, 
2H, OCH2), 3.76 (S. ЗН, ОСНз), 3.69 (s, 2Н, C g H ^ S ) , 3.47 (s, 2Н, 
CH2C=N); chemical-ionization mass spectrum, m/e (relative 
intensity): 466 ([M+CeHgO]4·, 15%), 422 ([M+C8H90-C02]+, 2%), 346 
([M+l]+, 1%), 345 (M+, C 1 8H 1gN04S, 2%), 238 ([M-C7H70]
+
, 3%). 194 
([M-C7H70-C02]+, 7%), 153 ([C8H90S]
+
, 8%), 121 ([СвНдО^, 100%), 
107 ([C7H70]+, 4%), 91 ([C7H7]+, 18%); positive FAB mass spectrum, 
m/e (relative intensity) : 346 ([M+l]+, 4%), 121 ([CeHgO]···, 32%). 
N-Benzyloxy-S-(4-methoxybenzyt)-D,L-cysteine 120 
To a solution of 119 (3.61 g, 10.4 imol) in 50 ml of dry 
dioxane, saturated with dry HCl, was added (СНз)зМ.ВНз (1.52 g, 
20.8 rmol) at room temperature. After stirring for Ih another 
portion of (СНз)зМ.ВНз (1.52 g, 20.8 mmol) was added. After stirring 
for 16h the reaction was complete as monitored by TLC (solvent 
system F). The solvent was evaporated in vacuo whereupon the 
residue was dissolved in EtOAc (100 ml) and washed with 0.1N NaOH 
(3x70 ml). Subsequently, the combined aqueous layers were acidified 
immediately with concentrated aqueous hydrochloric acid (12N) to pH 
4.4. The resulting precipitate was isolated by filtration and 
dissolved in CH2CI2; НагЗОд was added to the hazy solution and 
after stirring for a while, the suspension was filtered through 
Celite. Concentration of the filtrate in vacuo afforded 120 in 55% 
yield; iH-NMR : 6 7.30 (s, 5H, CßHs), 7.14 and 6.76 (AA'BB1, 4H, 
C6H4), 4.68 (s, 2Н, ОСНг), 3.75 (s, ЗН. ОСНз), 3.72, 3.63 and 3.56 
(3 lines, ЗН, C6H4CH2S and CHCO2H), 2.92-2.48 (AB part of ABX 
spectrum, 2H, CHCH2S); positive FAB mass spectrum, m/e (relative 
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intensity) : 34Θ ([M+l]+, C18H22NO4S, 3%), 121 ([C 8H90]
+
, 100%). 
N-Acetyl-N-benzyloxy-S-(4-methoxybenzyl)-D,L-cysteinyl-D-valine benzyl 
ester 123, via N-carboxy anhydride 122 
Compound 120 (0.699 g, 2 mmol) and activated charcoal (0.01 g) 
were suspended in freshly distilled, dry THF (5 ml). At room 
temperature trichloromethyl chloroformate 121 (Fluka, 0.32 ml, 2.6 
mmol) was added all at once to the vigorously stirred suspension. 
The reaction mixture was stirred at 40oC for two hours. Then it was 
filtered through Cel ite and concentrated to dryness in vacuo. The 
residue, crude 122, was used iirniediately In the following reaction. 
A solution of the crude product in dry CH2CI2 (4 ml) was added 
dropwise to a stirred and cooled (0'>C) solution of 104 (0.76 g, 2 
mmol) and triethylamine (0.202 g, 2 mmol) in 10 ml of dry CH2CI2. 
The reaction mixture was stirred at 0oC for 2h and at room 
temperature for 16h. Subsequently, a solution of freshly distilled 
acetyl chloride (0.315 g, 4 mmol) 1n dry CH2CI2 (1 ml) and a 
solution of pyridine (0.316 g, 4 mmol) in dry CH2CI2 (2 ml) were 
added successively at room temperature. After stirring for 5h the 
solution was washed with H2O (3 times), dried over N32604, and 
concentrated In vacuo. The residue was subjected to column 
chromatography (solvent system P) to afford 123 as a mixture of 
diastereomers In 5% yield, based on 120. The oily mixture was 
homogeneous on TLC (solvent system C) : Rf 0.32; ^-NMR : 6 7.34 
(s, 10H, 2XC6H5), 7.22 and 6.81 (AA'BB', 4H, СеНд), 6.98 (d, IH, 
NH), 5.18 and 5.13 (AB spectrum and s, 2H, JAB = 12.5 Hz, OCH2), 
5.08-4.64 (m, 3H, OCH2 and CHN0), 4.55 (dd, IH, J = 8.5 and 4.5 Hz, 
CHCO2), 3.76 (S, 3H, OCH3), 3.66 (S, 2H, C6H4CH2S), 3.09-2.95 (5 
lines, 2H, CHCH2S), 2.47-2.00 (m, IH, СН(СНз)2), 2.18 and 2.15 
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(2xs, ЗН, СНзС(О)), 0.98-0.81 (7 lines, 6Н, (СНз)2)·. exact mass 
caled, for C32H39N2O6S (M++1), m/e 579.253, found : 579.253; 
chemical-ìonization mass spectrum, m/e (relative Intensity) : 579 
([M+l]+, 22%), 537 ([M+1-CH2C0]+, 2%), 471 ([M-C7H70]+, 3%), 443 
([М-С^ОгГ. 2%), 414 ([М-СюН^Ог]*, 7%), 372 ([M-Ci2H16N02]
+
, 
12%), 211 (CCi5H150]+, 5%), 181 ([СідНіз]*. 6%), 121 ([C8H90]+, 
100%), 107 ([C7H70]+, 9%), 91 ЦСуНуУ, 31%). 
N-Acetyl-N-benzyloxy-S-benzyl-D.L-cysteinyl-D-valine benzyl ester 124 
A cooled (0oC) solution of U 2 (mixture of diastereomers 
(1 : 1), 0.205 g, 0.4 mmol) and acetyl chloride (0.035 g, 0.4 mmol) 
in dry CH2CI2 (5 ml) was treated with a solution of pyridine (0.035 
g, 0.4 rnnol) in dry CH2CI2 (2 ml). After stirring at room 
temperature for 4h the reaction was complete as monitored by TLC 
(solvent system F). The reaction mixture was washed with 0.05N HCl, 
H2O and brine, dried over N32804, and concentrated in vacuo. The 
residue was purified by column chromatography (solvent system P) to 
afford 124 as a mixture of diastereomers (1 : 1) In 42% yield. This 
mixture, an oil, was homogeneous on TLC (solvent system P): Rf 0.20; 
iH-NMR: Б 7.31 (s, 5H, Z ^ b ) , 7.28 (s, 5H, C 6H5), 7.24 (s, 5Н, 
С6Н5), 6.95 (d, IH, NH), 5.15 and 5.10 (AB spectrum and s, 2H, 
JAB=12.9 Hz, OCH2), 5.06-4.61 (m, ЗН, ОСНг and CHNO), 4.53 (dd, IH, 
J»8.6 Hz and 4.6 Hz, CHCO2), 3.68 (s, 2H, C6H5CH2S), 3.09-2.95 
(5 lines, 2H, CHCH2S), 2.44-1.97 (m, IH, СН(СНз)2), 2.16 and 2.13 
(2xs, ЗН, СНзС(О)), 0.98-0.80 (7 lines, 6H, (СНз)2); exact mass 
caled, for C31H37N2O5S (M++1), m/e 549.242, found: 549.241; 
chemical-ìonization mass spectrum, m/e (relative intensity): 549 
([M+l]+, 20%), 507 ([M+1-CH2C0]+, 6%), 443 ([M-C7H50]+, 4%), 425 
(CM-C7H7S]+, 6%), 384 ([М-СдНюКОг]-·-, 10%), 342 ([M-Ci 2H 1 6N02]
+
, 
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22%), 319 ([М-Сі4Ніз05]+, 42%), 229 ([Сі4Ніз05]+, 4%), 208 
(CCi2Hi8N02]+, 14%), 139 ([C7H7OS]+, 9%), 107 ([С7Н70]
+
, 58%), 91 
([С7Н7]+, 100%). 
N-Benzyloxycarbonyl-L -glutamic acid 127 
Benzyl chioroforniate (1.74 g, 10.2 mmol) was added dropwise to 
a vigorously stirred solution of L-glutamic add 125 (1.0 g, 6.8 
mmol) in 30 ml of aqueous IM МаНСОз at room temperature. After 
stirring for 4h the reaction mixture was washed twice with ether 
and subsequently cooled to 0°C. Then the aqueous alkaline solution 
was acidified to pH 3-4 by adding cautiously concentrated aqueous 
hydrochloric acid to the vigorously stirred solution. The product 
separated as an oil. The aqueous layer was decanted and washed 
thrice with EtOAc. The oil was dissolved 1n EtOAc and washed with 
H2O and brine. The combined EtOAc layers were dried over ^ З О д and 
concentrated in vacuo to leave an oil (76%) which solidified upon 
prolonged storage in a refrigerator. The product was, although not 
recrystalUzed, homogeneous on TLC (solvent system D): Rf 0.38; 
m.p.: 118-120oC (I1t. l 5 4 : 120-12ГС); ^H-MR: 6 7.32 (s, 5H, C6H5), 
5.59 (br.d., IH, NH), 5.10 (s, 2H, OCH2), 4.62-4.24 (m, IH, CH 
(CH2)2). 2.67-1.95 (m, 4H, (СНгЭг): exact mass caled, for СізН 1 6М0 6 
(M++1), m/e 282.0978, found: 282.0974; chemlcal-ionlzatlon mass 
spectrum, m/e (relative intensity): 328 ([M+47]+, 3%) 282 ([M+l]+, 
3%), 238 ([M+l-C02]+, 21%), 220 ([M-C02-0H]+, 8%), 130 ([С5Н8Н0з]
+
, 
87%), 107 ([C7H70]+, 9%), 91 ([C?^]···, 100%); anal, caled, for 
C13H15N06: C, 55.51; H, 5.38; N. 4.98, found: C, 54.87; H, 5.26; N, 
4.96. 
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α-BenzylN-benzyloxycarbonyl-L-glutamate 129 lOlb.c 
Dicyclohexylamine (3.22 g, 17.8 rimol) was added to a solution 
of 127 (5.0 g, 17.8 irniol) in 15 ml of dry DMF. The precipitated 
dicydohexylamine salt of 127 was collected by filtration and 
dried. Subsequently the compound was dissolved in 15 ml of dry DMF 
at 450C. Benzyl bromide (3.04 g, 17.8 mmol) was added dropwise to 
the solution, resulting in the precipitation of dicydohexylamine 
hydrobromide. After stirring for a while the reaction mixture was 
filtered and concentrated in vacuo. The residue was dissolved in 
EtOAc (25 ml) and stored in a refrigerator for 24h. Filtration 
followed by evaporation of the solvent in vacuo afforded \2B as an 
oil in 80% yield; iH-NMR: S 7.26 (s, Ю Н , 2хСбН5), 5.65-5.32 (Ьг., 
IH, NH), 5.11 and 5.06 (2xs, 4Н, 2хОСН2), 4.60-4.17 (m. IH, 
CH(CH2)2). 2.58-1.77 (m, 4H, (СНгіг); exact mass caled, for 
C20 H22 N 06 ( М + +1Ь m/e 372.1447, found: 372.1440; chemical-ionization 
mass spectrum, m/e (relative intensity): 418 ([M+47]+, 4%), 372 
([M+l]+, 7%), 328 ([M+l-C02]+, 26%), 310 ([M-C02-0H]+, 7%), 220 
([М-С8Н70з]+, 12%), 181 ( [ С ^ з Г , 19%), 129 ([С5Н7М0з]+, 21%), 
107 ([C7H70]+, 7%), 91 ([С7Н7]+, 100%); IR (СНСІ3): 3500-2500, 
3435, 1740, 1715, 1510 and Ш Б с п Г 1 . 
α-Benzyl N-benzyloxycarbonyl-L-glutamate dicydohexylamine salt 130^^b •c 
Dicydohexylamine (2.29 g, 12.6 irniol) was added dropwise to a 
cooled (0oC) solution of 129 (4.27 g, 11.5 rmiol) in 20 ml of dry 
EtOAc. After stirring for Ih the precipitate was collected by 
filtration, washed with cold EtOAc, and dried thoroughly in a 
vacuum desiccator over К0Н, affording 130 in quantitative yield. 
The product was recrystallized from EtOH; m.p.: 161-163°C 
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(üt .101b,c : i62-1640C); [α]25= -12.2°, c=2.1; MeOH ( l i t . 1 3 9 t a ^ 5 = 
-12.0°, c=2.1; MeOH); ІН-NMR: 6 7.31 (s. 10H, 2x CgHs), 7.09 (d, 2H, 
H2N+), 6.08 (br.d., IH.NH), 5.16 and 5.05 (2xs, 4H, 2x OCH2), 
4.46-3.91 (m, IH, CH(CH2)2). 2.88 (m, 2H, CH-N-CH), 2.49-0.77 (m, 
24H, (CH2)2 and NÍCHCsího^)· 
Formation of benzyl N-benzyloxycarbonyi-L-pyroglutamate 132 in an 
attempt to prepare N-benzyloxycarbonyl-L-y-glutamyl chloride α-benzyl 
ester 131 
Freshly dist i l led oxalyl chloride (1.03 g, 8.1 irniol) was added 
dropwise within 10 minutes to a stirred and cooled (0oC) solution 
of 129 (2.02 g, 5.4 mmol) and DMF (two drops) in 6 ml of dry 
CH2CI2. The reaction mixture was stirred at room temperature for 1 
h. Evaporation of the solvent in vacuo afforded a solid, which 
turned out to be benzyl N-benzyloxycarbonyl-L-pyroglutamate 132. 
The product was not recrystallized; m.p.: 105-109oC ( l i t . 1 4 1 · 1 4 2 : 
108-109eC); iH-NMR: δ 7.33 (s, ЮН, 2хС6Н5), 5.22 (s, 2Н, ОСНг), 
5.13 (s, 2Н, 0СН2), 4.81-4.61 (m, IH, СН(СН2)2). 2.96-1.80 (m, 4Н, 
(СН2)2); IR (CHCI3): 1795, 1750 and 1725 cm"1; exact mass caled. 
for C20H20NO5 (M++1), m/e 354.1341, found: 354.1340; chemical-
ionization mass spectrum, m/e (relative intensity): 354 ([M+l] + , 
5%), 338 ([M+l-0]+, 4%), 310 ([M+l-COz]*, 26%), 220 ([M-C8H502]+, 
14%), 181 ( [ С Н Н І З Г , 27%), 107 ([07470]+, 19%), 91 (ІСуНуУ* 
100%); anal, caled, for C20H19NO5: С, 67.98; H, 5.42; Ν, 3.96, 
found: С, 67.39; Η, 5.27; Ν, 4.04. 
N-(Benzyloxycarbonyl)-L-a-amlnoadipic acid 128 
Benzyl chioroformate (Aldrich, 7.16 g, 42 mmol) was added drop­
wise to a stirred solution of L-a-aminoad1pic acid 126 (Sigma, 
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4.83 g, 30 imol) in 102 ml of IN NaOH. The temperature of the 
reaction mixture was kept below 10oC by means of an ice-bath. 
During the course of the reaction the pH of the solution was 
monitored and kept at pH 11 by addition of an aqueous IN NaOH 
solution. 
After completion of the reaction, as monitored by the ninhydrin 
test*, the reaction mixture was washed twice with ether. In order 
to precipitate the product the aqueous alkaline solution was 
acidified to pH 2-3 by adding cautiously concentrated hydrochloric 
acid to the vigorously stirred and cooled (0oC) solution. The 
precipitated product 128 was filtered and dried. The filtrate was 
extracted with several portions of EtOAc. The combined extracts 
were washed with HjO and brine, dried over Na2S04, and concentrated 
to dryness in vacuo to leave a second crop of the product. Compound 
128, which was homogeneous on TLC (Rf: 0.39, solvent system D), was 
obtained in a yield of 90%. Recrystallization from МеОН/НгО gave 
small needles, m.p.: 134-1360C; iH-NMR (CD3OD): δ 7.38 (s, 5H, 
CsHs), 5.15 (S, 2H, СНгО), 4.33-4.05 (m, IH, CH-N), 2.36 (m, 2H, 
CH2C00H), 2.05-1.53 (m, 4H. CH2CH2CH2CO2H); exact mass caled, for 
C14 H18 N 06 ( M + +l). m/e 296.1134, found: 296.1130; chemical-
ionization mass spectrum, m/e (relative intensity): 342 ([M+47]+, 
22%), 296 ([M+l]+, 8%), 252 ([M+l-C02]+. 30%), 144 ([СбНюЖЭз]-»·, 
28%), 91 ([C7H7]+, 100%); anal, caled, for C^H^NOe: С, 56.95; H, 
5.80; Ν, 4.74, found: С, 56.55; Η, 5.77; Ν, 4.73. 
* Take a sample (a few drops) of the reaction mixture, acidify it 
to pH 5 with acetic acid and add it to 1 ml of a ninhydrin solution, 
which 1s prepared by dissolving ninhydrin (0.12 g) in a mixture of 
200 ml of n-BuOH and 8 ml of glacial acetic acid. If heating of the 
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resulting solution leads to a blue-violet colouration, which 
indicates the presence of an amino acid, the reaction is not 
complete. Sometimes an additonal amount of benzyl chi oroformate has 
to be added. 
L-4-[3-(Benzyloxycarbonyl)-S-oxo-4-oxazolidinylJ-butanoicacid 135 
A suspension of N-(benzyloxycarbonyl)-L-a-aminoadip1c acid 128 
(2.95 g, 10 ιπηοΐ), p-to1uenesulfonic acid monohydrate (0.114 g, 0.6 
mmol) and paraformaldehyde (0.81 g, 27 irniol) in 100 ml of toluene 
was heated under reflux. A Dean-Stark separator was used to trap 
the azeotropically removed water. After 45 minutes the reaction 
mixture was cooled, filtered and diluted with 10 ml of EtOAc. 
Neutralization of the diluted filtrate was accomplished by adding a 
solution of МагСОз (0.032 g, 0.3 mmol) in 1 ml of H2O. After 
stirring for 30 minutes the resulting mixture was extracted three 
times with H2O (1 ml). Then the solvent was evaporated In vacuo and 
the residue was dissolved in CH2CI2· The solution was dried over 
anhydrous N32804 and concentrated to dryness In vacuo to leave an 
oil, which was not entirely homogeneous on TLC (solvent system D): 
Rf 0.62. The crude product (yield 98%) was used in the next reac­
tion without further purification; [ a ] 2 0 = +82.0° (c= 1.0, CHCI3); 
iH-NMR: Б 7.33 (s, 5H, С 6Н5), 5.52 (d, IH, O-CH-N), 5.24 and 5.17 
(2xs, 3H, C6H5CH2 and O-CH-N), 4.42-4.17 (m, IH, NCHCH2), 2.52-2.19 
(m, 2H, CH2CO2H), 2.19-1.37 (m, 4H, CH2CH2CH2CO2H) ; exact mass 
caled, for CisH^NOe (M++1), m/e 308.1134, found: 308.1129; 
chemical-lonlzation mass spectrum, m/e (relative Intensity): 354 
([M+1+CH202]+, 100%), 308 ([M+l]+, 18%), 264 ([M+l-C02]+, 50%), 91 
(CC7H7]+, 75%); IR (CHCI3): 1605 (A) and 1715 cm"1 (B), A<B. 
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L-4-[3-(Benzyloxycarbonyl)-5-oxo-4-oxazolidinyl]-butanoyl chloride 136 
PCI5 (2.08 g, 10 mmol) was added all at once to a stirred and 
cooled (0oC) solution of 135 (3.07 g, 10 mmol) in 35 ml of dry 
toluene. Stirring was continued at 0oC for a few minutes and then 
at room temperature for 25 minutes. The clear solution was 
filtered to remove a jelly-like material (only a small quantity) 
and concentrated to dryness in vacuo. During this procedure the 
temperature of the heating bath was kept below 20oC. To remove 
residual POCI3 dry toluene was added to the residue and the mixture 
was evaporated again; this was repeated twice. The crude acid 
chloride (yield: 3.12 g) was used in the next reaction without 
further purification. Its purity was about 87% as estimated from 
the NMR spectrum; iH-NMR: 5 7.35 (s, 5H, C 6H5), 5.52 (d, IH, 
0-CH-N), 5.25 and 5.18 (2xs, 3H, СбН5СН2 and O-CH-N), 4.42-4.16 (m, 
IH, NCHCH2), 3.11-2.72 (m, 2H, CH2C(0)C1), 2.19-1.46 (m, 4H, 
cÜ2ct!2CH2c(0)c1); chemical-lonization mass spectrum, m/e (relative 
intensity): 374/372 ([M+1+CH202]+, 69%), 326 ([M+l]+, CisH^ClNOs, 
2%), 290 ([M-C1]+, 3%), 282/284 ([M+l-C02]+, 61%), 246 
([M-C1-C02]+, 34%), 156 ([С7НіоМОз]+, 58%), 91 (^Н;] 4-, 100%); IR 
(CHCI3): 1800 (A) and 1720 cm"1 (В), AüB. 
N-[L-4-(3-Benzyloxycarbonyl-5-oxo-4-oxazolidinyl)-butanoyl],N-
benzyloxy-S-benzyl-D,L-cysteinyl-D-valine benzyl ester 138 
A solution of 112 (1.52 g, 3 mmol) in 9 ml of dry CH2CI2 was 
added to a cooled (0oC) and stirred solution of crude 136 (2.17 g, 
± 5.8 nmol) in 11 ml of dry CH2CI2. Then the stirred and cooled 
mixture was supplied with a catalytic amount of 4-dimethylamino-
pyridine. Subsequently, a solution of dry pyridine (0.46 g, 5.8 
mmol) in dry CH2CI2 (2 ml) was added dropwise at 0oC. The reaction 
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mixture was stirred at room temperature until completion of the 
reaction (45 minutes) as monitored by TLC (solvent system E) and 
then washed with 0.05N HCl (2x 20 ml) and H2O (20 ml). The organic 
layer was dried over anhydrous N32804 and concentrated in vacuo. 
When the less polar diastereomer of Π 2 had been used as 
starting material, purification of the residue by column 
chromatography (solvent system E) afforded a pure diastereomer of 
138 in 81% yield. This compound, an oil, was homogeneous on TLC 
(solvent system E): Rf 0.18; iH-NMR: Б 7.34, 7.32, 7.27 and 7.23 
(4xs, 20H, 4хСбН5), 6.93 (d, IH, J=8.6 Hz, NH), 5.51 (d, IH, J=4.5 
Hz, OCHN), 5.22, 5.16 and 5.11 (3xs, 5H, OCHN and 2x0CH2), 
5.05-4.61 (m, 3H, CHNOCH2), 4.53 (dd, IH, J=8.6 Hz and 4.5 Hz, 
CHNH), 4.41-4.17 (m, IH, СН(СН2)з), 3.67 (s, 2H, C6H5CH2S), 3.01 
(d, 2H, J=7.7 Hz, CHCH2S), 2.86-1.38 (m, 7H (СН2)з and СН(СНз)2), 
0.89 (t, 6H, (СНз)2); positive FAB mass spectrum, m/e (relative 
intensity): 796 ([M+l]+, C44H50N3O9S. 5%), 582 ([М-СідНізЗ]*, 2%), 
507 ([C29H35N204S]+, 3%), 384 ([M-C22H2lN05S]+, 3%), 181 
(CCl4Hl3]+. 10%). 107 ([C7H70]+, 5%), 91 (^Н;]-·-, 100%). 
When a mixture of dlastereomers of И 2 , enriched (80-90%) in 
the more polar diastereomer, had been used as starting material, 
the residue was purfied by column chromatography, applying 
successively solvent system В and E. This procedure afforded the 
other (more polar) diastereomer of 138 in 66% yield. The compound, 
also an oil, was homogeneous on TLC (solvent system E): Rf 0.18; 
iH-NMR: 6 7.33 and 7.26 (2xs, 20H, 4XC6H5), 6.91 (d, IH, J=8.6 Hz, 
NH), 5.51 (d, IH. J=4.6 Hz, 0-CH-N), 5.23 and 5.16 (2xs, 5H, O-CH-N 
and 2xOCH2), 5.06-4.62 (m, 3H, CHNOCH2), 4.53 (dd, IH, J=8.6 Hz 
and 4.6 Hz, CHNH), 4.41-4.18 (m, IH, СН(СН2)з), 3.68 (s, 2H, 
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C6H5CH2S), 3.04 (d, 2H, J=7.6 Hz, CHCH2S), 2.60-1.42 (m, 7H, (СНгЭз 
and СН(СНз)2), 0.90 and 0.82 (2xd, 6H, (СНз)2); positive FAB mass 
spectrum, m/e (relative intensity): 796 ([M+l]+, C44H50N3O9S, 3%), 
5Θ2 ( [ M - C H H ^ S ] * , 2X), 507 ([C29H35N204S]+, ЗУ.), 384 
([M-C22H2lN05S]+, 2%), 181 ([СідНхзГ, 6%), 107 ([C7H70]+. At), 91 
([С7Н7Г, 100%). 
N-[L-4-(3-Benzyloxycarbonyl-5-oxo-4-oxazolidinyl}-butanoyl],N-benzyloxy-
S-(4-methoxybenzyl)-D,L-cysteinyl-D-valine benzyl ester 139 
A solution of И З (1.60 g, 3 mmol) in 9 ml of dry CH2CI2 was 
added to a cooled (0eC) and stirred solution of crude 136 (1.95 g, 
± 5.2 mmol) in 10 ml of dry CH2CI2. Then the stirred and cooled 
mixture was supplied with a catalytic amount of 4-dimethylamino-
pyridine. Subsequently, a solution of dry pyridine (0.41 g, 5.2 
imol) in dry CH2CI2 (2 ml) was added dropwise at O'X. The reaction 
mixture was stirred at room temperature until completion of the 
reaction (45 minutes) as monitored by TLC (solvent system E) and 
then washed with 0.05N HCl (2x20 ml) and H2O (20 ml). The organic 
layer was dried over anhydrous N32804 and concentrated to dryness 
in vacuo. The residue was purified by column chromatography, using 
successively solvent system E and С as eluant. This procedure 
afforded one pure diastereomer of 139 (the less polar one) in 9% 
yield and a mixture of two diastereomers of 139 in 49% yield. The 
pure diastereomer (an oil) was homogeneous on TLC (solvent system 
E): Rf 0.12; iH-NMR: S 7.32, 7.31 and 7.27 (3xs, 15H, 3xC 6H5), 
7.16 and 6.78 (AA'BB', 4H, C6H4), 6.91 (d, IH, NH), 5.53 (d, IH, 
J=4.5 Hz, 0-CH-N), 5.23, 5.17 and 5.10 (3xs, 5H, 0-CH-N and 2x 
C(0)-OCH2), 5.10-4.62 (m, 3H, CH2ONCH), 4.53 (dd, IH, J=8.5 Hz and 
4.5 Hz, CHNH), 4.42-4.21 (m, IH, СН(СН2)з), 3.76 (s, ЗН, OCH3), 
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3.64 (s, 2H. SCH2C6H4), 3.00 (d, 2H, J=7.7 Hz, CHCH2S), 2.69-1.37 
(m, 7H, (СН2)з and СН(СНз)2), 0 · 9 0 (t. 6H, (СНз)2); positive FAB 
mass spectrum, m/e (relative Intensity): 826 ([M+l]+, C45H52N3010S» 
6%), 537 ([C30H37N205S]+, 2%), 381 (2%), 121 ([C8H90]
+
, 100%), 91 
(CC7H7]+, 100%); negative FAB: 824 ([M-l]", С45Н5оМз01о5, 2%), 734 
([M-C7H7]-, 20%), 690 ([M-C7H7-CO2]-. 19%), 153 ([CeHgOS]-, 48%), 
91 ([C7H7]-, 100%). 
The mixture of dlastereomers (an oil) gave only one spot on TLC 
(solvent system E): Rf 0.12; iH-NMR: S 7.32 (s, 15H, ЗхСбНб), 7.18 
and 6.80 (АА'ВВ', 4Н, С6Н4), 7.00 (d, IH, NH), 5.52 (d, IH, 
0-CH-N), 5.22-5.04 (m, 5H, 0-CH-N and 2xC(0)0CH2), 5.04-4.64 (m, 
3H, CH2ON and CHCH2S), 4.64-4.42 (m, IH, CHNH), 4.42-4.16 (m, IH, 
СН(СН2)з), 3.76 (s, 3H, OCH3), 3.64 (s, 2H, SCH2C6H4), 3.11-2.87 
(2xd, 2H, CHCH2S), 2.61-1.38 (m, 7H, (СН2)з and СН(СНз)2), 1.04-0.70 
(m. 6H, (СНз)2). 
N-ß-(L-a-Arninoadipyl)], N-hydroxy-L-cysteinyl-D-valine, disulfide 144 
A IM solution of В(СРзС00)з in CF3COOH (8 ml) was added to a 
cooled (0oC) solution of the pure dlastereomer 139 (0.200 g, 0.24 
ninol) In 4 ml of CF3COOH. After stirring for 3h at room 
temperature, the excess of CF3COOH was evaporated in vacuo. H2O (40 
ml) and CH2CI2 (40 ml) were added to the residue and the resulting 
two-phase system was vigorously stirred at room temperature until 
two clear layers were obtained. After separation of the layers the 
aqueous solution was freeze-drled. The residue was purified by ion 
exchange chromatography (18 χ 1 cm column, Dowex 50X8-400, H +, 
Janssen Chimica) with a H2O-IM aq. pyridine gradient as eluant. The 
FeCl3-pos1t1ve fractions were combined and lyophilIzed to afford 
37.6 mg of the crude product. The crude product (22.6 mg) was 
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dissolved in 5 ml of H2O. The pH of the solution was adjusted to 
8-9 by adding a few drops of a diluted aqueous ammonia solution. 
Oxygen was bubbled through the solution for 4 hours after which the 
solution was freeze-dried. The residue was purified by reversed 
phase chromatography (octadecylsilane), using MeOH/25 mM NH4HCO3 
(20:80, v/v) as eluant. This afforded pure 144 in 2% yield; ^ -NMR 
(500 MHz, D2O): 5 5.22 (4 lines, X part of ABX spectrum, IH, CHNO), 
3.92 (d, IH, CHNH), 3.53 (t, IH, H2NCHCH2), 3.17-2.89 (8 lines, 
AB part of ABX spectrum, 2H, CH2S), 2.56-2.34 (m, 2H, CH2C(0)N), 
2.01-1.84 (m, IH, СН(СНз)2). 1.79-1.60 (m, 2H, CHCH2CH2), 1.60-1.39 
(m, 2H, CH2CH2CH2), 0.70 and 0.67 (2xd, 6H, (СНз)2); positive FAB 
mass spectrum, m/e: 779 ([M+Na]+, С г а ^ в ^ М а О ^ ) , 757 ([M+l]+), 
741 ([M+l-0]+), 380 ([Ci4H26N307S]+, monomer), 144 ([СбИюМОз]-··), 98 
([C5H8NO]+), 72 ([C4H10N]+). 
Incubation and bioassay 
The incubation of 144 (600 yg) with a partially purified 
preparation of isopenicilUn N synthetase was carried out in the 
Dyson Perrins Laboratory (Prof. J.E. Baldwin, Oxford) according to 
the procedure described by Baldwin and co-workers.36,46c Fe(II)S04 
(5 mM), ascorbic acid (50 mM), DTT (100 mM) and catalase (1/10 
suspension) were added as cofactors. The pH of the incubation 
mixture was adjusted to 7.5-8.0, using 150 mM aq. NaOH. 
Bioassays were carried out by the hole-plate method.17,148 
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CHAPTER V 
REDUCTION OF OXIMES TO N-HYDROXY-a-AMINO ACID DERIVATIVES 
USING NaBHsCN 
5.1 INTRODUCTION 
The chemistry of naturally occurring α-amino acids is well 
established and their biochemical importance is fully understood. 
Much less is known, however, about the chemical and biochemical 
behaviour of non-protein amino acids like N-hydroxy-a-amino acids, 
α,β-dehydroamino acids and a- or ß-functionalized amino acids. The 
chemistry of N-hydroxy-a-amino acids and derivatives thereof has 
been the subject of a review.1 A versatile approach for the 
synthesis of this class of compounds, featuring the reduction of 
α-oximino acid derivatives, has been developed in our laboratories.2 
This method has been employed by us for the synthesis of some 
racemic N-acetyl-N-hydroxy-a-amino acids 7 as shown in scheme 1.3 
The hydroxamic acids 7a, 7b and 7c were obtained in 34%, 37% 
and 32% overall yield respectively from the relevant a-ketocarboxyl-
ic acids 1. The crucial step involves reduction of the a-oximino 
acid derivatives 4a-c to the corresponding N-hydroxy-a-amino acid 
derivatives 5a-c using an amine-borane complex in the presence of 
a large excess of hydrochloric acid. This method2 works well when 
applied to simple compounds like 4a-c. Although more complex N-
hydroxy amino acid derivatives, like for example the N-hydroxy 
cystelne-derived peptides discussed in chapter IV, have also been 
synthesized in this way, the results were in general less 
satisfying. A large excess of the reducing agent is needed to 
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Scheme I 
o*V 
он OBil OH 
2a-c 
CH] fi' 
O ^ N - ^ f 0 
он он 
7»-c 
OBzl ONP 
За-с 
CH] В' 
OBzl OBzl 
6a-c 
OBzl OBzl 
H N ^ f 0 
OBzl OBzl 
5i-c 
a R' = CHj b R'^CHjCHj с R'sCHICHj), 
I С6Н5СНгОНН2.НСІ, H20 
I I 4-02NC6H40H, КС, EtOAc 
III C6H5CH20H, DBU, СН2СІ2 
І (СНэ)зИ.ВНз, HCl, Et20 
V СНэС(0)С], pyridine, СНгСІг 
Vi Pd(C), H 2 P CH3OH 
achieve complete conversion of the starting material and numerous 
by-products are formed. This makes purification of the crude 
product a laborious job, affording the desired compound in moderate 
to low yield. 
In an attempt to shorten the synthesis depicted in scheme I, a 
one-step conversion of 4b Into 6b by treatment of 4b with КаВНзСМ 
in acetic acid containing an excess of acetic anhydride was 
studied (eq.l). 4 Besides a considerable amount of the starting 
material 4b (44%) and the desired product 6b (36%) compound 8 was 
isolated in 20% yield. Probably, the aldehyde needed for the 
reductive alkylation 
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NaBHjCN, Ас
г
С f 
OBzl OBrl 
θ 
underlying the formation of the latter compound, is generated by 
partial reduction of the solvent.5 
Although the conversion was far from complete, the experiment 
showed that, as contrasted with earlier observations,6 МаВНзСМ is 
capable of reducing the carbon-nitrogen double bond of a-oximino 
esters. We anticipated that due to milder reaction conditions and 
easier removal of the excess of the reducing agent, МаВНзСМ might 
be an attractive alternative for the amine-borane complexes, 
especially in the synthesis of N-hydroxy peptides (see chapter IV). 
In this chapter the results of our attempts to develop procedures 
for the synthesis of the title compounds from the corresponding 
a-oximino acid derivatives by means of МаВНзСМ, are presented. 
5.2 REDUCTION OFa-OXIMINO ACID DERIVA TIVES WITH NaBHjCN 
The starting materials (4,9-12) were prepared according to 
known procedures (scheme I/II).2a-c 
It has been demonstrated that use of a carboxylic acid (formic 
or acetic acid) as solvent for the reduction of a-oximino esters 
with МаВНзСМ leads to a mixture of products, since reductive 
alkylation of the product takes place (see eq.l and section 5.3) in 
addition to reduction of the oxime double bond. So, to achieve 
selective formation of primary N-hydroxy amino acid derivatives 
another solvent had to be chosen. Methanol seemed to be most 
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convenient for this purpose.7 We observed that it is necessary to 
carry out the reaction at about pH 3. Obviously, hydride transfer 
is preceded by protonation of the oxime. Because the reduction 
consumes acid, methyl orange was used as Indicator to monitor the 
change in pH during the reaction.8 The pH was held at the red-
orange transition point ("pH 3") by the dropwise addition of 7N 
methanol 1c HCl. 
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The results of the reductions are summarized in table 1; in the 
second and third column the results of comparable reductions with 
pyridine- and trimethylamine-borane complexes, carried out by 
J.D.M. Herscheid ef.a/.Za"c, are mentioned. 
Table 1 
5c 
13a 
14a 
14c 
14d 
14e 
14f 
15a 
16a 
16f 
Rl 
І-С3Н7 
CH3 
CH3 
І-С3Н7 
H 
C6H5 
C6H5CH2 
CH3 
СНз 
C6H5CH2 
NaBH3CNa 
67b (І5) 
90 b (6) 
88b.d (is) 
95b (15) 
84b (13) 
15b (15) 
56b
 ( 15) 
40 b (15) 
30b (15) 
0 b (15) 
pyridin« 
_ „ 
100b, 
94c 
— 
95c 
0b 
50c 
85b 
65b 
0b 
!-boranea 
75c (3) 
(3) 
(3) 
(3) 
(3) 
(5) 
(3) 
(3) 
trimethylamine-borane3 
65C 
58C 
100b 
— 
100b 
65C 
80c 
40c 
100b, 
94С 
(2.5) 
(1) 
(1) 
(1) 
(4) 
(2) 
(1) 
89 c (2) 
(3) 
a: The number of equivalents of the reducing agent used is given 
in parentheses. 
b: Yield (%) estimated from the ІН-NMR spectrum. 
c: Yield (%) of product isolated by preparative HPLC. 
d: Neither the reaction rate nor the yield (83%b) was substantially 
Influenced by the addition of water to the reaction mixture 
(12.5%, v). 
Because the reactions proceeded quite cleanly, they could be 
monitored by ^ -NMR spectroscopy. The results indicate that in 
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general МаВНзСМ is inferior to the borane complexes. The advantages 
associated with the use of МаВНзСМ, i.e. mild reaction conditions 
and easy removal of the excess of the reducing agent by a simple 
extraction procedure, are counteracted by incomplete conversions, 
which then requires separation of the product from the starting 
material in an additional purification step. Attempts to reduce 
peptides having an O-protected α-oxlmino function, e.g. compounds 
94 and 109 described In chapter IV, with МаВНзСМ to the 
corresponding N-hydroxy peptide derivatives failed completely. 
5.3 SYNTHESIS OF SECONDARY N-BENZYLOXY-a-AMINO ACID DERIVATIVES BY 
REDUCTIVE ALKYLATION 
As indicated in eq.l it is possible to obtain secondary N-
benzyloxy-a-amlno a d d esters from the corresponding α-benzyloximino 
esters by treatment with НаВНзСМ in acetic acid. The reaction 
involves initial reduction of the oxime double bond, followed by a 
reductive alkylation. Since, as far as we know, the synthesis of 
secondary N-hydroxy-a-amino acid derivatives by reductive alkyl­
ation has never been reported before, we decided to Investigate the 
scope of this mild conversion In more detail. 
Primarily our attention was focused on the reductive alkylation 
In carboxyllc acid media. When no additional reagents are used, then 
the choice of the solvent determines the nature of the alkyl group. 
However, only a few carboxyllc acids seem to be suitable as solvents, 
which limits the range of alkyl groups to be introduced in this way. 
It was realized that the addition of a large excess of an 
appropriate aldehyde to the reaction mixture might be a way to 
circumvent this restriction. 
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A study of the feasibility of this alternative approach was 
included in the investigation. The results are depicted in table 2. 
Table 2 
CM, 
OBzl OBzl 
4b 
CH, 
HN 
OBzl OBzl 
5b 
RN 
OBzl OBzl 
_β R = CH]CH¡ 
Π R = CH] 
18 R=n-CjH7 
19 R = C6H5CH, 
solvent 
HCOOH 
HCOOH 
HCOOH 
CH3COOH 
CH3COOH 
aldehyde (eq.) 
-
СНзСН2СН=0 (21) 
C6H5CH=0 (13) 
СНзСН2СН=0 (13) 
C6H5CH=0 (13) 
ед.МаВНзСМ 
3 
14 
10 
10 
10 
y1eld(%) 
4b 
-
-
50 
-
3Θ 
5b 
15 
10 
-
10 
-
8 
-
-
-
23 
30* 
17 
6Θ 
44 
18* 
-
-
la 
-
10 
-
34 
-
19 
-
-
-
-
-
* In these experiments also the formation of benzyl alcohol was 
observed. 
The results show that the product formation cannot be 
controlled by the addition of a large amount of an aldehyde because 
of the interference by the solvent. Consequently the choice of 
another solvent had to be considered. 
In preliminary experiments methanol was used as solvent for the 
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reductive aikylatlon of an N-benzyloxy-a-amino acid ester (eq.2: 
14a -» 20). Monitoring the reaction by TLC revealed that the fastest 
conversion of the starting material takes place at pH 5.0-5.5 ; 
NaBHjCN.CHjOH 
leq 21 10a Ka 
~ methyl orange, pH 3 ~ 
methyl red was used to monitor the pH, which was held at the red-
orange transition point (approximately pH 5.5) by the addition of 
7N methanol 1c HCl. The results of an experiment carried out at this 
pH looked very promising, since according to TLC only one product 
had been formed.9 Finally, it has been observed that a one-pot 
conversion of 10a to N-alkyl-N-benzyloxy amino acid ester 20 
(eq.2) in MeOH Is possible. 
5.4 CONCLUSIONS 
To our best knowledge this chapter presents the first examples 
of the reduction of a-(benzyl)ox1m1no esters and amides with 
МаВНзСМ,
10
 and of the synthesis of secondary N-hydroxy amino acid 
derivatives by reductive aikylatlon. As far as the reduction of 
a-(benzyl)ox1m1no compounds is concerned, the synthetic usefulness 
of NaBH3CN is restricted to simple compounds. For the synthesis 
of compounds containing an amide function, e.g. N-hydroxy peptides, 
one has to fall back upon the amine-borane complexes. 
On the other hand, the preliminary experiments described in 
section 5.3 indicate that for the reductive aikylatlon in an inert 
solvent like MeOH, NaB^CN might be the reagent of choice. The 
NaBHjCN, RCH=0, CHjOH C H 
fty methyl red, pH 5 5
 [ 
OBzl OCjH; 
20 R = CH] orC¡H5 
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advantage of this way of introducing an alkyl group is that the 
chiral centre is not affected. 
5.5 APPENDIX 
The hydroxamic acids 7a-c have been used as model systems for 
studying the validity of an idea involving stereospecific 
conversion of N-hydroxy-a-amino acid derivatives into a-
functionalized amino acid derivatives. This investigation was 
undertaken for the following reason. 
In our laboratory a method for the synthesis of a-
functionalized α-amino acid derivatives 23 has been developed, 
involving treatment of O-alkylated- or O-acylated N-acyl-N-hydroxy-
a-amino acid derivatives 21 with a strong base in the presence of 
an excess of a nucleophile (ед.З). 1» 1 1· 1^ 
R 
CHJ 
іч э)
 о
Л , > н 
OR' ОСгН, 
t-BuOK 
O ^ N .0 
сн.он 
CH3 
H 
OCH] 
о 
oc ¡Ht 
21 R'= Ac or Bil 22 23 
The intermediacy of an α-acylimino carboxylic acid derivative 22 
was proposed.ЫІ. 12 Consequently, when no additional chiral 
centres are present in 21, the procedure Is unsuited for the 
synthesis of optically active compounds. 
We wondered whether it would be possible to accomplish such a 
transposition of an N-hydroxy group to an a-functionality in a 
stereospecific way by applying the so-called principle of self-
reproduction of chirality, which has been formulated for the first 
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time by Seebach.13 The framework of this idea is outlined in 
scheme III. 
Scheme III 
o^Y 
он он 
CIjCCH-O, н* 
си, 
Ο ^ Ν 
H CCI, 
25 
HjC 
„Λ" 
0 ^ , 0 
н ccij 
2Í 
H CCI3 
26 
NuH 
R 
он 
27 
2β 
l íbase 
Ь)Н* 
Ο ^ Ν 
ОН 
29 
The first step should involve a diastereoselective condensation 
of an optically pure N-acetyl-N-hydroxy-a-amino acid 7 with chloral. 
Then a base-catalyzed rearrangement of 24 should afford the five-
membered heterocycle 26 with inversion of configuration at the 
α-carbon atom. The Intermedlacy of 25 Is obvious, and so the second 
chlral centre, created In the condensation step, has to preserve 
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the chirality at this stage; it must control the stereochemical 
course of the rearrangement. The chlorine atoms were expected to be 
helpful in stabilizing the negative charge on the oxygen atom in 
25, thus preventing undesirable side reactions like the base-
consuming formation of the α,Ρ-dehydroamino acid derivative 29. The 
net result of the conversion should be a transposition of an N-
hydroxy group to an α-functionalIty with retention of configuration 
(7 + 27). 
To study the attainability of the chemical conversions we had 
in mind (scheme III), the optically Inactive14 N-acetyl-N-hydroxy-
a-amino acids 7a-c were selected as model compounds. However, all 
attempts to accomplish the formation of 24 by refluxlng a mixture 
of one of the hydroxamic acids 7a-c, chloral and a catalytic amount 
of trifluoro- or trichloroacetic acid In a variety of solvents, 
under azeotroplc removal of water (if formed), failed.15 In all 
cases the starting material was recovered unchanged. Further 
investigations had to be postponed In consequence of changed 
priorities. 
5.6 EXPERIMENTAL SECTION 
Melting points were taken on a Köfler hot stage (Leitz-Wetzlar) 
and are uncorrected. Infrared spectra were measured with a Perkin-
Elmer Model 397 spectrophotometer. Proton magnetic resonance spectra 
were measured using a Varían Associates Model T-60 or a Bruker WH-90 
spectrometer. Chemical shifts are reported as S-values (parts per 
million) relative to tetramethylsilane as an Internal standard; 
deuteriochloroform was used as solvent unless stated otherwise. Mass 
spectra were obtained with a double-focusing VG 7070E spectrometer. 
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Thin-layer chromatography (TLC) was carried out by using Merck 
precoated silica gel F-254 plates (thickness 0.25 mm). Spots were 
visualized with an UV hand lamp, Iodine vapour or CI2-TDM.16 
Hydroxamic acids were detected (red spots) by spraying with a 3% 
РеСІз (w/v) solution in concentrated HCl/MeOH (4:96, v/v). 
For column chromatography Merck silica gel H (type 60) was used. 
The Miniprep LC (Jobin Yvon) was used for preparative HPLC. 
a-Benzyloximino carboxylic acids 2 
These compounds were prepared according to the procedure 
described by Herscheid et. a/.17. For some data concerning 2a and 
2c, see ref. 17. Zb : solid; iH-NMR : δ 9.96 (s, IH, CO2H), 7.33 
(S, 5H, CeHs), 5.26 (s, 2H, OCH2), 2.60 (q, 2H, CH2CH3), 1.06 (t, 
3H, CH3). 
Compound 2c has also been prepared according to a slightly 
modified version of the published procedure.17 To a vigorously 
stirred suspension of the sodium salt (13.θ g, 0.1 mol) of 3-methyl-
2-oxo-butanolc a d d te and O-benzylhydroxylamine hydrochloride 
(16.75 g, 0.1 mol) In 550 ml of H2O was added 10 ml of concentrated 
aqueous HCl (12N). Then the reaction mixture was heated gently 
(40-50eC) for about 15 minutes. While stirring was continued at 
room temperature for 3h, the product separated as an oil. When 
the oil had settled down the water layer was decanted and washed 
three times with EtOAc. EtOAc (250 ml) was added to the residue in 
the flask and the resulting solution was washed twice with H2O. The 
combined EtOAc layers were dried over N32504. Then the solvent was 
evaporated in vacuo to afford 2ç as an oil in quantitative yield. 
According to the ^-NMR spectrum only one isomer (Z or E) was 
obtained; ^-NMR : Б 9.35 (s, IH, OH), 7.26 (s, 5H, CgHs), 5.21 
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(s, 2H, CH2), 3.43 (m, IH, CH), 1.23 (d, 6H, (СНз)2). 
α -Benzyloximino 4-nitrophenyl esters 3 
These compounds were also prepared according to a procedure 
described by Herscheid et. a/.17 For some data concerning Ja and 
3ç, see ref. 17. 3b : 69% yield; m.p.: 79-810C; ^H-HHR : δ 8.22 and 
7.28 (AA'BB', 4H, C6H4) 7.35 (s, 5H, C 6H5), 5.35 (s, 2H, NOCH2), 
2.70 (q, 2H, CH2CH3), 1.15 (t, ЗН, CH3). 
α -Benzyloximino benzyl esters 4 
A solution of DBU (9.12 g, 60 mmol) 1n 120 ml of CH2CI2 was 
added dropwise to a stirred solution of 3 (60 mmol) and benzyl 
alcohol (6.48 g, 60 mmol) in 240 ml of CH2CI2. Stirring was 
continued at room temperature until completion of the reaction (3h) 
as monitored by TLC (CH2Cl2/n-hexane, 1:1 v/v). The reaction mixture 
was washed successively with 0.1N aqueous HC1 and 0.1N aqueous NaOH 
until the yellow colour of the organic layer had disappeared 
completely. The organic layer was then separated and dried (МагЗОд). 
The solvent was evaporated to give crude 4, which could be used in 
the next reaction without further purification, in quantitative 
yield. Column chromatography on silica gel (Merck, silica gel Η 
(type 60), CH2Cl2/n-hexane (1:1, v/v) as eluant) can be applied to 
remove traces of impurities. 4a : oil; ^-NMR : 6 7.30 (s, 10H, 
2ХС6Н5), 5.25 (S, 4H, 2xOCH2), 2.04 (s, ЗН, СН3). 4b : oil; iH-NMR : 
6 7.40 (s, Ю Н , 2хС 6Н5). 5.30 (s, 4Н, 2хОСН2), 2.63 (q, 2Н, 
СНгСНз), 1.06 (t, ЗН, СНз). 4с : oil; ιΗ-Η№ : 6 7.35 (s, ЮН, 2х 
CeHs), 5.26 and 5.21 (2xs, 4H, 2xOCH2), 3.43 (m, IH, CH), 1.16 (d, 
6H, (СНз)2). 
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N-Benzyloxy-a-amino acid benzyl esters 5 
Trimethylamine-borane (1.83 g, 25 тлоі) was added at room 
temperature to a stirred solution of 4 (10 mmol) in 100 ml of 
anhydrous ether, saturated with dry HCl. Stirring was continued at 
room temperature until completion of the reaction (16h) as 
monitored by TLC (CH2CI2). After evaporation of the solvent, the 
residue was dissolved in 50 ml of EtOAc. This solution was washed 
three times with 30 ml of a 5% aqueous МаНСОз solution and then 
once with brine. The organic layer was separated and dried 
(N32504). The residue, obtained after evaporation of the solvent, 
was purified by column chromatography (Merck, silica gel H (type 
60), dlisopropyl ether/n-hexane (1:1, v/v) as eluant). 5a : 45% 
yield18; oil; iH-NMR : Б 7.23 (s, Ю Н , 2хСбН5), 5.77 (Ьг., IH, NH), 
5.13 (s, 2Н, (0)С0СН2), 4.66 (s, 2Н, МОСНг), 3.73 (q, IH, СНСН3), 
1.17 (d, ЗН, СНз). 56 : 58% yield; oil; ιΗ-Η№ : δ 7.33 and 7.30 
(2xs, Ю Н , 2хСбН5), 5.98 (br.. IH, NH), 5.20 (s, 2H, (0)С0СН2), 
4.71 (s, 2Н, N0CH2), 3.61 (m, IH, CHN), 1.51 (m, 2H, СН2СН3). 0.90 
(t, ЗН, СНз). §£ '· 65% yield; oil; iH-NMR : δ 7.31 and 7.26 (2xs, 
Ю Н , 2хС
б
Н5), 5.93 (br., IH, NH), 5.20 (s, 2H, (0)C0CH2), 4.66 (s, 
2Н, N0CH2), 3.45 (d, IH, CHN), 2.13-1.46 (m, IH, СН(СНз)2), 0.93 
and 0.81 (2xd, 6H, (СНз)2); exact mass caled, for C19H24NO3 (M++1), 
m/e : 314.1756, found : 314.1758; chemical-ionization mass 
spectrum, m/e (relative Intensity) : 314 ([M+l]+, 8%), 181 
([Cl4Hl3]+. 33%), 107 ([C7H70]+, 19%), 91 (Ι^Η;]*. 13%). 
N-Acetyt-N-benzyloxy-а-атіпо acid benzyl esters 6 
A solution of pyridine (0.87 g, 11 imiol) in 5 ml of dry CH2CI2 
was added to an Ice-cooled, stirred solution of 5 (10 mmol) and 
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freshly distilled acetyl chloride (0.86 g, 11 mmol) in 30 ml of dry 
CH2CI2· Stirring was continued at room temperature for Ih after 
which time the salt was removed by filtration. The filtrate was 
washed with 0.1N aqueous HCl (2x30 ml), 5% aqueous МаНСОз (2x30 ml) 
and H2O (1x30 ml). The organic layer was separated and dried 
(Na2S04) and the solvent was evaporated to give pure 6. 6a : 94% 
yield; oil; iH-NMR : S 7.31 and 7.26 (2xs, 10H, 2XC6H5), 5.13 (s, 
2H, (0)COCH2), 4.99 (q, IH, CHCH3), 4.84 (s, 2H, NOCH2), 2.09 (s, 
3H, С(О)СНз), 1.53 (d, 3H, CHCH3). 6b : 93% yield; oil; iH-NMR : 
S 7.33 (s, Ю Н , 2хСбН5), 5.18 (s, 2Н, (0)С0СН2), 4.90 (t, ЗН, 
N0CH2 and CHN), 2.36-1.65 (m, 2Н, СН2СН3), 2.13 (s, ЗН, С(О)СНз), 
0.96 (t, ЗН, СН2СН3). 6с : 90% yield; oil; lH-mR : δ 7.35 (s, Ю Н , 
2х С 6Н5), 5.21 (s, 2Н, (0)С0СН2), 4.96 and 4.80 (AB spectrum, J A B = 
11 Hz, 2H, N0CH2), 4.79 (d, IH, CHN), 2.90-2.11 (m, IH, СН(СНз)2), 
2.11 (s, ЗН, С(О)СНз), 1.03 and 0.90 (2xd, 6Н, (СНз)2)· 
N-Acetyl-N-hydroxy-a-amino acids? 
A solution of 6 (10 пгші) in 100 ml of MeOH was treated at room 
temperature and atmospheric pressure with H2 and 10% Pd/C (150 mg) 
until 450 ml of H2 (20 mmol) had been consumed. After removal of 
the catalyst by filtration the solvent was evaporated to give pure 
7 1n quantitative yield. The compound was crystallized from 
acetone/n-hexane. 7a : oil; ^-NMR (CDCI3/CD3OD 1:1 ν/ν): δ 5.07 
(q, IH, CHCH3), 2.16 (s, ЗН, С(О)СНз), 1.44 (d, ЗН, CHCH3). 7b : 
m.p. 112-1140C; iH-NMR (CDCI3/CD3OD 1:1 ν/ν): δ 5.41-4.68 (m, CHN 
and H00 1 9), 2.21 (s, ЗН, С(О)СНз), 2.21-1.60 (m, 2H, CH2CH3), 0.95 
(t, ЗН, CH2CH3); IR (KBr) : 3360, 3100-2200, 1720 and 1605 cm"1; 
exact mass caled, for C6H12NO4 (M++1), m/e 162.0766, found: 
162.0767; chemical-ionization mass spectrum, m/e (relative 
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intensity): 162 ([M+l]+, 19%), 146 ([М+1-0]+, 36%), 128 
([Μ+1-0-Η2θ]+, 10%), 120 ([М+1-СН2СО]+, 26%), 104 ([М+1-0-СН2С0]+, 
45%), 100 ([М+1-Н20-С02]+, 59%), 74 (ССНзСН2СН(=М0Н)+1]+, 25%), 58 
([СНзСН2СН(=МН)+1]+, 100%); anal, caled, for C 6H 1 1N04: С, 44.72; Η. 
6.88; Ν, 8.69, found: С, 44.65; Η, 6.87; Ν, 8.66. 7с : m.p. 
139-1410C; iH-NMR (CDCI3/CD3OD 1:1 ν/ν): δ 4.86 (d, IH, CHN), 
2.83-1.75 (m, IH, СН(СНз)2), 2.18 (s, ЗН. С(О)СНз), 1.11 and 0.90 
(2xd, 6Н, (СНз)2); IR (КВг): 3380, 3100-2200, 1710 and 1605 cm"1; 
exact mass caled, for C7H14NO4 (M++1), m/e 176.0923, found: 
176.0920; chemical-ionization mass spectrum, m/e (relative 
intensity): 176 ([M+l]+, 27%), 160 ([M+l-0]+, 52%), 142 
([M+l-0-H20]+, 16%), 134 ([M+1-CH2C0]+, 19%), 118 ([M+l-0-CH2C0]+, 
31%), 114 ([M+l-H20-C02]+, 100%), 88 ([(СНз)2СНСН(=М0Н)+1]+, 21%), 
72 ([(СНз)2СНСН(=МН)+1]+, 79%); anal, caled, for C7HÍ3N04: С, 47.99; 
Η, 7.48; Ν, 8.00, found: С, 47.74; Η, 7.47; Ν, 7.95. 
Attempted conversion of 4b into 6b with NaBHjCN/acetic anhydride 
МаВНзСМ (0.28 g, 4.4 mmol) and acetic anhydride (3.14 g, 30.8 
mmol) were added at room temperature to a stirred solution of 4b 
(1.30 g, 4.4 rmol) in 20 ml of acetic acid. After stirring for 
three days the conversion was not complete as judged by TLC 
(CH2CI2). After adding an additional amount of МаВНзСМ (0.28 g, 4.4 
rmol) and acetic anhydride (2.24 g, 22 rtriol) to the reaction 
mixture stirring was continued at room temperature for another 4 
days. Then the reaction was interrupted although it was still not 
complete as monitored by TLC (CH2CI2). The solvent was evaporated 
in vacuo, and the resulting residue was dissolved in Et20. The 
solution was washed with 5% (w/v) aqueous МаНСОз (3x) and brine, 
dried over Na2S04 and finally concentrated to dryness in vacuo. The 
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residue was purified by column chromatography (solvent system: 
СНгСІг/п-Ьехапе, 3:1 v/v), affording the starting material 4b 
(44%), the desired product 6b (36%) and benzyl N-ethyl-N-benzyloxy-
a-amlnobutanoate 8 as an oil in 20% yield; ^-NMR : 5 7.30 and 7.25 
(2xs, 10H, 2XC6H5), 5.16 (s, 2H, (0)C0CH2), 4.72 (s, 2Н, МОСНг), 
3.50 (dd, IH. С(О)СН), 3.13-2.70 (m, 2Н, МСНг), 1.96-1.61 (m, 2Н, 
СНСН2СН3), 1.18 (t, ЗН, NCH2CH3), 0.90 (t, ЗН, СНСН2СН3); exact 
mass caled, for C20H26NO3 (M++1), m/e 328.1913, found: 328.1920; 
chemlcal-ionization mass spectrum, m/e (relative Intensity): 328 
([M+l]+, 100%), 236 (CM-C7H7]+, 8%), 192 ([M-C(0)0CH2C6H5]
+
, 29%), 
176 ([M-C02-OCH2C6H5]
+
, 6%), 133 (6%), 107 ([C;^]"·-, 8%), 91 
([C7H7]+. 54%). 
The preparation of the a-(benzyl)oximino acid derivatives 9-12 
has been described previously.2b Only the synthesis of 9f and Wf 
differed from this procedure: 
Ethyl 3-phenyl-2-oximino-propanoate 9f. 
To a solution of phenylpyruvic acid sodium salt monohydrate 
(6.12 g, 30 imol) In 50 ml of EtOH 10 ml of 7N ethanolic HCl was 
added. After stirring at room temperature for one hour, TosOH (150 
mg), hydroxylamine hydrochloride (2.09 g, 30 rrniol) and EtOH (150 
ml) were added. The resulting mixture was heated under reflux to 
remove water azeotTopically. Meanwhile an additional amount of EtOH 
(150 ml) was added dropwlse to the reaction mixture. After 2 hours 
of reflux 250 ml of distillate was collected and the reaction was 
complete as monitored by TLC (solvent system : CH2CI2). Then the 
mixture was concentrated to dryness in vacuo. The residue was 
dissolved in CH2CI2, washed with 0.05N aqueous NaOH and brine, and 
dried over N32504. Evaporation of the solvent in vacuo afforded 
216 
crude 9f, which was subjected to column chromatography (solvent 
system : МеОН/СНгСІг, 1:99 v/v). Pure 9f was thus obtained in 79% 
yield; ^-NMR : 5 10.20 (br., IH, N-OH), 7.26 (m, 5H, C6H5), 4.29 
(q, 2H, CH2CH3), 4.00 (s, 2H, C6H5CH2), 1.30 (t, 3H, CH3); 
chemical-ionization mass spectrum, m/e (relative intensity) : 208 
([M+l]+, 100%), 190 ([M-0H]+, 21%), 162 ([M-0C2H5]+, 98%), 134 
([M-C02C2H5]+, 14%), 118 ([C6H5CH2CN+1]
+
, 70%), 91 ([C7H7]+, 67%). 
Ethyl 3-phenyl-2-benzylox'imino-propanoate IQf 
The compound was prepared according to the procedure described 
above, using O-benzylhydroxylamine hydrochloride (4.79 g, 30 mmol) 
instead of hydroxylamine hydrochloride. The crude product, obtained 
after concentration of the reaction mixture in vacuo, was dissolved 
in CH2CI2. washed with 0.1N aqueous HCl and 0.1N aqueous NaOH, and 
dried over N32504. Evaporation of the solvent in vacuo afforded 
pure lOf in 86% yield; ^-NMR : S 7.30 and 7.18 (2xs, Ю Н , 2XC6H5), 
5.31 (s, 2H, C6H5CH2O), 4.26 (q, 2H, CH2CH3), 3.95 (s, 2H, 
C6 H5 CM2 C)· І · 2 8 (*> зн> с н 3 ) ; e x a c t m a s s caled, for C18H20NO3 
(M++l), m/e : 298.1443, found : 298.1435; chemical-ionization mass 
spectrum, m/e (relative Intensity) : 298 ([M+l]+, 21%), 252 
([M-0C2H5]+, 12%), 190 ([hM^O]··-, 6%), 118 ([C6H5CH2CN+1]
+
, 26%), 
107 ([C7H70]+, 7%), 91 ([С7Н7Г, 100%). 
General procedure for the reduction of u-(benzyl)oximino esters and amides 
withNaBHjCN 
With regular intervals of at least one hour NaBH3CN was added 
in portions of 0.32 g (5 mmol) to a stirred solution of the a-
oxlmino acid derivative (5 mmol) and a trace of methyl orange in 
10 ml of MeOH at room temperature. During the reaction the pH was 
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held at the red-orange transition point of the indicator by the 
dropwise addition of 7N methanolic HCl. The progress of the 
reaction was monitored by TLC, using CH2CI2 or a MeOH/CH2Cl2-mixture 
as eluant. In general the reaction mixture was stirred at room 
temperature for 2-3 days. The reaction was interrupted by 
neutralizing the reaction mixture with МаНСОз· After filtration the 
solvent was evaporated in vacuo. The residue was dissolved in a 
mixture of EtOAc (20 ml) and 0.5M aqueous КаНСОз (20 ml). Then the 
layers were separated and the water layer was washed with EtOAc 
(20 ml). The organic layers were combined, washed with brine, dried 
over Na2S04 and finally concentrated to dryness in vacuo. The yield 
of 5 and 13-16 (Table 1) was determined from the ^-NMR spectrum of 
the crude product. The product could be separated from the starting 
material by column chromatography, using CH2CI2 or a МеОН/СНгСІг-
mixture as eluant. The spectroscopic data of the pure products have 
been reported before.2Ь,с 
General procedure for the reductive alkylation in carboxyiic acids 
With regular intervals of at least one hour МаВНзСМ was added 
in portions of 0.113 g (1.8 mmol) to a solution of 4b (0.53 g, 1.8 
rnnol) and, if relevant, the appropriate aldehyde (13-21 eq.) in 10 
ml of formic or acetic acid at room temperature. The reaction 
mixture was stirred at room temperature for 1-2 days. The carboxyiic 
acid was evaporated in vacuo and the residue was dissolved in 
Et20. The solution was washed with 5% (w/v) aqueous МаНСОз (3*) a n d 
brine, dried over N32804 and finally concentrated to dryness in 
vacuo. The residue was subjected to column chromatography, using 
CH2Cl2/n-hexane (1:1, v/v) as eluant. The spectroscopic data of the 
products are as follows : 8, benzylN-ethyl-N-benzyloxy-<x-amino-
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butanoate : vide supra. 17, benzyl N-methyl-N-benzyloxy-а-атіпо-
butanoate; ^-NMR : δ 7.29 and 7.24 (2xs, 10H, ZxCßHg), 5.16 (s, 
2H, CO2CH2), 4.66 (S, 2H, NOCH2). 3.36 (dd, IH, CHCOj), 2.64 (s, 
ЗН, МСНз), 1.93-1.49 (m, 2Н, СН2СН3), 0.89 (t, ЗН, СН2СН3); exact 
mass caled, for С1дН24М0з (M++1), m/e : 314.1756, found : 314.1749; 
chem1cal-1onization mass spectrum, m/e (relative intensity) : 314 
([M+l]+, 100%), 222 ([M-C7H7]+, 2%), 206 ([M-C7H70]+, 4%). 178 
([М-С02СН2СбН5]+, 54%), 162 ([М-С02-ОСН2СбН5]+, 15%), 133 (6%), 107 
(CC7H70]+, 4%), 91 ([C7H7]+, 53%). 18. benzyl N-(n-propyl)-N-
benzyloxy-Q-aminobutanoate; ^-NMR : 5 7.29 and 7.24 (2xs, 10H, 2x 
C6H5), 5.14 (s, 2H, CO2CH2), 4.71 (S, 2H, NOCH2), 3.50 (dd, IH, 
CHCO2), 2.95-2.54 (m, 2H, CH2N), 1.98-1.43 (m, 4H, NCH2CH2CH3 and 
CHCH2CH3), 0.91 (t, 6H, 2XCH2CH3); exact mass caled, for C21H28NO3 
(M++l), m/e : 342.2069, found : 342.2067; chemical-ionization mass 
spectrum, m/e (relative Intensity) : 342 ([M+l]+, 43%), 250 
([M-C7H7]+, 9%), 234 ([M-C7H70]+, 8%), 206 ([М-СОгСНгСбНб]-1-, 21%), 
190 ([М-С02-0СН2СбН5]+, 4%), 107 ([C7H70]+, 7%), 91 ([Ч^]-·-, 100%). 
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SAMENVATTING 
Hydroxamzuren afgeleid van N-hydroxy-a-aminozuren: syntheses en 
toepassingen 
Hydroxamzuren zijn verbindingen die veelvuldig in de natuur 
aangetroffen worden; zij worden gekenmerkt door de aanwezigheid van 
een geoxideerde amide band, de zogenaamde hydroxamzuur funktie Ц , 
p.2). De eigenschappen van deze verbindingen worden in belangrijke 
mate bepaald door deze funktie. Het zijn zwakke zuren met een 
pK
a
-waarde die, afhankelijk van het substitutie patroon, varieert 
van 7 tot 11. Een andere in het oog springende eigenschap is het 
vermogen om zeer stabiele complexen te vormen met metaalionen, met 
name met ionen van overgangsmetalen (schema III, p.ll). De hoogste 
complexatie constanten worden vertoond door de intens roodgekleurde 
ferri-compiexen (schema V, p.12). Het is derhalve niet verbazing­
wekkend dat veel lagere organismen juist hydroxamzuren gebruiken 
voor het verzamelen en vasthouden van metaalionen. 
De meest voor de hand liggende manieren waarop hydroxamzuren 
gevormd kunnen worden, zijn oxidatie van een amide band en N-
acylering van een hydroxylami ne derivaat (schema XVII,p.29). 
Aangetoond is dat beide processen in de natuur plaatsvinden. 
In dit proefschrift vormen hydroxamzuren die afgeleid zijn van 
N-hydroxy-a-aminozuren, d.w.z. N-acyl-N-hydroxy-a-aminozuur deri­
vaten en N-hydroxy peptides (5, p.3), het centrale thema. De 
probleemstelling heeft betrekking op de synthese, toepassing en 
biosynthetische relevantie van deze klasse van chirale hydroxam­
zuren. 
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Hoofdstuk I is een algemene inleiding waarin onder meer de 
werkhypothese geschetst wordt die ten grondslag ligt aan een 
belangrijk deel van het onderzoek dat in dit proefschrift beschre-
ven wordt. Volgens deze werkhypothese, die voortkomt uit het in de 
jaren 1978-1982 in de werkgroep verrichte onderzoek, kan de 
verscheidenheid aan gemodificeerde aminozuren, die kenmerkend is 
voor een groot aantal schimmelmetabolieten, o.a. via N-hydroxy-a-
aminozuur derivaten ontstaan. 
De N-hydroxy-a-aminozuur derivaten nemen in de werkhypothese 
zowel in de onderlinge relaties tussen gemodificeerde aminozuren 
als in de samenhang tussen gewone en gemodificeerde aminozuren een 
centrale plaats in (schema I, p.3). Gepostuleerd werd dat deze 
schematische samenhang van zowel Synthestische als biosynthetische 
betekenis Is. 
Diverse aspecten van de chemie van hydroxamzuren worden nader 
toegelicht in hoofdstuk II. Onder andere wordt aandacht geschonken 
aan de aciditeit, de (bio-)synthese en de reactiviteit van 
hydroxamzuren, alsmede aan de complexatie met metaalionen. 
In hoofdstuk III wordt een onderzoek naar de toepasbaarheid van 
chlrale hydroxamzuren als liganden in asymmetrische, metaalgekata-
lyseerde reacties beschreven. Hydroxamzuren zijn in dit opzicht 
Interessante verbindingen gezien hun vermogen om met verschillende 
metaalionen stabiele complexen te vormen; derhalve zijn ze poten-
tieel bruikbaar zijn in allerlei metaal-gekatalyseerde reacties. 
In het kader van dit onderzoek werden een aantal rigide 
hydroxamzuren gesynthetiseerd uitgaande van goedkope uitgangsstoffen, 
nl. (S)-proline en enige racemische a-halocarbonzuren (schema 
III, p.41). Als intermediairen werden de N-(2-bromo-acyl)-(S)-
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proline derivaten 10-13 gesynthetiseerd in opbrengsten variërend 
van 54% tot 86%. In de meeste gevallen (1_1, 12 en 13) werd een 
mengsel van diastereomeren verkregen. Bovendien bleek dat m.b.v. 
iH-NMR spectroscopie in oplossing rotameren van de verbindingen 
12b, 13a en 13b gedetecteerd kunnen worden (fig.l, p.42). 
Verbinding 13, die een aantal malen in 88% opbrengst gesyntheti-
seerd werd uit het van 9 afgeleide zuurbromide (schema IV, p.43), 
vertoonde een bijzondere eigenschap. Terwijl chromatografische 
scheiding van de diastereomeren Д а en 13b niet mogelijk was, kon 
het diastereomerenmengsel quantitatief omgezet worden in 13a d.m.v. 
een kristallisatie-gei'nduceerde asymmetrische transformatie. 
Dissociatie van de C-Br band ligt waarschijnlijk ten grondslag aan 
dit proces. 
Na behandeling van de verbindingen 10, 12a en 13a met hydroxyl-
amine werden de gewenste hydroxamzuren 14, 16a en 17a in resp. 25%, 
61% en 75% opbrengst gefsoleerd. Op dezelfde wijze kon uit het 
diastereomerenmengsel Ua.b uiteindelijk slechts één zuiver 
diastereomeer (15b) verkregen worden in 46% opbrengst. Ringsluiting 
van 12b leverde In 20% opbrengst een optisch actief mengsel van 
beide enantiomeren van 16a op (schema V, p.47). Verbinding Vb epi-
meriseerde onder de reactieomstandigheden tot 17a (eq.4, p.48) en 
kon in slechts 14% opbrengst uit het chloor-analogon van 13b (21b, 
p.46) verkregen worden. 
Het chiraal inducerende vermogen van de hydroxamzuren werd 
getoetst in een bekende metaalgekatalyseerde reaktie, nl. de epoxl-
datie van allylalcoholen (Sharpless-epoxidatie). De beste resulta-
ten werden behaald met een katalytische hoeveelheid van een 
vanadiumcomplex van 17a; afhankelijk van de omstandigheden 
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(temperatuur, aantal equivalenten hydroxamzuur) en het gebruikte 
substraat werden optisch actieve epoxyalcoholen verkregen met een 
enantiomere overmaat van 38-66% (eq.7 en tabel 1, p.51; tabel 2, 
p.53). Toepassing van andere overgangsmetalen (titanium, molybdeen) 
leverde slechtere resultaten op (eq.8 en tabel 3, p.53,54). 
Vervolgens werd de invloed van twee hydroxamzuren op het 
stereochemisch verloop van een andere metaal-gekatalyseerde reak-
tie, nl. de oxidatie van een sulfide, bestudeerd. Gebruik makend 
van de katalysator, die in de Sharpless-epoxidatie de beste 
resultaten had opgeleverd, d.w.z. 1% V 5 + op molbasis en 3 of 5% 
17a, werd In de oxidatie van thioanisol het betreffende sulfoxide 
verkregen met een optische zuiverheid van 6.5 tot 11% (eq.9 en 
tabel 4, p.54,55). Toepassing van 17b in deze reaktie leidde tot 
een sulfoxide met een optische zuiverheid van slechts 3%. 
De resultaten wijzen erop dat, bij aanwezigheid van een substi-
tuent op de 6-positie (zie U p.39) in een trans-oriëntatie t.o.v. 
de proline ring, beide chirale centra een coöperatief effect hebben 
op de chirale inductie. 
Hoofdstuk IV is gewijd aan de synthese van een aantal N-
hydroxy peptides (35-37, p.105) in het kader van een onderzoek naar 
de biosynthese van penicilline. 
In de biosynthese van penicilline (schema I, p.94) funktioneert 
het zogenaamde Arnstein tripeptide (14, p.94) als precursor van iso-
penicilline N (15, p.94). Ondanks naarstig onderzoek was, toen wij 
met dit onderzoek begonnen, nog niet vastgesteld via welk mecha-
nisme 14 door het enzym isopenicilline N synthetase in het anti-
bioticum 15 omgezet wordt. Het bicyclische skelet van penicilline 
is opgebouwd uit twee ß-gefunktionaliseerde α-aminozuren (cysteine 
225 
en valine). Op basis van onze werkhypothese (schema I, p.3) hebben 
wij gepostuleerd dat de N-hydroxy peptides 35-37 (p.105) als inter-
medialren optreden In de omzetting van 14 in lj> (schema IX, p.107; 
schema X, p.108). Het was de bedoeling dit postulaat te toetsen 
door incubatie van elk der N-hydroxy tripeptides 35-37 met het iso-
penicilline N synthetase. 
Met dit oogmerk werd aanvankelijk gelijktijdig aan de synthese 
van de drie verschillende N-hydroxy tripeptides 35-37 gewerkt. De 
synthese van 35 en 36 werd echter niet voltooid omdat gaandeweg 
publicaties verschenen, waaruit bleek dat beide verbindingen geen 
rol spelen in de biosynthese van penicilline. Overigens dient ver-
meld te worden dat een cruciale stap in de bereiding van 35 (schema 
XI, p.112), namelijk de koppeling van een cysteine derivaat (44) 
met racemisch N-benzyloxy valine benzyl ester 45, gerealiseerd kon 
worden m.b.v. fosgeen als activerend reagens. Het beschermde N-
hydroxy dipeptide 46 werd als een mengsel van diastereomeren in 25% 
opbrengst verkregen. 
De synthese van 37, evenals 36 (schema XX, p.127) een N-hydroxy 
cysteine derivaat, werd wel afgerond. Voor N-hydroxy cysteine deri-
vaten zijn in de literatuur geen precedenten voorhanden. Ze zijn 
niet toegankelijk vla directe oxidatie van een cysteine derivaat 
vanwege de aanwezigheid van het gemakkelijk oxideerbare zwavel-
atoom. De gekozen benadering (schema XXV, p.135) behelsde de 
bereiding van drie N-hydroxy dipeptide derivaten (111-113, p.135) 
uit een ß-bromo-a-ox1m1no derivaat door nucleoflele substitutie met 
drie verschillende mercaptanen, gevolgd door selectieve reduktie 
van de oxim C=N band. Met behulp van deze procedure werden de 
beschermde N-hydroxy dipeptides 111-113 (p.135) In 13-38% opbrengst 
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verkregen uit 105. De volgende sleutelreactie was de koppeling van 
deze verbindingen met een beschermd a-aminoadipinezuur derivaat. In 
verband met de noodzakelijk sterke activering van de γ-carbonzuur 
funktie (eq.9, p.lll) was een wijziging nodig van de aanvankelijk 
gekozen beschermgroepen strategie ten aanzien van a-aminoadipine­
zuur (schema XXVII, p.140). Uit een model experiment was namelijk 
gebleken dat een intramoleculaire reaktie van het urethaan N-atoom 
met het zuurchloride kan optreden (eq.24, p.141). De a-aminogroep 
van 126 (schema XXVIII, p.143) moest daarom zodanig beschermd wor­
den dat het stikstofatoom niet meer nucleofiel was; dit werd gecom­
bineerd met de bescherming van de a-carbonzuur funktie. Koppeling 
van 112 en 113 met het geactiveerde a-aminoadipinezuur derivaat 136 
(eq.27, p.144) leverde de volledig beschermde N-hydroxy tripeptides 
138 en 139 op in resp. 81% en 58% opbrengst. 
Voor de ontschermingsreakties waren twee zuivere diastereomeren 
van 138 en één zuiver diastereomeer van 139 beschikbaar, allen met 
een onbekende configuratie van het chirale cysteine koolstofatoom. 
Afhankelijk van de aard van de S-beschermgroep werden verschillende 
ontschermingsmethoden bestudeerd (schema XXV, p.135 ; schema XXIX, 
p.147). Alhoewel in tegenstelling tot de overige stappen in de 
synthese deze reakties slecht verliepen, lukte het uiteindelijk 
toch om in lage opbrengst een zuiver N-hydroxy tripeptide te 
synthetiseren uit 139 m.b.v В(02ССРз)з. 
Incubatie van het verkregen N-hydroxy tripeptide met isopeni­
cilline N synthetase leverde een biologisch actief produkt op 
waarvan de structuur vooralsnog onbekend is; waarschijnlijk hebben 
we te maken met N-hydroxy isopenicilline N (145, p. 151). Uit dit 
resultaat moet voorlopig geconcludeerd worden dat het postulaat dat 
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ten grondslag lag aan dit onderzoek In elk geval niet opgaat voor 
de blosynthese van penicilline. 
Tenslotte worden 1n hoofdstuk V de eerste voorbeelden gegeven 
van de bereiding van primaire en secundaire N-hydroxy-a-amlnozuur 
derivaten uit de overeenkomstige a-oxlmlnozuur derivaten m.b.v. 
NaBtfjCN. De reduktle van a-ox1m1nozuur derivaten, een sleutel stap 
In de bereiding van diverse 1n dit proefschrift beschreven 
hydroxamzuren, kan met МаВНзСМ onder milde omstandigheden uitge­
voerd worden (schema II, p.203). In het algemeen worden met deze 
methode echter lagere opbrengsten gerealiseerd dan bij toepassing 
van de tot dusverre gebruikte reductiemiddelen, namelijk pyrldlne-
of trlmethylamlne-boraan In sterk zuur milieu (tabel 1, p.204). 
Voor een analoge omzetting In de bereiding van N-hydroxy peptides 
is МаВНзСМ echter niet geschikt. 
In methanol kunnen N-hydroxy-a-aminozuur derivaten met behulp 
van een aldehyde en NaBtfjCN reductlef gealkyleerd worden tot de 
overeenkomstige secundaire N-hydroxy-a-amlnozuur derivaten (eq.2, 
p.207). Als voor deze reactie een carbonzuur als oplosmiddel 
gebruikt wordt, verloopt de alkylering ten gevolge van oplosmid­
delparticipatie niet meer eenduidig (tabel 2, p.206). 
Tenslotte werd vastgesteld dat in aanwezigheid van een aldehyde 
een één-pots omzetting van een a-oximinozuur derivaat in een secun-
dair N-hydroxy-a-aminozuur derivaat mogelijk is met behulp van 
МаВНзСМ (eq. 2, p.207). 
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ABBREVIATIONS 
Ac acetyl 
7-ACA 7-aminocephalosporan1c acid 
AcOH acetic a d d 
(LLD)-ACV S-(L-a-aminoadipyl)-L-cyste1nyl-D-va11ne 
6-APA 6-am1nopen1c1l1an1c acid 
BOC.Boc t-butyloxycarbonyl 
(п-Ви)зМ tr1-n-butylam1ne 
n-BuOH n-butanol 
t-BuOK potassium t-butoxlde 
Bzl benzyl 
BzlCI benzyl chloride 
BzlOH benzyl alcohol 
DBU l,8-d1azab1cyclo[5.4.0]undec-7-ene 
DCC dicydohexylcarbodHmlde 
DCHA dicydohexylamlne 
DIBAL-H d11sobutylalum1num hydride 
DMAP 4-d1methylam1nopyr1d1ne 
DME 1,2-dimethoxyethane 
DMF N.N-dimethylformamide 
DTT dlthlothreltol 
ENZ enzyme 
Et ethyl 
Et3N triethylamine 
EtzO diethyl ether 
EtOAc ethyl acetate 
EtOH ethanol 
IPN isopenlclllin N 
IPNS isopenlclllin N synthetase 
MBOC 4-methoxybenzyloxycarbonyl 
MCPBA 3-chloroperoxybenzolc acid 
Me methyl 
MeOH methanol 
NMP N-methylpiper1d1ne 
Nps 2-nitrophenylsulfenyl 
ONP 4-nltrophenyloxy 
Pd(C) palladium on activated carbon (palladium content 10%) 
Ph phenyl 
PMB 4-methoxybenzyl 
PNB 4-n1trobenzyl 
TBHP t-butyl hydroperoxide 
TDM 4,4l-tetramethyld1am1nod1pheny1methane 
TEA triethylamine 
THF tetrahydrofuran 
TMA trimethylamlne 
TosCl 4-toluenesulfonyl chloride 
TosOH(.H20) 4-toluenesulfonlc acid (monohydrate) 
Ζ benzyloxycarbonyl 
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STELLINGEN 
Het feit dat alleen het R-enantiomeer verantwoordelijk is voor 
de langdurige opname van ibuprofeen in vetweefsel en derhalve 
op langere termijn mogelijk bijwerkingen kan veroorzaken, toont 
opnieuw aan dat bij de toepassing van een racemisch geneesmid­
del het onwerkzame enantiomeer - in dit geval R-ibuprofeen -
niet zonder meer als onschadelijke ballast bestempeld mag 
worden. 
Williams, K; Day, R.; Knihinicki, R.; Duffield, Α., Biochem. 
Pharmacol. (1986), 35, 3403. 
De vorming van een spoortje 4-nitrobenzyl bromide bij de behan­
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vermoeden rijzen, dat het door Citterio et.al. gebruikte 
glaswerk niet volledig schoon was. 
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Kolasa en Miller hebben ten onrechte verzuimd de optische 
zuiverheid van de gesynthetiseerde N-hydroxyaminozuur derivaten 
te bepalen, omdat in tegenstelling tot hun aanname de toege­
paste omzetting van een α-aminozuur in een a-acetoxyzuur 
niet altijd stereospecifiek verloopt. 
Kolasa, T.; Miller, M.J., J.Org.Chem. (1987), 52, 4978. 
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Aangezien in het door Suzukamo en Fukao gepatenteerde proces 
behalve racemisatie ook epimerisatie optreedt, is het correcter 
dit proces als een isomerisatie te omschrijven. 
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De publicatie van Brownbrlgde en Jowett wekt ten onrechte de 
Indruk dat de toepassing van N-broomsucc1n1m1de in de bereiding 
van sulflnaat esters uit disulfides nieuw Is. 
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De door Cinquini et.al. beschreven bereiding van 2-methyl-
l,4-butaand1ol uit c1s-3,7-d1methyl-l,5-cyclooctaandion is geen 
ideaal voorbeeld van "la coupe du roi", omdat ten gevolge van 
de lage regloselectlvitelt van de tweede Baeyer-Villiger 
omlegging de uitgangsstof gedeeltelijk in een bljprodukt omge-
zet wordt. 
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